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For a historian and a naturalist 
from a scientist 
O! mickle is the poweiful grace that lies 
In herbs, plants, stones, and their true qualities: 
For nought so vile that on earth doth live 
But to the earth some special good doth give, 
Within the infant rind of this weak flower 
Poison hath residence and medicine power: 
Romeo and Juliet, II, iii 
ABSTRACT 
In order to compare the pyrrolizidine alkaloid content of two closely related species, 
Senecio chrysocoma and S. paniculatus, nine populations of plants, ,I.istributed between the 
two species, were examined. Three novel pyrrolizidine alkaloids, 76-angelyl-l-methylene-
SO!-pyrrolizidine, 70!-angelyl-l-methylene-SO!-pyrrolizidine and 70!-angelyl-l-methylene-
SO!-pyrrolizidine-4-oxide, as well as eight known pyrrolizidine alkaloids, 7-
angelylhastanecine, 9-angelylhastanecine, 7-angelylplatynecine, 9-angelylplatynecine, 9-
angelylplatynecine-4-oxide, sarracine, neosarracine and retrorsine, were isolated and 
identified by NMR and GC-MS techniques. Traces of five tiglyl isomers, 9-
tiglylplatynecine, 9-tigl ylplatynecine-4-oxide, 76-tiglyl-l-methy lene-SO!-pyrrolizidine, 
sarranicine and neosarranicine, were also isolated and tentatively identified; however, these 
compounds could have been artefacts of the extraction and analytical procedures. 
While both species of plant investigated, S. chrysocoma and S. paniculatus, were found 
to be morphologically different, their pyrrolizidine alkaloid content was, in fact, very 
similar. The presence of retrorsine in S. paniculatus plant extracts, but not in those from 
S. chrysocoma plants, was the only major chemical difference observed. It is perhaps 
significant that retrorsine was the only macrocyclic pyrrolizidine to be identified. 
A comprehensive, computerised database of physical data for pyrrolizidine alkaloids has 
been compiled, which has facilitated the identification of new pyrrolizidines and the 
examination of trends in proton and carbon-13 NMR data for pyrrolizidine alkaloids. 
A stereospecific synthesis of 76-angelyl-l-methylene-SO!-pyrrolizidine was undertaken to 
confirm the absolute stereochemistry of the product isolated from S. chrysocoma and S. 
paniculatus. An inseparable 5:2 mixture of 71l-angelyl-l-methylene-SO!-pyrrolizidine and 
71l-angelyl-l ,2-didehydro-l -methyl-SO!-pyrrolizidine, together with a small amount of tiglyl 
isomer, was finally synthesised. The application of various chiral differentiating 
chromatographic and spectroscopic techniques confirmed that both the natural and synthetic 
products had the same stereochemistry, permitting the natural alkaloid to be identified as 
76-angel y l-l-methylene-SO!-pyrrol izidine. 
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INTRODUCTION SECTION 1. 
1. INTRODUCTION 
Senecio species were recognised as toxic to livestock at the turn of the century.'·3 The 
active metabolites, pyrrolizidine alkaloids, were only identified later. Since these earliest 
studies their toxicity has been of interest and pyrrolizidine alkaloids have been linked to 
a number of livestock diseases which are characterised by chronic hepatic lesions . 
Diseases, such as dunsiekte,. Molteno"·> Pictou,' stomach staggers' and Winton"·> are all 
forms of one disease, which is caused by a number of pyrrolizidine alkaloids. '.0 The 
diseases have been reported in many countries and pyrrolizidine alkaloids are known to 
affect horses ,7 sheep/·8 goats ,8 COWS,"·9.'O pigs8 and poultry." Sheep , however , tend to be 
less susceptible to pyrrolizidine poisoning than cattle. 10.'2 This is said to be due to 
different rumen microflora which, in sheep, can detoxify the pyrrolizidine alkaloids 13 and, 
possibly, to the presence of different hepatic pyrrolizidine alkaloid metabolising enzymes 
and to different absorption capabilities of the rumen wall. 13 
Pyrrolizidine alkaloid containing plants still account for large stock losses in many parts 
of the world, and it is estimated that stock loss, in the north western United States of 
America, as a result of such poisoning, costs millions of dollars annually. '4 The estimate 
for 1991 alone was $20 million! In Rio Grande do Sui Senecio species are the most 
important cause of premature death in adult cattle" and, in the Southern Australian autumn 
of 1993, ca. 150 thousand chickens and ca. 3000 pigs died in three months as a result of 
Heliotropium europaeum contaminated grain feed ." H. europaeum has been shown to 
contain pyrrolizidine alkaloids .,o.2o So great is the stock loss from pyrrolizidine alkaloids 
that, besides research into herbicides, biological control programmes are underway to 
control the growth of plants containing these alkaloids.2' 
Hepatotoxic, teratogenic, mutagenic and carcinogenic effects of pyrrolizidine alkaloids 
have also been noted in humans. Large-scale human poisoning was first recognized in 
South Afr ica in the I 920'S22 and , subsequently, in Afghanistan,23 India," and the former 
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USSR.2 Poisoning has usually resulted from the contamination of wheat, and thus bread, 
with pyrrolizidine alkaloid containing plant species.2.5 However, there are now concerns 
about the presence of pyrrolizidine alkaloids in other food-stuffs and, in particular, in 
certain herbal remedies, bush teas, milk and honey.2 People have died in Western Europe 
and the United States of America as a result of the consumption of medicinal herbs like 
Senecio longilobus.8 Some countries have restricted the sale of Russian comfrey 
(Symphytum X uplandicum), which is used dried as a tea or fresh in salads, since the leaves 
contain 0.01-0.15% dry weight of hepatotoxic pyrrolizidine alkaloids (mainly echimidine 
1 and lycopsamine-7-acetate 2).26 Most of the Australian territories have introduced some 
form of noxious weed legislation to control the distribution of pyrrolizidine alkaloid 
containing plants.27 
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Although pyrrolizidine alkaloids are frequently toxic and carcinogenic, some have been 
shown to have antitumour properties. A number of pyrrolizidine alkaloids have been 
tested,28 and are still being tested,29 against a range of tumours. The only real success has 
been achieved with indicine-4-oxide 3 (see Section 1.4.2, p. 33).'0 
The presence of pyrrolizidine alkaloids in a wide diversity of plant families (see Section 
1.1, p. 3) and their toxic effects on both man and livestock make them of considerable 
economic importance. Their range of biological activities encompassing their acute 
toxicity, on one hand, and their anti tumour activity, on the other, have also stimulated 
research into their chemistry. 
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1.1 OCCURRENCE OF PYRROLIZIDINE ALKALOIDS 
A considerable number of plant genera have been found to contain pyrrolizidine alkaloids 
(Table 1.1) . The majority of these genera are in three families: Boraginaceae, 
Compositae, and Leguminosae, with Heliotropium, Senecio, and Cratalaria respectively 
being representative genera. In fact, pyrrolizidine alkaloids are most abundant within the 
huge Senecio genus, with over 150 species having been investigated . 31 
Pyrrolizidine alkaloids have also been found in insects which feed on pyrrolizidine 
containing plant species. The pheromones, danaidone 4, danaidal 5, and hydroxydanaidal 
6, of some male Lepidopterans are biosynthesised from ingested pyrrolizidine alkaloids .32 
M CRO cO OR CRO CO 
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Table 1.1: Plant genera in which pyrrolizidine alkaloids have been found. 3l•33.,' 
Family Genus 
Apocynaceae Alafia. Anodendron. Parsonsia. Strophanthus. Tabemaemontana. Urechlites 
Boraginaceae/ Alkanna. Amsinlda. Anchusa. Arnebia. Asperugo. Borago. Caccinia. 
Ehretiaceae Cerin/he. Cordia.Cryptanlha. Cynoglossum. Echium. Ehrelia. Hackelia. 
Heliolropium. Lappula. LindeloJia. Lithaspermum. MacrolOmia. Merlensia 
Messerschmidia. Mollildopsis. Myosotis. Neatostema. Omphalodes. 
Onosma. Paracaryum. Paracynoglossum. Rindera. Solenanlhus. 
Symphylum. Tourneforlia . Trachelanthus. Trichadesma. Turneforeia. 
Ulegbelda 
Celastraceae Bhesa 
Compositae/ Adenostyles. Ageralum. Arnica. Brachyglollis. Cacalia. Chersodoma. 
Asteraceae Chromolaena. Cirsium. Conociinium. Crassocephalum. Doronicum. 
Echinaceae. Emilia. Erechlites. Eupalorium. Farfugium. Gynura. 
Homogyne. Jacmaia. Kleinia. Limris. Ligularia. Nardosmia. NOlonia. 
Packera. Pelasiles. Schismus. Senecio. Syneilesis. Tussi/ago. Werneria 
Convolvulaceae Ipomoea 
Elaeocarpaceae Aristotelia 
Euphorbiaceae Phyllanlhus. Securinega 
Grarnineae Festuca. Lolium. Thelepogon 
Leguminosae/ Adenocarpus. Alexa. Buchenroedera. Caslanospermum. Crotalaria. Cylisus. 
Fabaceae Laburnum. LolOnonis. Onosma 
Linaceae Hugonia 
Orchidaceae Chysis. Dorilus. Hammarbya. Kingiella. Liparis. Malaxis. Phalaenopsis. 
Vanda. Vandopsis 
Papaveraceae Glaucium 
Ranunculaceae Callha. Trollius 
Rhizophoraceae Cassiopourea 
Santalaceae Thesium 
Sapotaceae Mimusops. Planchonella 
Scrophulariaceae Caslillega . Melampyrum. Pedicularis 
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Butterfl ies of the Danaus genus have been shown to sequester and store unmodified 
pyrrolizidine alkaloids from their food supply.32.56.>? It is presumed that they use the 
pyrrolizidines for self-defence, as they have been shown to be distasteful to insect and 
arachnid predators. 32.56.58 The larval stage of the moth, Utetheisa ornatrix, obtains 
pyrrolizidine alkaloids, notably monocrotaline 7, from the Crotalaria species on which it 
feeds ;32.59 the adult then converts monocrotaline 7 to hydroxydanaidal 6. Another moth, 
Gnophaela vermiculata, modifies pyrrolizidines ingested from Hackelia californica. fYJ 
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Chrysomelid beetles, which feed on pyrrolizidine alkaloid containing plants , also sequester 
the alkaloids and store them as N-oxides in their defence secretions. 61 .63 They cannot 
oxidise pyrrolizidines, but must ingest them in the oxidised form if they are to be stored. 62 
Those Chrysomelid beetles which do not feed on pyrrolizidine alkaloid containing plants 
reject such plants as a food supply. 63 Ants" and frogs65 synthesise their own pyrrolizidine 
alkaloid derivatives as a defence mechanism. In ants the alkaloids are found in the venom, 
while in frogs they are found in the skin. 
1.2 EXTRACTION AND PURIFICATION 
Before the pyrrolizidine alkaloid components of a plant can be identified they have to be 
extracted and then purified to remove other chemical components. Then, as a plant 
generally contains more than one pyrrolizidine alkaloid, they have to be separated. Often 
the purification and separation can take place together. Although it is poss ible to identify 
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pyrrolizidines in a mixture using, for example, gas chromatography-mass spectrometry, it 
is necessary to have an absolutely pure pyrrolizidine alkaloid for biological testing. Very 
few pyrrolizidines are available commercially so they have t,.; be isolated from natural 
sources or synthesised as required. 
1.2.1 STABILITY OF PYRROLIZIDINE ALKALOIDS 
If dried plant material is to be extracted, the stability of the pyrrolizidine components must 
be considered. During storage, the ratio of the pyrrolizidine alkaloids to their N-oxide 
derivatives can change.66 Isomerisation can also take place, particularly between (E)- and 
(Z)-double bonds. Ultraviolet radiation has been shown to convert usaramine 8 to 
retrorsine 9.67 The only difference between the two being the stereochemistry of the C(15)-
C(20) double bond. This being analogous to angelic acid esters, which over time have 
been shown to convert to tiglic acid esters;6' a (Z)-double bond changing to an (E)-double 
bond. Plants must also be dried quickly to reduce the effects of enzyme action, without 
excessive heat or exposure to direct sunlight.69 The alkaloids are susceptible to hydrolysis 
at high pH (> 9) and, therefore, basic solutions must be kept cool and must not be stored.69 
Moreover, pyrrolizidine alkaloids should not be stored in halogenated solvents due to the 
possibility of forming quaternary salts especially if exposed to sunlight.69 
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1.2.2 EXTRACTION OF PYRROLIZIDINE ALKALOIDS 
A general approach is given by Mattocks .70 Most often dried, shredded plant material is 
extracted using either hot or cold solvents .35.39.7 •. 78 The initial extraction involves two 
steps: one to remove fats from the plant, typically with hexane or petroleum ether,77.78 and 
a second to extract the pyrrolizidine alkaloids with an alcohol. 73.77.79.80 The pyrrolizidine 
alkaloids are then separated from other alcohol soluble components by partition between 
an aqueous and an organic phase.37•79.8• As pyrrolizidine alkaloids are often present in 
plants as N-oxides, which are not particularly soluble in organic solvents, they are 
reduced , while in acidic solution, with zinc dust" -" and then, finally , the acidic solution 
is basified39.73•80." and the pyrrolizidine alkaloids are extracted into an organic solvent such 
as chloroform or ethyl acetate.37.".86 This is the most common approach to the extraction 
of pyrrolizidine alkaloids and was the one used in this investigation (Section 2.3, p. 51). 
Other authors have used ion exchange resins to purify the alcoholic extract rather than 
using solvent partition. 87 The extraction system can be set up to be continuous with 
alcohol passing through the plant material and then through a cation exchange resin before 
returning to the plant material to repeat the cycle. 88•89 Huizing and Malingre90•9• used a 
column containing a redox polymer, "Serdoxit" , in conjunction with the ion exchange 
isolation. The redox column was to reduce any N-oxides present. One of the 
disadvantages of using a resin is that regeneration is difficult. Dowex-50, a commonly 
used resin , becomes coated with waxes and tar,,2 The regeneration is time-consuming and 
requires large volumes of hydrochloric acid . In addition, the beads tend to swell and 
crack. 
A microextraction method has been developed to extract the pyrrolizidine alkaloids from 
herbarium specimens.93 The finely shredded plant material is extracted with methanol 
using a sonifier for 10 minutes to solubilize the pyrrolizidines; the solution is then 
centrifuged and the supernatant collected. The solvent is removed with an air stream and 
then solutions of exact concentration are made up for comparison, with standards, using 
thin layer chromatography. 
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A methanol soxhlet extraction of plant material IS time-consuming and requires large 
amounts of solvent and plant material. Off-line supercritical fluid extraction is often very 
rapid with high recovery from very small amounts of material. 94 An attempt to extract 
pyrrolizidine alkaloids with various densities of supercritical carbon diox ide was 
unsuccessful, probably due to an inappropriate polarity and solvent strength of the carbon 
dioxide. The polarity can be increased by adding methanol as a modifier. The most 
efficient extraction was achieved with a pressure of 15 MPa, a temperature of 55 °C, a 
carbon dioxide density of 0.65 and using 800 ~L of methanol. 94 The success of the 
separation was measured using capillary gas chromatography. 
1.2.3 SEPARATION AND PURIFICATION OF PYRROLIZIDINE ALKALOIDS 
The mixture of pyrrolizidine alkaloids extracted can be separated into its individual 
components by a number of methods. Isomers are frequently extremely difficult to 
separate, although gas chromatography and high performance liquid chromatography are 
occasionally proving to be more successful. 
1.2.3.1 RECRYSTALLISATION 
Crystalline pyrrolizidines can be purified by recrystallisation. Methanol,.5.96 ethanol, 75.97.100 
ethyl acetate 101·106 acetone 78.102.1O7·113 water 114.1lS petroleum etherll2·116·118 and ether lO6 have , , , 
all been used for recrystallisation, either pure, or as mixtures .7S·78.102.114.119.122 Some 
pyrrolizidines, for example senecionine 10 and seneciphyll ine 11, co-crystallise and hence 
can not be separated by recrystallisation.123.125 
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If the pyrrolizidine alkaloid is not crystalline a crystalline derivative, such as a 
perchlorate,"8 picratel00.106.126-129 or picrolonate,l29 can be synthesised which can then be 
purified by recrystallisation. The wide variety of chromatographic techniques now 
available has reduced the need for recrystallisation. 
1.2.3.2 TIllN LAYER CHROMATOGRAPHY 
The progress of the separation and purification can be followed usmg thin layer 
chromatography (TLC). A number of different solvent systems have been used for 
developing the plates, the choice being dependent on what stationary phase is used 
(commonly silica gel46-48,101,130-132 and, more rarely, aluminium oxide46,47,132). The Rf values 
for individual pyrrolizidines vary depending on the solvent, temperature, degree of 
chamber saturation and amount of compound applied. A known alkaloid can be applied 
for comparison. Closely related isomers, like symphytine 12 and symlandine 13, and 
intermedine 14 and Iycopsamine 15, are difficult if not impossible to separate by TLC26,133 
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The pyrrolizidine alkaloids can be visualised on the plates using ultraviolet light or iodine 
vapour , but neither of these methods is specific for the alkaloids. For unsaturated 
pyrrolizidine alkaloids and their N-oxides, tests based on Erhlich's reagent are the most 
sensitive. The plates are first sprayed with a reagent, e.g. o-chloranil (tetrachloro-o-
benzoquinone), to convert the pyrrolizidines to pyrroles, I34,135 before being sprayed with 
Erhlich's reagent. 136 Unfortunately, Erhlich's reagent is very sensitive to water so is not 
easily stored for routine analyses. A modified iodobismuth reagent, Dragendorff's 
reagent, is very useful for detecting both saturated and unsaturated pyrrolizidines; 
however, it is not specific for pyrrolizidine alkaloids. m.139 
As TLC is used to follow the progress of the separation so preparative layer 
chromatography (PLC) is used to purify small amounts of crude pyrrol izidine alkaloid 
material for identification. Plates are normally coated with silica gel:6,47,76,132,I40.144 but 
alumina46,47 has also been used. The solvents used are similar to those used for developing 
the analytical TLC plates. 
1.2.3.3 COLUMN CHROMATOGRAPHY 
Column chromatography has been a standard, preparative method of separating 
pyrrolizidine alkaloids. The solid stationary phases used have included silica gel:5,140,145.152 
Sephadex LH-20,153 and aluminium oxide:7,'41,'54 but silica gel is by far the most popular. 
Eluting solvents tend to be similar to those used for TLC, but often a gradient'55 is used, 
slowly increasing the polarity of the eluting solvent. 60,145,154,156·159 The disadvantage of 
column chromatography is the tendency of pyrrolizidine alkaloids to bind irreversibly to 
the solid stationary phase.67 Column chromatography does not always give complete 
separation and is often followed by a series of preparative TLC separations. It is, 
however , relatively inexpensive and does not require complex apparatus , Flash column 
chromatography was used as the initial separation technique in this study, 
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1.2.3.4 GAS LIQUID CHROMATOGRAPHY 
The first gas liquid chromatographic (GLC) characterisation of pyrrolizidine alkaloids was 
performed by Chalmers et at. ·r<> in 1965 and it is now a widely used technique. 161 
Capillary columns have given better separation, but as a result GLC provides analytical 
rather than preparative separations. Coupled to mass spectrometry (Section 1.3.4, p. 18), 
GC-MS is a formidable identification technique. More recently GLC has been coupled to 
Fourier transform infra-red spectroscopy as well. 162 GLC is capable of resolving (E)- and 
(Z)-isomers, like senecionine 10 and integerrimine 16, platyphylline 17 and 
neoplatyphylline 18, and triagularicine 19 and neotriangularicine 20,68 but is less successful 
in separating diastereoisomers, such as lycopsamine 15 and intermedine 14. The use of 
chiral stationary phases may improve this situation, but these systems do not yet appear 
to have been applied to pyrrolizidine alkaloids. 
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1.2.3.5 IDGH PERFORMANCE LIQUID CHROMATOGRAPHY 
SECTION 1.2.3.5 
High performance liquid chromatography (HPLC) has been shown to be an excellent 
method for resolving closely related pyrrolizidine alkaloids. The first successful HPLC 
separation, in which the pyrrolizidine alkaloids of Senecio vulgaris were separated, was 
reported by Qualls and Segall in 1978. 163 Since then the isolation of individual 
pyrrolizidine alkaloids has been greatly improved by the use of reverse phase HPLC. Two 
isomeric pyrrolizidines, ipanguline A 21 and isoipanguline A 22, were separated by 
reverse phase HPLC," and the technique has also been used to analyse the pyrrolizidine 
alkaloid content in rumens. 14 
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Reverse phase columns requIre the use of methanol-based solvent systems, a more 
economical solvent than the tetrahydrofuran (THF) used in normal phase columns and one 
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that allows for better ultraviolet detection. Pyrrolizidine alkaloids are best detected below 
230 nm, and while THF shows strong absorption below this value, methanol does not. 
Alkaline conditions dissolve silica gel, so the slightly acidic conditions required for reverse 
phase HPLC increase the life of the column.75 Preparative ion-pair adsorption HPLC has 
also produced good results as shown by the resolution of the pyrrolizidine alkaloids of 
comfrey. 164.16' 
HPLC has been able to separate senecionine 10 from seneciphylline 11166. 167 and retrorsine 
9 from riddelline 23 .75 More surprisingly, a resolution of C(15)-C(20) double bond 
isomers has been reported. 168 HPLC, unlike GLC, operates favourably at room 
temperature, thus preventing the formation of thermal degradation products. 
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1.2.3.6 DROPLET COUNTER CURRENT CHROMATOGRAPHY 
Pyrrolizidine alkaloids tend to adsorb irreversibly to solid phases such as silica gel , 
alumina, and reverse phase HPLC stationary phases resulting in large losses of 
material. 67.169 Droplet counter current chromatography (DCCC) is a liquid-liquid 
extraction technique and involves the partition of the alkaloids between a steady stream of 
droplets and a surrounding stationary phase. The droplets can be ascending or descending. 
There is no loss of material due to adsorption. The method has been used for the efficient 
separation and purification of pyrrolizidine alkaloids .35 ,67,72,169,170 The solvents used for 
polar pyrrolizidines include varying ratios of chloroform, methanol, and water,'S,67 in 
descending mode, while for moderately polar pyrrolizidines chloroform-toluene-methanol-
water (5:5 :7:2),44,67,72.170 has been used in ascending mode. 
1.3 IDENTIFICATION 
1.3.1 STRUCTURE OF PYRROLIZIDINE ALKALOIDS 
Most pyrrolizidine alkaloids consist of two parts: the necine base, a bicyclic ring system 
with a bridgehead nitrogen, and the necic acid(s) (Figure 1.1). The traditional, non-
IUPAC, numbering system of the necine base is shown in Figure 1.1. 
The ring is not planar but is actually "V"-shaped like a partly open book. Whether the 
"V" opens towards or away from the viewer depends on the stereochemistry at C-8. The 
base may be saturated or unsaturated; if unsaturated, the double bond is usually between 
carbons I and 2 . Pyrrole types, with double bonds between carbons 1 and 8 and between 
carbons 2 and 3, are more rare. The base ring system may be oxygenated at C-9 and/or 
C-7 and , sometimes at carbons 1, 2 or 6. The otonecine base 24 has lost the C(S)-N bond 
and has, instead, a methyl group on the nitrogen and a ketone functionality at C-S. 
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Figure 1.1: The structure of pyrrolizidine alkaloids showing the 
traditional necine base numbering system. 
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Often the only difference between two necine bases is the stereochemistry at carbons 1, 
7 or 8, e.g. platynecine 25, hastanecine 26, and turneforcidine 27. Hydroxyl groups at 
either (or both) carbons 7 and 9 may be esterified to give a wide range of acyclic mono-
and diesters and macrocyclic diesters. Any hydroxyl groups at carbons 2 and 6 may also 
be esterified. 
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There are a number of acids found as esters of necine bases, the simplest being acetic acid. 
Only acetate esters have been found at carbon-2, while for other positions a range of esters 
are knl'wn. Necic acids are mono- or dicarboxylic acids of branched carbon chains 
normally containing 5 to 10 carbon atoms, exceptions include acetic acid (C,,), nervogenic 
acid (C17), malaxanic acid (CIS)' kurameric acid (C23) and nervosinic acid (c,.).17l The 
latter four are very rarely found. The majority of necine acids contain 10 carbon atoms. 
Monocarboxylic acids give acyclic esterification products, while dicarboxylic acids afford 
macrocyc1es. The macrocyc1e can be constructed of 11, 12, 13 or 14 atoms, as in 
crotalarine 28, senecionine 10, doronenine 29 and parsonsine 30, respectively. 
'--N---' 
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Figure 1.2 shows the traditional, non-IUPAC numbering system used for the necic acid 
portion of the pyrrolizidine alkaloid. For monoester and macrocyclic pyrrolizidines, the 
ester linkage oxygens are numbered. However, for acyclic diesters only one ester linkage 
oxygen is numbered and that is the one at C-9. 
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Figure 1.2: The traditional numbering of the necic acid portion of pyrrolizidine alkaloids. 
1.3.2 MELTING POINTS AND X-RAY CRYSTAL STRUCTURES 
Pure crystalline pyrrolizidine alkaloids have characteristic melting points , which can help 
to confirm an identification. More importantly, x-ray crystal structures can be obtained 
for pure crystalline alkaloids to provide an absolute identification. Crystal structures have 
been obtained for a number of pyrrolizidines as well as for a number of crystalline 
pyrrolizidine alkaloid derivatives. 172 
1.3.3 INFRA-RED SPECTROSCOPY 
This technique is now seldom used in the identification of pyrrolizidine alkaloids. It does 
allow for the recognition of functional groups commonly found in these systems, viz. , 
carbon-carbon double bonds, hydroxyl groups , esters and terminal methylene groups.m.174 
a ,ll-Unsaturated esters show a conjugated carbonyl stretch at 1710-1720 cm-I (a non-
conjugated ester carbonyl band is at 1730-1740 cm-I ) and a C=C stretching band at 1640-
1660 cm-I .'74 Unsaturated necine bases and esters also show a weak band at 3025-3090 
cm-I due to vinyl hydrogen stretching. 174 
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1.3.4 MASS SPECTROMETRY 
This is a very useful technique for determining the structure of pyrrolizidine alkaloids, 
especially when coupled with gas chromatography. Both electron impact ionisation and 
chemical ionisation techniques have been employed, however , electron impact ionisation 
mass spectrometry of pyrrolizidine alkaloids tends to be more reproducible and gives a 
wide range of fragments. A review has been published on the mass spectrometry of 
pyrrolizidine alkaloids. 175.176 The main features of electron impact mass spectra are 
outlined below followed by a brief section on chemical ionisation mass spectra. 
1.3.4.1 PYRROLIZIDINE ALKALOIDS CONTAINING AN UNSATURATED 
NECINE BASE 
Retronecine 31, a typical unsaturated necine base, is the most common of the necine bases 
and there is thus a great deal of information available on it. Macrocycles having a 
retronecine base typically show triads at mlz 93,94, and 95; 119, 120, and 121; and 136, 
137, and 138.105.127.177-182 As an example, the fragmentation of senecionine 10 and 
anacrotine 32 is shown in Scheme 1.1. 177 The only difference between anacrotine 32 and 
senecionine 10 is that the former has a hydroxyl group on carbon-6 and, consequently , 
until carbon-6 is lost the fragments of anacrotine will be 16 atomic mass units higher than 
the corresponding fragments of senecionine. 
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Three possible fragmentation paths are illustrated in Scheme 1.1; path (a) is initiated by 
homolytic fission of the allylic ester moiety, path (b) by a 8- and/or 6-membered 
Mclafferty rearrangements (Scheme 1.2), and path (c) by an 8-membered Mclafferty 
rearrangement (Scheme 1.3).175 Regardless of how the fragmentation was initiated, the 
triads around mlz 94 and mlz 137 result from eventual homolytic fission of the C(7)-(C)8 
bond, followed by loss of the acid moiety, while acid loss by Mclafferty rearrangement 
gives the triad mlz 119, 120, and 121. 175 
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Macrocycles can be distinguished from acycles by the presence of the M+ -C02 peak which 
is absent in the mass spectra of acycles. '75 In acyclic diesters the carboxylate moiety at 
C-9 is readily lost by McLafferty rearrangement and there are relatively few mass 
fragments found between the M + peak and the peak for the loss of the acid. Of lesser 
importance is the loss of the ester group at C-7 . In macrocycles, fission of the ester at 
C-9 does not result in the loss of the carboxylate group as it is still linked through to C-7; 
subsequent fragmentation of the acid, however , leads to numerous peaks . 175 
For the monoesters of retronecine 31 and heliotridine 33, the ester at C-9 is particularly 
susceptible to cleavage. A triad at mlz 137, 138, and 139 (one mlz unit higher than for 
macrocycles) is characteristic, and the peak at mlz 138 is often the base peak. Usually the 
mlz ll9, 120, and 121 triad is insignificant, while the peak at mlz 93 is strong and those 
at mlz 94 and mlz 95 have medium and low intensity, respectively.'75 
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The diastereomers, retronecine 31 and heliotridine 33, which differ only in the 
stereochemistry at carbon-7, exhibit identical fragmentation as do their 7-angelyl 
derivatives; 183 a proposed fragmentation pattern is shown in Scheme 1.4. ' 83 Heliosupine 
34 and echimidine 1, acyclic diesters of heliotridine and retronecine respectively, also 
exhibit identical fragmentation. '83 Supinidine 35, in which the C-7 hydroxyl group is 
missing, has a similar mass spectrum to retronecine and heliotridine, but with additional 
peaks at mlz 108, 110, 120, 122 and 139(M+). '84 
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1.3.4.2 PYRROLIZIDINE ALKALOIDS CONTAINING A SATURATED NECINE 
BASE 
The prominent peaks in the mass spectrum of a saturated necine pyrrolizidine alkaloid are 
typically two mlz units higher than those for their unsaturated analogues. 185 The base peak 
is often observed at mlz 82,,44,155,,85.,88 and fragmentation is dominated by the loss of the 
ester at C-7 when this group is present, 189,190 
For macrocycles with a saturated base, e,g. platyphylline 17 and neoplatyphylline 18, the 
base peak is observed at either mlz 140 or mlz 82.155 ,191 The other important characteristic 
peaks are found at mlz 95, 96, 122, 123 and 138. '86,'87,'92 For acyclic diesters , e.g. 
sarracine 36, the base peak is often at mlz 138.155 Interestingly, the peak at mlz 95 
(66.7%) in fuchsisenecionine 37 is presumed to indicate esterification at C_9. '93 However, 
the mass spectra of 7- and 9-angelylplatynecine, 38 and 39, are so similar'55 that no 
deductions about the location of the ester functions can be drawn from the intensity of the 
mlz 95 peaks. 
In general, saturated 7,9-dihydroxy necine bases exhibit two significant peaks, one at mlz 
82 and the other at mlz 113 (Scheme 1.5).'94 In saturated pyrrolizidine necine bases the 
initial fissions are of bonds B to the nitrogen. 194 Due to the 7-hydroxy group the C(7)-C(8) 
bond is B to both a nitrogen and an oxygen atom and is , therefore, most labile and breaks 
easily. 
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When the 7-hydroxyl is absent, as in isoretronecanol 40 and trachelanthamidine 41, C(I)-
C(8) bond fission predominates, giving a base peak at mlz 83 (Scheme 1.6) .194 
Macronecine 42 has two hydroxyl groups: one at C-I and the other at C-2, and the major 
peaks in the mass spectrum of this compound are the base peak at mlz 83 and the peaks 
at mlz 55 and 98. 194 
40 41 
Scheme 1.6 
1.3.4.3 OTONECINE-BASED PYRROLIZIDINE ALKALOIDS 
In the otonecine base, as mentioned earlier, the N-C(8) bond is absent and there is a 
ketone functionality at C-8 and a methyl group on the nitrogen. Characteristically, these 
compounds show an M+ -IS peak corresponding to the loss of the N-methyl group, and the 
base can generally be identified by strong peaks at mlz 94, 96, 100, 110, 122, 123, 149, 
150, 151 and 168.154.195.196 The peaks at mlz 100, 110, lSI and 168, however , are 
considered to be particularly diagnostic as they do not feature strongly in the mass spectra 
of other pyrrolizidine alkaloids. 154 
1.3.4.4 MASS SPECTRA OF PYRROLIZIDINE ALKALOID-4-0XIDES 
Due to low volatility and thermal instability, pyrrolizidine alkaloid-4-oxides give very poor 
mass spectra.197 N-oxides also elute poorly on some GLC columns used for pyrrolizidine 
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alkaloids and thus when GLC is coupled to mass spectrometry poor spectra generally 
result. In such cases the molecular ion peak is either very small or absent. The major 
fragments are associated with N-O cleavage197.198 and the mass can, therefore, sometimes 
be determined by the presence of the peaks mlz M+ -16 and M+ -18, which represent the 
loss of 0 and H20 respectively,..9 
1.3.4.5 USE OF MASS SPECTROMETRY TO DETERMINE THE MODE OF 
ESTER ATTACHMENT 
Often one needs to establish which of two acid moieties is esterifying the 9-hydroxyl 
group, leaving the other to be bonded at position 7 or, in some cases, position 6. For 1,2-
unsaturated pyrrolizidine alkaloids the allylic (or primary) ester at C-9 is more vulnerable 
to electron impact fission than the secondary ester (at C_7).'54.189 In an acyclic diester, 
therefore, the necic acid attached at carbon-9 is lost more readily than that attached to 
carbon-7. For macrocycles , cleavage of the C(9)-O bond will open the macrocycle and 
careful study of the fragmentation data may indicate the mode of ester attachment. Similar 
C(9)-O bond cleavage patterns apply to otonecine-based alkaloids. According to 
Bredenkamp and Wiechers/oo however, this is an oversimplification of a complex 
fragmentation pattern. The necic acid component of merenskine 43, sceleratine 44, and 
their derivatives is almost symmetrical so the mass spectra can accommodate both possible 
modes of ester attachment to the necine base. This is due to the transfer of the free radical 
centre within the acid portion of the pyrrolizidine alkaloid. 200 
'---N---' '---N---' 
43 44 
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1.3.4.6 CHEMICAL IONISATION (CI) 
The mass spectrometric patterns discussed above involve electron impact (EI) ionisation 
which is reproducible and so useful for identifying pyrrolizidine alkaloids. However, the 
high energy involved during EI ionisation means that the molecular ion peak is often not 
detected. 176 Chemical ionisation is a less energetic method for ionising a molecule and, 
therefore, the molecular ion peak is generally observed with little subsequent fragmentation 
occurring. Thus, the CI mass spectrum of jacozine 4S (using methane as the reagent gas) 
only exhibits three peaks, mlz 120, 138 and 350. 185 
\ OH 
.... a .,""? 
a 
L--N----' 
45 
Proton transfer and hydride extraction reactions result in the formation of (M + 1)+ and 
(M-1)" ions in a sample. In nitrogen containing compounds , like pyrrolizidine alkaloids, 
proton transfer is more efficient than hydride extraction. 176 Chemical ionisation mass 
spectrometry is particularly useful for determining molecular weights of pyrrolizidine 
alkaloids but, surprisingly, only a relatively small number of pyrrolizidine alkaloids have 
been examined using this ionisation technique. Positive ion chemical ionisation (PIC I) is 
achieved using methane or ammonia gas:3 while hydroxide ions are used for negative ion 
chemical ionisation (NICI). The most striking feature of NICI mass spectra is the 
presence of relatively intense peaks, which are due to the necic acid portion of the 
pyrrolizidine alkaloid and which are not present in the PICI mass spectra. 201 ,202 
Retronecine 31- and otonecine 24-based pyrrolizidines can be distinguished from each 
other by chemical ionisation mass spectrometry as only the retronecine-based systems give 
a (M-1)' peak due to proton abstraction; otonecine-based alkaloids, on the other hand, give 
an M' peak due to an electron capture process .201 
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1.3.5 NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY 
With the advent of high field (400 MHz and higher) NMR instruments, NMR spectroscopy 
has become a very powerful means of determining the structure of pyrrolizidine alkaloids . 
Although the pyrrolizidine levels in plants are very Iowa proton NMR spectrum can be 
run on approximately I mg of material in a short time. A carbon-13 spectrum, however, 
takes considerably longer to acquire. 
In view of the availability of extensive physical and spectroscopic (particularly proton and 
carbon-13 NMR) data . for pyrrolizidine alkaloids , it became clear that a database would 
be an invaluable tool to facilitate identification of newly isolated pyrrolizidines. During 
the course of this project such a data base has been constructed, by remodelling and 
extensively enlarging a skeleton database begun earlier by co-workers . This database has 
helped tremendously in the identification of known pyrrolizidine alkaloids which were 
isolated in this study. In addition, other alkaloids , which were isolated, were rapidly 
shown to be new and hence needing additional investigation. A complete discussion of the 
development and application of this database is given in Section 3 (p. 97). A number of 
trends in the published proton and carbon-13 NMR data became apparent and these are 
discussed in Section 3.2 (p . 102). 
The signals in one dimensional spectra are not always readily distinguishable or easy to 
assign. Two dimensional spectra are increasingly being used to solve this problem. lH_1 H 
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correlation spectroscopy (COSY) often helps with proton allocations.6,76,85.14,,15,,188.203.200 
The assigning of carbons is made easier by heteroatom correlation (HETCOR) or 1H_ 
detected heteronuclear multiple quantum coherence (HMQC) 
spectroscopy:,67,76,113,149,159,188,203.205.20' Both techniques detect 13C_1 H couplings but, for 
weak samples, HMQC spectroscopy is a better option as the coupling between the carbon 
nucleus and proton nucleus is detected from the side of the more sensitive proton.2\o.212 
The problem of determining the mode of necic acid attachment to a necine base in diesters 
has also been solved by two dimensional NMR techniques. Both carbon-detected 
correlation spectroscopy via long-range coupling (COLOC) and proton-detected 
heteronuclear multiple bond connectivity (HMBC) spectroscopy have been 
used.76,85, 14" IS,,20' Both experiments detect coupling between a hydrogen and a carbon one 
or two atoms removed from the one to which the hydrogen is bonded. These techniques 
therefore show coupling between the carbonyl carbon of the necic acid and the protons on 
carbons 6, 7 or 9 of the necine base, hence linking the necic acid to the respective site. 
The proton-detected method is favored due to enhanced sensitivity. 212,213 
Relative stereochemistry of the necine base portion of pyrrolizidine alkaloids has been 
determined by two dimensional techniques which utilise the nuclear Overhauser effect 
(NOE) , viz. , nuclear Overhauser effect spectroscopy (NOESY) and rotating frame nuclear 
Overhauser effect spectroscopy [ROESY - also know as CAMELS PIN (cross-relaxation 
appropriate for minimolecules emulated by locked spins)]. 149,204 ,206 The nuclear Overhauser 
effect is also utilised in NOE-difference spectroscopy",,214,21S which is a one dimensional 
technique with faster acquisition times than NOESY or ROESY as only the proton signals 
of importance are decoupled . Before these more advanced techniques were developed, the 
necine bases were distinguished, in a standard proton spectrum, by the width, at half-
height, of the H-7 signal measured in Hertz216 and the shift position of the H-6 
signaI. S7,n .216, 217 For retronecine-based pyrrolizidines the H-6 multiplet is downfield of2.3 
ppm, while for heliotrine-based pyrrolizidines it is upfield of this value. 
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The width of the H-7 signal has been used to distinguish between retronecine 31- and 
heliotridine 33-based alkaloids and between platynecine 25-, hastanecine 26- and 
turneforcidine 27-based pyrrolizidines.155.186.194.21 •. 218 For the unsaturated bases , retronecine 
and heliotridine, values for the width at half-height of 8.8 and 13.9 Hz, respectively , have 
been reported. For the esterified bases, however, there is an overlap. Culvenor and 
Woods21• quote 11 Hz for both retronecine-and heliotridine-based pyrrolizidines and there 
are similar anomalies when looking at saturated bases. For unesterified platynecine a 
value of 8.2 Hz has been reported,216 while for platynecine-based pyrrolizidines some 
published values include: platyphylline 17 (14.2 Hz)."· neoplatyphylline 18 (17.4 HZ), '9' 
sarracine 36 (6.5 HZ),155 sarracine-4-oxide (13 Hz)21. and 7-angelylplatynecine 38 (6.4 
Hz) .'" The big difference between the values for esterified and non-esterified necine bases 
is said to be due to the difference between enda and exa buckling.21. The H-7 signal for 
hastanecine 26 has a width at half-height of 12.0 HZ,'94.218 while for hastacine 46, a 
hastanecine-based pyrrolizidine, a value of 24 Hz has been reported. '94 With NMR data 
available for more pyrrolizidine alkaloids, it is now clear that the width of the H-7 signal 
at half-height is not definitive: and Aasen et at. 194 conclude that the half-height width does 
not assist in arriving at the stereochemistry at C-7 of hastanecine 26 and the amino alcohol 
from retusine (turneforcidine 27). For turneforcidine 27 a value of 14.1 Hz has been 
reported. 218 
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1.4 BIOLOGICAL ACTIVITY 
1.4.1 TOXICITY 
The toxic properties of pyrrolizidine alkaloids prompted the early investigations of plants 
containing them . Liver damage has been found to be the main characteristic of 
pyrrolizidine poisoning.219 Their toxicity to other organs, viz., lungs , heart, kidneys , 
pancreas, brain and intestines,220 and their carcinogenicity were only recognised later. 2 
In the liver, the 1,2-unsaturated pyrrolizidine alkaloids are metabolised to cytotoxic 
pyrrolic compounds by microsomal enzymes . Pyrrolizidine alkaloids containing a 
saturated necine base, however , are not activated by these enzymes and thus are not 
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hepatotoxic. 221 The primary metabolites, pyrrolic esters 47, are more reactive than the 
secondary metabolites, dehydroaminoalcohols 48, as they can cause non-specific alkylation 
of cell constituents leading to necrosis of the liver and to a lesser extent of the lung 
endothelium.22o,222 Horses and cattle are more susceptible than sheep and goats to the toxic 
effects of pyrrolizidine alkaloids. 2,28 
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Pyrrolizidine alkaloids have also been shown to cause pulmonary hypertension and arteritis 
which can lead to chronic heart damage.22o Rats dosed with monocrotaline 7 have 
developed necrosis of the renal tubes, while monkeys dosed with retrorsine 9 have 
developed severe toxic nephritis with damaged glomeruli. 220 Other pyrrolizidines have 
destroyed pancreatic cells and caused the spongy degeneration of calf and sheep brains.220 
In northern Queensland, Australia, oesophageal disease in horses (or Chillagoe horse 
disease) has resulted from pyrrolizidine alkaloid ingestion, which causes ulceration of the 
oesophagus and squamous mucosa of the stomach, 28 
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1.4.2 CARCINOGENICITY AND ANTITUMOUR PROPERTIES 
In the early 1970's pyrrolizidine alkaloids were found to be carcinogenic.223 As it was 
known that some foodstuffs , such as honey and milk,224.226 contained pyrrolizidine 
alkaloids, a spate of investigations followed. 
Hepatic enzymes convert pyrrolizidine alkaloids to cytotoxic metabolites, primarily, highly 
toxic pyrrolic esters. The tumours appear at the liver and not at the site of pyrrolizidine 
alkaloid application. The carcinogens are, therefore, the metabolites produced in the 
liver. 227 
Macrocyclic or acyclic diester pyrrolizidine alkaloids containing otonecine 24, retronecine 
31 or heliotridine 33 are hepatocarcinogenic. 228 Thus, monocrotaline 7, retrorsine 9 and 
its N-oxide, senecionine 10, seneciphylline 11, symphytine 12, petasitenine 49, 
lasiocarpine 50 and senkirkine 51 have caused liver tumours and carcinomas. 229 Some 
pyrrolizidine alkaloids are also known to cause tumours in the pancreatic tissue or in the 
central nervous system. 230 
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Interestingly, a number of pyrrolizidine alkaloids exhibit antitumour activity. In studies 
in which 18 pyrrolizidine alkaloids were tested, nine were active against one or more of 
the four tumour systems, adenocarcinoma 755, sarcoma 180, Walker 256 intramuscular 
and Walker 256 subcutaneous .28 The nine alkaloids are monocrotaline 7, senecionine 10, 
lasiocarpine 50, crispatine 52 , fulvine 53, heliotrine 54 and its N-oxide, spectabiline 55 
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and supinine 56. Structure activity relationship studies have shown that the antitumour 
activity is not dependent on the allylic ester. 231 
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Extracts of Heliotropium indicum were effective against Walker 256 tumours in rats and 
against leukaemia 1210 in mice. 232 The active component was found to be indicine-4-oxide 
3. To date , indicine-4-oxide is the only pyrrolizidine alkaloid to have undergone clinical 
tests.233 Twenty nine human patients with advanced solid tumours were dosed with 
indicine-4-oxide, but showed no objective therapeutic response. 234 The major toxic effect 
was myelosuppresion (bone marrow suppression). Indicine-4-oxide was also tested in ten 
people with advanced leukaemia, two of whom showed complete remission and one partial 
remission.235 Once again the toxic effects were myelosuppression and jaundice. The 
mechanism of antitumor action of indicine-4-oxide is unknown.233 
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A semisynthetic pyrrolizidine, 9-(2-hydroxy-2-phenylbutyryl)-retronecine 57, which is 
structurally similar to indicine-4-oxide 3, is claimed to be more active against P388 
lymphatic leukaemia. 236 
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Other pyrrolizidine alkaloids are being tested for anti tumour properties by the National 
Cancer Institute in the United States of America.29 
1.5 SYNTHESIS OF PYRROLIZIDINE ALKALOIDS 
Pyrrolizidine alkaloids often need to be synthesised to confirm their stereochemistry. 
NMR techniques, for example NOE-difference spectroscopy, may permit the relative 
stereochemistry to be determined, but synthesis is often required for establishing absolute 
stereochemistry. Furthermore, only very small quantities of alkaloid are generally 
available from natural sources so, for further investigation of the metabolism and 
biological activity, synthesis of larger quantities may be required. The toxicity of natural 
pyrrolizidine alkaloids tends to outweigh their beneficial properties. Consequently, less 
toxic derivatives which keep the beneficial properties are being synthesised. Mattocks'" 
reviewed the synthesis of pyrrolizidine alkaloids until 1985, while Robins' annual 
reviews23'.'" have reviewed the synthesis of pyrrolizidines to June 1994. 
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Pyrrolizidine alkaloids consist of a necine base and one or two necic acids. In the brief 
overview which follows, the synthesis of the two parts will be discussed separately 
followed by various coupling techniques . 
1.5.1 SYNTHESIS OF NECINE BASES 
As can be expected the synthesis of a necine base can be very challenging, particularly if 
the stereochemistry is taken into account. Some bases differ only in stereochemistry 
(compare retronecine 31 with heliotridine 33, and platynecine 25 with hastanecine 26 and 
turneforcidine 27). There are two approaches to necine bases; an ab initio approach using 
acyclic or simple monocyclic precursors and a semi-synthetic approach utilising a readily 
available pyrrolizidine alkaloid. 
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1.5.1.1 AB INITIO SYNTHESIS 
Ab initio syntheses often involve numerous steps and, over the years, a wide range of 
starting materials have been used. The stereochemistry, as mentioned earlier, is very 
important but many of the published syntheses produce both optical isomers of a necine 
base. As a result there is a continuing search for stereospecific procedures. The synthesis 
of optically active necine bases using L-proline derivatives , optically active malic acids , 
carbohydrates and chiral auxiliaries was reviewed by Dai et aU" in 1990. Many 
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syntheses for the simpler necine bases having only one hydroxyl group have been reported; 
such target molecules include supinidine 35, isoretronecanol 40, and trachelanthamidine 41. 
Those with more than one hydroxyl group are synthesised less frequently. Proline 
derivatives are often used to provide one of the five membered rings of the necine base.254. 
266 The proline is then bonded to a carbon chain which cyclises to form the other half of 
the necine base. Succinimide and s-pyroglutamic acid and their derivatives are used in a 
similar manner.267.27• Due to their low cost, availability, and precise stereochemistry, 
carbohydrates are being used increasingly as starting materials.m .277 
dSOH H yHzOH Cb N 
35 40 41 
Another important starting material for the necine base is the Geissman-Waiss lactone, 
notable in its use in the very first synthesis of (+)-retronecine 31 (Scheme 1.7).278 There 
are now many paths to the Geissman-Waiss lactone and its derivatives!45.247.256.259.263.279.2Bo 
i, ii, iii 
• 
viii, i.x 
• 
HO COzEt 
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Scheme 1.7: Reagents: i, Na; ii, HCI, HzO; iii, EtOH, HC]; iv, NaBH.; v, Ba(OH)z; vi, HCI; vii, 
BrCH2C02Et; viii, KOEt; ix, Hz, Pt. CH,COzH; x. Ba(OH)z; xi. EtOH, HCI; xii, LiAlH •. 
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1.5.1.2 MODIFICATION OF AN EXISTING SYSTEM 
Retronecine 31, which is common to many pyrrolizidine alkaloids, has often been modified 
to produce other n~cine bases. It can be synthesised from simple precursors, but is 
regularly obtained by saponification of a macrocyclic, retronecine-containing pyrrolizidine 
alkaloid (e .g. monocrotaline 7 or retrorsine 9) using a base such as barium 
hydroxide?02.208.2,6,281.284 Once obtained, retronecine can then be altered to produce a variety 
of other necine bases. The stereochemistry at carbon-7 of retronecine 31 can be inverted 
as in the synthesis of helionidine 33 (Scheme 1.8).285 
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Scheme 1.8: Reagents: i, PhC02H, N,N'-carbonyldiimidazole, THF, room temperature, 16 
h; ii, CH,SO,Cl, Et,N, CH,Cl" _2°C, 1 h; iii, CH ,CO,Cs, dimethylformamide; iv, Ba(OH)" 
room temperature. 
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Rearrangement of the double bond in retronecine 31 from an endocyclic to an exocyclic 
position has recently been carried out by Hanselmann and Benn283 to produce 7B-hydroxy-
I-methylene-8a-pyrrolizidine 58, which was then converted to hadinecine 59 (Scheme 1.9) . 
The same authors have also synthesised hadinecine 59 and rosmarinecine 60 via the 1,2-
epoxide of retronecine (Scheme 1.10).283 Platynecine 25 (Scheme 1.11) has been 
synthesised from retronecine 31 by catalytic hydrogenation/80 while free radical 
deoxygenation of retronecine 31 (Scheme 1.12) results in the production of supinidine 
35.287 
OH OH HO ZD HO B B ",OH ., ' ~ 1, 11 Jll • • N N 
31 58 59 
Scheme 1.9: Reagents : i, SOC I,; ii, Zn, 1M H,SO, ; iii , OsO.(cat), 4-methyl morpholine-N-oxide , 
acetone, H,O. 
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Scheme 1.10: Reagents: i, mera-chloroperbenzoic acid; 11 , Zn, CH3C02H; iii , catalytic 
hydrogenation; iv, diisobutylaluminium hydride. 
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Scheme 1.11: Reagents: Hz(l atm), Pd-charcoal. 
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Scheme 1.12: Reagents: i, see Scheme 1.8; ii , PhCOzH, N,N' -carbonyldiimidazole, THF; iii, 
PhOCSCI, 4,4-dimethylaminopyridine, CH,CN; iv, n-Bu,SnH, ilZo-bis-isobutyronitrile, PhCH" 
75°C, 3 h; v, NH,F CH,OH, 60 °C, 18 h. 
1.5.2 SYNTHESIS OF NECIC ACIDS 
There are a wide variety of necic acids. They can be obtained directly from the parent 
pyrrolizidine alkaloids by hydrolysis or hydrogenolysis ,288 the latter approach , however, 
may be complicated by the formation of lactones and decomposition products . Necic acids 
are branched carbon chains with hydroxy, methoxy and acetoxy substituents . Since they 
may contain one or more chiral centres and/or double bonds, isomers are possible. One 
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of the main aims when synthesising necic acids is stereoselectivity, e.g. Kochetkov 's289 
synthesis of all four isomers of 2-isopropyl-2,3-dihydroxybutyric acid, the [2S,3R] and 
[2R,3S] isomers of which are (+)- and (-)-trachelanthic acid (61 and 62), respectively, 
while the [2R,3R] and [2S,3S] isomers are (+)- and (-)-viridifloric acid (63 and 64). A 
number of pyrrolizidine alkaloids contain trachelanthic and viridifloric acid but until 
Kochetkov 's synthesis their absolute stereochemistry was uncertain. Since then other 
shorter syntheses of one or more of the isomers have been realised. "'()·293 As many of the 
acids are 'Y- or o-hydroxyacids they are isolated as the corresponding 'Y- or o-lactones, 
which are then used for coupling to the desired necine base. 239,294,2.' 
HO V 
O~ 
HO H OH 
61 
Hq .. 
o 
HO H OH 
62 
1.5.3 COUPLING REACTIONS 
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A variety of coupling reagents have been used in pyrrolizidine alkaloid syntheses to join 
a necine base to a necic acid . The 9-chloro necine base has been reacted with the sodium 
salt of the acid. 281 ,296,297 Diesters of retronecine have been synthesised by mixing 
retronecine with excess necic acid chloride. 298 Selective coupling to the 9-position of the 
necine base has been achieved using N,N' -dicyclohexylcarbodiimide (DCC) and 4-
dimethylaminopyridine (DMAP) .202,292,293 N,N' -carbonyldiimidazole (CDI) has been more 
successful as a selective coupling reagent for the synthesis of 9_monoesters. 202,236,299 
During coupling protection of the hydroxyl groups of the necic acid or selective protection 
of one or other of the hydroxyl groups of a dihydroxy necine base may be 
required.293,294,300 The protection is to ensure regioselective coupling of an unsymmetrical 
dial to an unsymmetrical dicarboxylic acid and thus decrease the chance of hav ing a 
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mixture of products. Such protection is not always essential as the allylic alcohol is more 
reactive than the secondary alcohol. 
A modified form of the necic acid can be used instead of a protecting group to ensure 
regioselectivity. Niwa et at. 300 coupled a cyclic anhydride derivative of integerrinecic acid 
with a stannoxane obtained from retronecine to synthesise integerrimine 16 (Scheme 1.13). 
This method ensured regioselective coupling. A similar approach was used for the 
synthesis of senecionine 10301 and yamataimine 65. 302 
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Scheme 1.13: Reagents: i, N,N-dicyclohexyJcarbodiimide, CH2Cl2 ; ii, Bu2SnO, benzene, 
reflux; iii , 5°C to room temperature; iv, 2,4,6-trichlorobenzoyJchloride, Et,N, THF; v, 4,4-
dimethylaminopyridine, reflux; vi, Ph3C·BF" CH2Cl2 • 
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SECTION 1.6 
The present study aimed to isolate, identify, and compare the pyrrolizidine alkaloid content 
of Senecio chrysocoma and S. paniculatus as the two species have often been confused 
botanically. It was intended that the results would be of taxonomic assistance as 
pyrrolizidine alkaloids have previously been used as taxonomic markers in the Symphytum93 
and Amsinkia303 species. During the course of the study the novel structured 7-angelyl-l-
methylenepyrrolizidine alkaloids were identified and a synthesis of 7B-angelyl-l-
methylene-8a.-pyrrolizidine was undertaken to confirm the stereochemistry. 
An ancillary part of the project was the reconstruction, major updating, and completion of 
what was a skeleton database of published physical data on pyrrolizidine alkaloids. 
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2. SENECIO CHRYSOCOMA AND SENECIO PANICULATUS 
Both Senecio chrysocoma and S. paniculatus grow on recently disturbed ground and are, 
therefore, found beside roads, in recently burnt areas, and on agricultural land . The 
pyrrolizidine alkaloid content of the plants can be used as an indication of their possible 
toxicity to livestock. There is also some discussion amongst botanists as to whether they 
are in fact separate species, and an investigation into the pyrrolizidine alkaloid content of 
both species should show the chemical differences and similarities between the two species. 
S. paniculatus has been reported to contain the macrocyclic pyrrolizidine alkaloids , 
senecionine 10 and platyphylline 17,'1.33 while S. graminifolius, synonymous with S. 
chrysocoma (see Section 2.1, p. 46), has been reported to contain retrorsine 9.304 S. 
chrysocoma had, therefore, initially been extracted as a potential source of macrocyclic 
pyrrolizidine alkaloid GC-MS standards. 305 However, no macrocyclic alkaloids had been 
found,152 so a full investigation of the alkaloidal constituents was undertaken. 
17 
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2.1 A BOTANICAL COMPARISON OF THE TWO SPECIES, 
SENECIO CHRYSOCOMA AND SENECIO PANICULATUS 
The National Botanical Institute (NBI) of South Africa now views Senecio chrysocoma 
Meerb. and Senecio paniculatus Berg. as two different, yet closely related, species. 306 In 
1894 S. paniculatus Berg. was described with three variants: peucedanifolius, intermedius, 
and reclinatus. 307 S. paniculatus Berg. var. reclinatus was also known as S. chrysocoma 
Meerb .307 S. chrysocoma Meerb. was described as a separate species, in 1973, by Hilliard 
and Burtt'°8 although they gave S. reclinatus Linn. f., S. graminifolius Jacq., S. 
paniculatus Berg. var. reclinatus (Linn. f.), S. paniculatus auct. and Jacobaea reclinata 
(Linn. f.) Thunb. as synonymous names for the species. S. chrysocoma has been 
described as having entire linear to linear-Ianceolate leaves and discoid flower heads (9-11 
mm) with white, cream or yellow flowers (but mostly yellow).306.309 S. paniculatus, on the 
other hand, has linear and entire to pinnatipartite leaves even on the same plant. The 
flower heads are discoid (6-8 mm) and also white, cream or yellow, although most of the 
NBI specimens are described as having white f1owers. 306 The NBI records indicate that 
S. chrysocoma is found east of Uniondale, in the Western Cape, to southern Kwazulu-
Natal, South Africa, while S. paniculatus is found to the west of Uniondale to the west 
coast of the Western Cape (See Figure 2.1).306.309 
2.2 PLANT COLLECTIONS 
In total, nine populations of plants were collected and extracted (see Figure 2.1): three east 
of Uniondale - at Grahamstown, at Trifolia near Humansdorp, and at the Port Elizabeth 
municipal water works' Van Stadens River dams; three west of Uniondale - on the farm 
Assegaaibos near Riversdale and at the summits of the Robinson and Tradouw Passes; and 
three from the east-west distribution borderline - near the Dieprivierhoogte picnic spot, 
beside the Wittedrif road, and alongside the Prince Alfred Pass. Specimen samples of the 
plants collected were identified by the staff of the Selmar Schonland Herbarium, 
Grahamstown, and Paul ine Bohnen, a botanist in Riversdale. 
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SENECIO CHRYSOCOMA AND SENECIO PANICULATUS SECTION 2.2 
Those collected east of Uniondale and on the borderline were identified as S. chrysocoma. 
They had the entire linear-Ianceolate leaves and those which were in flower had yellow 
disc florets (Figure 2.2). The three populations collected west of Uniondale were 
identified as S. paniculatus. The Assegaaibos population had finished flowering so the 
colour of the flowers is unknown, but the Robinson Pass population had yellow disc 
florets , while the Tradouw Pass population had white disc florets (Figure 2:3). All three 
had pinnatipartite leaves. 
Figure 2.2: Senecio chrysocoma, with yellow disc florets and linear-
lanceolate leaves. (Photograph: B.A. Logie) 
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Figure 2.3: Senecio paniculatus, with white disc 
florets and pinnatipartite leaves. 
(Photograph: Caryl G. Logie) 
SECTION 2.2 
The Grahamstown, Humansdorp and Van Stadens River dam populations were collected 
from recently burnt (within 18 months) areas. The Van Stadens River dam site was a 
felled. pine tree forest and, at the time of collection, had horses grazing on it. The 
Assegaaibos population was gathered on land that supported cattle. The remaining 
populations were collected beside roads. All plants , therefore , were collected in 
regenerating environments , however , S. paniculatus plants were found in slightly more 
overgrown regions than the S. chrysocoma plants (Figure 2.4). Although some of the 
plants were collected where animals were grazing , there was little danger of intoxication 
since as will be shown later in this chapter , only traces of hepatotoxic pyrrolizidine 
alkaloids were found , and then only in S. paniculatus extracts. 
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(a) 
(b) 
Figure 2.4: Examples of the typical environments in which (a) S. chrysocoma 
plants (Van Stadens River dams), and (b) S. paniculatus plants 
(Tradouw Pass) were found. (Photographs: Caryl G. Logie) 
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2.3 EXTRACTION OF THE PYRROLIZIDINE ALKALOIDS 
The standard procedure (Figure 2.5), described in Section 5.3.1 (p. 137), was used for the 
extraction of the pyrrolizidine alkaloids from the nine plant populations. Soaking in cold 
solvents was chosen above continuous soxhlet extraction as the latter tended to cause 
charring. The extraction to remove waxes and chlorophylls can be delayed and the 
methanol extract washed with hexane or petroleum ether,7I ·75.I8' but it made more sense to 
remove as much non-alkaloidal material as possible before extracting the pyrrolizidines. 
The crude, tarry mixtures, obtained after concentrating the methanolic extract, are 
typically dissolved in either an acidic (sulphuric or hydrochloric acid) or an organic solvent 
(chloroform, dichloromethane or ethyl acetate) before continuing with the aqueous/organic 
separations.70 In the present study, however, a large proportion of the crude mixture 
would not dissolve when only one solvent was used, so a 50:50 mixture of 2M-sulphuric 
acid and chloroform was used . 
As pyrrolizidine alkaloid N-oxides are not particularly soluble in organic solvents, they 
were reduced with zinc dust prior to extraction of the alkaloids with chloroform. The 
most convenient way to do this was to add zinc dust to the acidic solution and stir 
overnight, but occasionally a shorter time sufficed . . Despite the reduction step , two N-
oxides were identified in this study. They were either not reduced, but still extracted , or 
they reformed after extraction. It is possible that they would be extracted even if they 
were not reduced as it has been shown that some N-oxides are soluble in organic 
solvents.7o On the other hand, if the N-oxides reformed after extraction there should be 
a steady, noticeable increase in the N-oxide concentration with time, but this was not 
observed . 
After the zinc reduction, the solution was filtered to remove excess zinc and the pH 
adjusted to 9 with concentrated ammonium hydroxide. In a few cases an emulsion 
developed at this pH which disappeared if the pH was increased to 10 or 11 by adding 
more ammonium hydroxide. 
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DRY, SHREDDED PLANT MATERIAL j ","""',, .i<h oold h,~ 
DEFATTED PLANT MATERIAL 
j ~.- extraction ,,:,ith cold methanol II - concentratIOn 
CRUDE EXTRACT j ~Iph"'" ."",Wooofo= p.rtm" 
ALKALOIDS IN AN ACIDIC SOLUTION 
j i-reduction with zinc dust ii - filtration iii - basification to pH 10 with ammonium hydroxide 
REDUCED ALKALOIDS IN BASIC SOLUTION 
j i.- extraction ,,:,ith chloroform II - concentratton 
MIXTURE OF PYRROLIZIDINE ALKALOIDS 
Figure 2.5: A general approach to the extraction of the pyrrolizidine alkaloids. 
It was found that a re-extraction helped to clean the crude pyrrolizidine alkaloid mixture 
further before separation. The re-extraction involved dissolving the crude mixture in a 
small volume of chloroform, extracting with acid, washing the acidic solution with 
chloroform before increasing the pH to 10 and then extracting the pyrrolizidine alkaloids 
back into chloroform. This alkaloidal mixture was then separated to yield, as cleanly as 
possible, the individual pyrrolizidine alkaloids . 
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2.4 SEPARATION AND PURIFICATION OF THE PYRROLIZIDINE 
ALKALOIDS 
Of the many techniques which have been used for the separation and purification of 
pyrrolizidine alkaloid extracts , the use of three was explored in this study and, ultimately, 
only two were used as droplet counter current chromatography proved unsuccessful. 
These two techniques, flash column and preparative layer chromatography (PLC) permitted 
adequate separation of the alkaloids. However, it was not possible to separate completely 
isomers that differed only in the geometry of a double bond in the necic acid portion of 
the pyrrolizidine. Angelic acid esters were always slightly contaminated by the tiglic acid 
equivalent, and sarracine and neosarracine could never be totally separated. Stelljes et 
at. 68 have noted the spontaneous conversion of angelates to tiglates during storage. 
All the fractions obtained were analysed by TLC as a primary check of the degree of 
purification. Silica gel plates were used with a chloroform-methanol-25 % ammonium 
hydroxide solution (85: 14: 1) solvent system. Developed plates were viewed under 
ultraviolet light and then generally sprayed with Dragendorff's reagent. Dragendorff's 
reagent was chosen in preference to Erhlich's reagent for several reasons. Staining with 
Erhlich's reagent was more time-consuming as the plates had to be sprayed first with an 
o-chloranil solution and then with Erhlich's reagent, with warming in an oven after each 
application. 135 Saturated pyrrolizidine alkaloids do not stain with Erhlich ' s reagent136 (and 
most of the pyrrolizidine alkaloids identified in this investigation were saturated) , while 
both unsaturated and saturated pyrrolizidines stain with Dragendorff's reagent. Moreover, 
Erhlich's reagent is water sensitive making storage difficult; Dragendorff's reagent, on the 
other hand, can be stored for a longer time. The disadvantage of Dragendorff's reagent 
is its lack of selectivity; a positive response does not always indicate the presence of a 
pyrrolizidine.135.137.138. 139 The hexane extracts and the chloroform washings of the acidic 
fractions were tested for pyrrolizidines using Dragendorff's reagent and their presence was 
suggested by an orange spot. However, NMR spectroscopy indicated that the compound 
responsible was not a pyrrolizidine alkaloid . 
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Droplet counter current chromatography (DCCC) is a fairly new technique with which 
some authors have achieved very good separations of pyrrolizidine alkaloid 
mixtures.44.67.72.l7o In particular, EIZ-isomers were separated and, consequently, this was 
intended to be the primary method of separation. There is no solid support to irreversibly 
adsorb the alkaloids, the solvent consumption is low and a variable sample size (from 
milligram to multigram quantities) can be loaded. 16' However, the efficiency of the 
method depends entirely on droplet formation. 169 In the end, the only separation attempted 
was that of the pyrrolizidine alkaloids from the Grahamstown S. chrysocoma population. 
The solvent system chosen, chloroform-benzene-methanol-water (5:5:7:2), had been used 
previously by Zalkow et al.:7 but a decent drop rate and form were never achieved. The 
drops tended to slide down the side of the tube and, towards the end of the "separation", 
stationary phase as well as mobile phase was being pumped off the columns. Zalkow et 
al. 67 also noticed that, towards the end of their separation, stationary phase was being 
pumped off the column. The tubes of the droplet counter current chromatograph were 
cleaned as described in the accompanying manual by flushing them sequentially with 
methanol, distilled water, a 20% Extran solution and then distilled water again before 
loading the stationary phase, but this did not improve the droplet formation. As a result, 
the separation obtained was extremely poor and extensive preparative layer 
chromatography (PLC) was required to separate the alkaloids of the Grahamstown 
population. 
Flash column chromatography on silica gel was found to be a very good initial separation 
technique, but needed to be followed by comprehensive preparative layer chromatography; 
a few fractions were clean enough not to require PLC separation. The only crude 
mixtures not initially subjected to flash column chromatography were those from the 
Grahamstown and Dieprivierhoogte S. chrysocoma populations and the Assegaaibos S. 
paniculatus population. The Grahamstown population was initially separated by DCCC, 
as indicated above. As pyrrolizidine alkaloids tend to adhere to silica gel, a certain 
amount of methanol was required in the elution solvent. Since methanol does dissolve 
silica to some extent, a gradient elution was used where the percentage of methanol was 
slowly increased, with only the final elution, of approximately 200 mL, being neat 
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methanol. The silica that did dissolve was removed from the fractions by evaporating 
them to dryness and then dissolving the alkaloidal material in chloroform or 
dichloromethane and filtering. 
Further separation of the fractions obtained from DCCC and flash column chromatography 
was achieved by preparative layer chromatography on silica plates using, generally, 
chloroform-methanol-25 % ammonium hydroxide (85: 14: 1) as the mobile phase. Some of 
the fractions , particularly those collected off the droplet counter current chromatograph, 
were separated using a different chloroform-methanol-25 % ammonium hydroxide mixture 
(80: 19: 1). In a few cases, the solvent system, chloroform-cyclohexane-diethylamine 
(5:4: 1), gave better separation than the standard 85: 14: 1 (chloroform-methanol-25 % 
ammonium hydroxide) mixture. The diethylamine helped to compact the bands which 
normally tended to streak. For mixtures of which there was very little material « 15 mg) 
analytical glass-backed plates were used as "preparative" layer chromatography plates. As 
a 400 MHz nuclear magnetic resonance spectrometer was used for identifying the 
pyrrolizidine alkaloids, small samples of ca. 2 mg were not too small. Developed plates 
were viewed under ultraviolet light to distinguish the bands. On occasion, a thin strip on 
the side of the plate was sprayed with Dragendorff's reagent to aid in determining which 
bands could contain pyrrolizidine alkaloids. The bands of interest were removed from the 
plate and the compounds removed from the silica using a mixture of chloroform and 
methanol , and any dissolved silica was removed as described previously . 
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2.5 IDENTIFICATION OF THE PYRROLIZIDINE ALKALOIDS 
Table 2.; shows the pyrrolizidine alkaloids, identified by NMR techniques, in extracts 
from each population investigated. Additional alkaloids were identified in some 
populations' extracts by comparison of the individual gas chromatograms, but these are 
discussed in Section 2.6 (p. 79). The alkaloids identified by NMR spectroscopy can be 
divided into four groups:-
i) the monoesters (7-angelylhastanecine66, 9-angelylhastanecine 67, 7-angelylplatynecine 
38, 9-angelylplatynecine 39 and 9-angelylplatynecine-4-oxide 68); 
ii) the I-methylenepyrrolizidines (7c.-angelyl-l-methylene-Sc.-pyrrolizidine 69, 7 c.-
angelyl-l-methylene-Sc.-pyrrolizidine-4-oxide 70, and 7B-angelyl-l-methylene-Sc.-
pyrrolizidine 71); 
iii) the acyclic diesters (sarracine 36 and neosarracine 72); and 
iv) the macrocyclic diester alkaloid (retrorsine 9). 
The identity of the pyrrolizidines was determined almost exclusively by nuclear magnetic 
resonance (NMR) spectroscopy, although mass spectrometry was used to confirm the 
structures. 
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Table 2.1 : Pyrrolizidine alkaloids, identified by NMR techniques, in the extracts from the 
various plant populations. 
Pyrrolizidine alkaloid Population 
7-angelylhastanecine 66 Grahamstown and Humansdorp 
9-angelylhastanecine 67 Van Stadens River Dams and 
Dieprivierhoogte 
7-angelylplatynecine 38 Wittedrif and Prince Alfred's Pass 
9-angelylplatynecine 39 Grahamstown, Humansdorp, Wittedrif, 
Dieprivierhoogte, Assegaaibos and 
Tradouw Pass 
9-angelylplatynecine-4-oxide 68 Wittedrif, Tradouw Pass, and Prince 
Alfred's Pass 
7a-angelyl-l-methylene-8a- Van Stadens Dam 
pyrrolizidine 69 
7a-angelyl-l-methylene-8a- Grahamstown 
pyrrolizidine-4-oxide 70 
71l-angelyl-l-methylene-8a- all nine populations 
pyrrolizidine 71 
sarracine 36 all nine populations 
neosarracine 72 all nine populations 
retrorsine 9 Tradouw Pass 
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2.5.1 THE MONOESTER AND ACYCLIC DlESTER PYRROLIZIDINE 
ALKALOIDS 
The identification of the five monoesters and two acyclic diesters is discussed together as 
the NMR spectra of these pyrrolizidines have very similar features due to their similar 
structures. Sarracine 36 and neosarracine 72, the two acyclic diester pyrrolizidine 
alkaloids , could be named 7-angelyl-9-sarracinylplatynecine and 7-angelyl-9-
isosarraciny lplatynecine, respectively. The proton and carbon NMR spectra of 
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pyrrolizidine alkaloids show distinctive shifts (see Section 3.2, p. 102) and in these 
pyrrolizidine alkaloids, the chemical shifts for the protons on carbons 2, 7 and 9 were 
important. 
To facilitate assignment of the 'H NMR signals of the pyrrolizidines examined (Table 2.2) 
COSY spectra [Figure 2.6 (9-angelylplatynecine 39) and Appendix] were required . The 
resonances for H-2 and H-6 overlap as do those for H-l , H-3 and H-5 . The key to 
assigning the shifts was recognising the H-7, H-8 and H-9 resonances as they are in an 
uncluttered region of the spectrum (ca . 3.5-5.5 ppm). 
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Figure 2.6: COSY spectrum of 9-angelylplatynecine 39. 
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Table 2.2: Proton NMR data (ppm) for 7-angelylhastanecine 66, 9-angelylhastanecine 67, 
7 -angelylplatynecine 38, 9-angelylplatynecine 39, 9-angelylplatynecine-4-oxide 
68, neosarracine 72 and sarracine 36. * 
Atomt 66 67 38 39 68 72 36 
1 2.42 2.83 2.31 2.64 3.19 2.68 2.83 
2u 2.05 2.12 1.91 1.78 2.14 1.75 1.95 
2d 2.08 2.26 2.14 1.90 2.32 1.81 
3u 2.84 3. 19 2.68 2.75 3.70 2.74 2.90 
3d 3.65 3.64 3.38 3.13 3.89-4.01 3.13 3.33 
5u 2.88 3.21 2.77 2.81 3.83 2.64 2.79 
5d 3.68 3.93 3.42 3.27 3.89-4.01 3.28 3.52 
6u 2.22 2.17 2.17 1.81 2.20 1.94 2.05 
6d 2.36 2.26 I. 91 2.60 2.02 2.14 
7 5.46 4.60 5.37 4.23 4.69 5.25 5.41 
8 4.22 4.18 3.89 3.36 3.89-4.01 3.58 3.84 
9u 3.60 4.49 3.57 4.47 4.47 4.14 4.24 
9d 3.77 4.62 3.72 4.57 4.63 4.29 4.40 
13 6.18 6.10 6.15 6.06 6.10 6.88 6.36 
14 2.01 1.98 2.02 1.97 1.98 1.83 2.03 
15 1.88 1.87 1.90 1.87 1.86 4.24 4.22 
18 6.02 6.12 
19 1.91 1.97 
20 1.83 1.88 
For solutions In CDCl,. 
t Upfield (u) and downfield (d) shifts of non-equivalent methylene protons. 
The site and extent of esterification was determined by examining the H-7 and H-9 
chemical shifts . The non-equivalent 9-methylene protons were observed as a pair of 
signals (double doublets , when not obscured by other signals) ca. 0.2 ppm apart. Both the 
H-7 and H-9 resonances shift downfield by ca. 1 ppm on esterification of the adjacent 
hydroxyl groups. Thus, the H-7 signal for the 7-angelyl derivatives, 7-angelylhastanecine 
66 and 7-angelylplatynecine 38, resonates downfield of H-9 while the pattern is reversed 
for the 9-angelyl derivatives, 9-angelylhastanecine 67 and 9-angelylplatynecine 39. For 
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the two 7,9-diesters, sarracine 36 and neosarracine 72, both the H-7 and the H-9 signals 
are shifted downfield. 
The H-7 and H-8 nuclei are coupled in all the pyrrolizidines examined, thus excluding the 
possibility of an otonecine base. The H-7 and H-6 nuclei are weakly coupled, and this 
coupling was not always observed on the COSY spectra without significantly increasing 
the signal intensity. The saturated character of the necine base portion of the alkaloids 
examined was indicated by the downfield position (between 1.9 and 2.5 ppm) of the H-2 
signal. From careful consideration of the various coupling relationships unambiguous 
assignment of the other signals was possible. 
There are three known saturated dihydroxypyrrolizidine bases, viz., platynecine 25, 
hastanecine 26, and turneforcidine 27. They have been distinguished by the width of the 
H-7 signal at half-height but this is not as well established for saturated necine bases as 
it is for the unsaturated bases. Although the width of the H-7 shift at half-height was 
determined for these pyrrolizidine alkaloids, nuclear Overhauser effect (NOE) difference 
spectroscopy was found to be more reliable. 
OH OH 
HO 9 HO 
J:I H 
6 7 8 2 
5 N 3 '---N---' 
25 26 
The signals for the protons on carbons 1, 7, and 8 were irradiated individually in separate 
experiments. If the protons are on opposite faces of the necine base, irradiation of the 
signal for one will not cause an increase in intensity of the other. For the hastanecine-
based alkaloids no through space interactions for the protons on carbons 1, 7 and 8 were 
apparent, as was the case for 7-angelylhastanecine 66 (see Figure 2.7) where irradiation 
of the H-8 nucleus causes no enhancement of the H-7 or H-I resonances, indicating that 
H-8 is on a different face of the necine base from H-7 and H-1. The platynecine-based 
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alkaloids, on the other hand, showed interactions between H-7 and H-8, and between H-8 
and H-l (see Figure 2.8); the NOE-difference spectrum for 9-angelylplatynecine 39, 
irradiated at H-8, shows enhancement of both the H-7 and H-l signals, indicating that all 
three protons are on the same face. The width at half-height of the H-7 peak was 10.2 Hz 
for 7-angelylhastanecine 66 and 7.2 Hz for 9-angelylhastanecine 67. For the platynecine 
based alkaloids,7-angelylplatynecine 38, 9-angelylplatynecine 39, neosarracine 72 and 
sarracine 36, however, the values ranged from 7.6 to 9.5 Hz; this range covers one of the 
hastanecine-based values, showing that this method is unreliable for saturated necine bases. 
66 
Figure 2.7: NOE-difference spectrum (a), irradiated at H-8, for 7-angelylhastanecine 66 
compared to the 'H NMR spectrum (b) . 
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Figure 2.8: NOE-difference spectrum (a) , irradiated at H-8, for 9-angelylplatynecine 39 
compared to 'H NMR spectrum (b) . 
The necic acid portions of the pyrrolizidines were easily identified by their characteristic 
quartets for a vinylic proton between 6.0 and 7.0 ppm. The acids were angelic acid (ca. 
6.1 ppm), present in the monoesters and the acyclic diesters, sarracinic acid (6.4 ppm) 
present in sarracine 36, and its isomer isosarracinic acid (6.9 ppm) in neosarracine 72 . 
In addition, both sarracinic and isosarracinic acid have characteristic singlets at 
approximately 4.3 ppm due to their hydroxy methylene units. The quartet for the vinylic 
proton couples on the COSY spectrum to both methyl groups for angelic acid and a methyl 
and methylene group for sarracinic and isosarracinic acid. On the COSY spectra for 
mixtures of neosarracine and sarracine the different necic acid moieties are clearly visible, 
while the remainder of the proton resonances for the two pyrrolizidines cannot be 
distinguished from one another. Tiglic acid isomers were also present as indicated by the 
vinylic proton resonance at approximately 6.7 ppm, but they were present iii such low 
63 . 
SENECIO CHRYSOCOMA AND SENECIO PANICULATUS SECTION 2.S.1 
concentrations that not all shift values were visible for their compounds. In view of the 
similarity of the proton and carbon-13 NMR shifts for neosarracine and sarracine, the 
tiglate isomers probably have similar chemical shifts to their angelate counterparts. 
However, due to the known spontaneous conversion of angelates to tiglates, the possibility 
that tiglyl-containing alkaloids are an artefact of the isolation procedure cannot be ruled 
out. In fact, a small increase in the concentration of tiglic isomers was noticed with time 
even though the samples were stored at low temperature, ca. 5°C. 
The carbon-13 shift assignments (Table 2.3) were made with the aid of HMQC spectra and 
by comparison with published data. There has been some conflict in the literature 
concerning the carbon-13 shifts for the angelate moiety of pyrrolizidine alkaloids. For 
example, in one publication'" the carbon shifts of the angelate moiety in 7-
angelylplatynecine 38 and 9-angelylplatynecine-4-oxide 68 have been differently assigned. 
The HMQC spectra [Figure 2.9 (9-angelylplatynecine 39) and Appendix] of the angelate 
containing pyrrolizidines in this study showed clearly that the terminal methyl group of the 
necic acid moiety (C-14 in example 39) has the upfield shift of ca. 15.6 ppm while C-15 
resonates at ca. 20.5 ppm. The geometric isomer of angelic acid, tiglic acid, follows the 
same pattern but the terminal methyl group resonates slightly further upfield at ca. 14 
ppm. Isosarracinic and sarracinic acid fit this pattern too. 
The NMR data for 7-angelylhastanecine 66 and 9-angelylhastanecine 67 (Tables 2.2 and 
2.3) have not previously been reported and the proton shift assignments, while atypically 
high compared to those of other monoester alkaloids, were confirmed by COSY and 
HMQC experiments. The signals for the necine base portion of pyrrolizidine alkaloids 
shift downfield when the alkaloid is oxidised. The observed shifts of the C-8 signals, 
however , clearly indicate that the nitrogen atoms of the hastanecine-based alkaloids 
examined (66, 67) were not oxidised. On the other hand, the C-8 signal for 9-
angelylplatynecine-4-oxide 68 moved from 70.30 ppm for the parent alkaloid 39 to 88 .18 
ppm for the oxidised form. The H-8 signal is also considerably further downfield. 
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Figure 2.9: HMQC spectrum for 9-angelylplatynecine 39. 
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Table 2.3 : Carbon-13 NMR data (ppm) for 7-angelylhastanecine 66, 9-angelylhastanecine 
67, 7-angelylplatynecine 38 , 9-angelylplatynecine 39, 9-angelylplatynecine-4-
oxide 68, neosarracine 72 and sarracine 36. * 
Atom 66 67 38 39 68 72 36 
1 40.22 39.98 40.13 40.70 37.98 39.94 40.01 
2 30.26 28.69 30.98 28.91 28 .94 28.49 28.64 
3 54 .88 54.32 55.13 55 .23 70.41 54.68 54.62 
5 52.36 53.85 52.33 53.69 68.24 53 .27 53.44 
6 34.48 36.73 34.85 37.41 34.81 34.69 34.76 
7 73.29 71.55 73 .93 72 .72 71.51 74.91 74.69 
8 71 .69 71.48 71.82 70.30 88.18 68.43 68 .87 
9 63 .46 62.28 64.75 64.33 62.58 63.90 63.23 
11 166.29 167.65 166.83 168. 10 167.78 166.89 166.68 
12 126.59 127.20 126.96 127.77 127.35 131.93 131.74 
13 140.83 139.20 140.23 137.83 138.98 140.93 140.98 
14 15.87 15.47 15.88 15.65 15 .86 14.04 15.67 
15 20.51 20.54 20.58 20.68 20.56 56.10 68 .89 
16 166.46 166.36 
17 126.79 126.62 
18 139.55 140.55 
19 15.51 15.78 
20 20.51 20.2 1 
For solutions In CDCl, . 
The structures of the monoesters, 7-angelylhastanecine 66, 9-angelylhastanecine 67, 7-
angelylplatynecine 38 , 9-angelylplatynecine 39 and 9-angelylplatynecine-4-oxide 68 , had 
now been determined. However, both the diesters , neosarracine 72 and sarracine 36, had 
been discovered to contain an angelic acid moiety and one other, either isosarracinic or 
sarracinic acid, but the mode of attachment was unknown. This was determined by 
heteronuclear multiple bond correlation (HMBC) spectroscopy, which detects coupling 
between protons and carbons one or two removed from the one to wh ich they are d irectl y 
bonded. The HMBC spectrum of neosarracine 72 (Figure 2. 10) shows coupling between 
H-7 and a carbonyl carbon and between that carbonyl carbon and the vinylic proton of 
angelic acid showing that the angelyl unit was attached at carbon 7 of the necine base 
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system. This leaves the isosarracinyl or sarracinyl unit to be attached at carbon 9. 
Moreover, the HMBC spectrum shows coupling between the vinylic proton of the 
isosarracinyl or sarracinyl moiety and the other carbonyl carbon and a coupling between 
this carbonyl carbon and the protons on carbon 9. 
Mass spectrometry (Table 2.4) helped to confirm the results obtained from NMR 
techniques . The saturated bases were indicated by characteristic major peaks at mlz 82, 
95, 138, 139 and 140. 185 An intense peak at mlz 9S (see Section 1.3.4.2, p. 23) is claimed 
to show esterification at carbon 9193 and was absent from the spectra for 7-
angelylhastanecine 66 and 7-angelylplatynecine 38. On the other hand, the peak at mlz 9S 
appeared as the base peak in the spectra for 9-angelylhastanecine 67 and 9-
angelylplatynecine 39. This observed difference in the mass spectra of 7- and 9-
angelylplatynecine is, in fact, contrary to that which has been reported previously. IS> For 
sarracine 36 and neosarracine 72, which are both esterified at position 9 as well as position 
7, the peak at mlz 95 is a major peak, but the base peak appears at mlz 138, which 
corresponds to the loss of both necic acid moieties from the alkaloid. The mass spectrum 
of 9-angelylplatynecine-4-oxide 68 does not fit the pattern for saturated pyrrolizidines; this 
may be due to the typical low volatility and thermal instability of N-oxides. 
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Figure 2.10: A section of the HMBC spectrum for neosarracine 72. 
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Table 2.4: Mass spectral data for the mono- and acyclic diester pyrrolizidine alkaloids . 
Pyrrolizidine alkaloid Mass Fragments* 
7-angelylhastanecine 66 239(W,0.3), 219(0.2), 156(47), 140(6), 
139(64), 138(13), 114(12), 113(13), 83(13), 
82(100), 55(9). 
7-angelylplatynecine 38 239(M +,I), 208(1), 156(40), 140(21), 
139(85), 138(29), 109(10), 108(41), 83(30), 
82(100) , 55(16) . 
9-angelylhastanecine 67 239(W,6), 221(32) , 195(6), 155(5), 140(29), 
139(11), 138(16), 122(49), 121(7), 120(7), 
96(91) , 95(100), 94(19) , 83(28), 82(96) , 
55(71). 
9-angelylplatynecine 39 239(M+ ,2), 221(5), 195(1), 156(2), 140(6), 
139(4), 138(5), 122(9), 121(2), 120(2), 
96(36), 95(100), 94(5), 82(94), 55(19). 
9-angelylplatynecine-4-oxide 68 219(1), 120(14), 119(100), 118(7), 107(5), 
106(59), 79(6) , 77(4) , 55(5). 
sarracine 36 237(8) , 222(10), 140(37), 139(32), 138(100), 
123(26), 122(57), 121(13), 96(46), 95(47), 
83(35), 82(74) , 55(35). 
neosarracine 72 237(9) , 222(9), 140(29), 139(27), 138(100), 
123(22) , 122(38), 121(15), 96(30) , 95(51) , 
83(24) , 82(64), 55(27) . 
* Mlz values followed by % relatIve abundance In parentheses. 
The extracts from the Grahamstown S. chrysocoma popUlation contained sarracinic acid 
methyl ester 73 and isosarracinic acid methyl ester 74 but it is not known if these esters 
are artefacts of the extraction procedure or not. The proton NMR chemical shifts for 
compounds 73 and 74 (Table 2.5) correlate with those for the sarracinic and isosarracinic 
moieties of sarracine 36 and neosarracine 72. 
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Table 2.5: Comparative proton NMR data (ppm)* for sarracinic acid methyl ester 73, 
isosarracinic acid methyl ester 74, sarracine 36 and neosarracine 72. t 
~OH o 2 1 ""':: 3 CI-ljO 4 
73 
Atomt 73 
3(13) 6.37(q) 
4(14) 2.06(d) 
5(15) 4.22(s) 
-
OCR3 3.79(s) 
. .. 
* MultIphclty In parentheses . 
t For solutions in CDC I,. 
(OH 
O~ 
CH,O 
74 
36 74 72 
6.36 6.99(q) 6.88 
2.03 1. 9O(d) 1.83 
4.22 4.35(s) 4.24 
3.77(s) 
t Number in parentheses is the equivalent atom number in sarracine and neosarracine. 
2.5.2 THE 7-ANGELYL-l-METHYLENEPYRROLIZIDINE ALKALOIDS 
I-Methylenepyrrolizidines have previously only been found in Crotalaria and Onosma 
species, which belong to the Legume family.41.310 They had never previously been found 
esterified at carbon-7 or in Senecio species or in the Compositae family, and there are 
features of the NMR spectra of these compounds which are unusual for pyrrolizidine 
alkaloids. 
The proton chemical shifts for these alkaloids are given in Table 2.6. Esterification at 
position 7 is indicated, in all three cases, by an H-7 chemical shift of ca. 5.6 ppm. What 
are assumed to be the H-9 signals are at an unusually low field, but indicate the possibility 
of esterification at position 9. Signals attributable to H-8 were also visible and indicate 
the presence of a bicyclic necine base (not an otonecine base) in each system. The upfield 
H-2 signals, once identified, indicated that the base was saturated . The H-l signals were 
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not visible in the proton NMR spectra but can often be obscured by the signals for the 
protons on carbons 2, 3 or 5; unfortunately their presence could not be confirmed by 
integration as impurities in the fraction led to irregularities. However, as the H-2 shift 
was in an upfield position ("typical" in saturated necine bases) the H-I signal was assumed 
to be present but obscured by overlapping signals. The esterifying acid in each spectrum 
was angelic acid as shown by a characteristic quartet at ca. 6.0 ppm. A far smaller 
quartet at ca. 6.7 ppm indicated the presence of very small amounts of the tiglic acid 
analogues, which could, again, be artefacts of the extraction procedure. 
Table 2.6: Proton NMR data (ppm)* for 7a-angelyl-l-methylene-8a-pyrrolizidine 69, 7a-
angelyl-l-methylene-8a-pyrrolizidine-4-oxide 70 and 76-angelyl-l-methylene-
8a-pyrrolizidine 71. t 
Atomt 69 70 71 
2u 2.66(t) 2.69(m) 2.55(m) 
2d 3.12(m) 
3u 2.90 3.79(m) 2.76(m) 
3d 3.41 3.16(m) 
5u 2.92 3.84(m) 2.83(m) 
5d 3.60(t) 3.91(m) 3.27(m) 
6u 2. 17(dd) 2.22(m) 2.08(m) 
6d 2.32 3.01(m) 2. I7(m) 
7 5.62(t) 5. 84(dt) 5.52(dt) 
8 4.46(s) 4.66(d) 4.14(d) 
9u 4.96(s) 5.04(d) 4.88(d) 
9d 5.04(s) 5.24(d) 5.07(d) 
13 6.07(q) 6.1O(dq) 6.03(dq) 
14 1. 97(d) 1. 98(dd) 1. 99(dd) 
15 1. 83(s) 1. 84(t) 1. 84(t) 
. . . . 
* Multlphclty of ShiftS, where It could be determIned, IS In parentheses . 
t For solutions in CDCI,. 
t Up field (u) and downfield (d) shifts of non-equivalent methylene protons. 
The COSY spectra [Figure 2.11 (71l-angelyl-l-methylene-8a-pyrrolizidine 71) and 
Appendix] also did not reveal the presence of the H-l signal. The H-2 signal couples to 
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H-3 but not H- l ; neither does the H-8 signal couple to H-l. The two signals assumed to 
be the H-9 signals couple to H-8, as would be expected, but do not couple with each other, 
which is unusual. The rest of the couplings are typical for a pyrrolizidine alkaloid. 
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Figure 2.11: COSY spectrum for 71l-angelyl-l-methylene-8or-pyrrolizidine 71. 
The carbon-13 NMR spectra of7ll-angelyl-l-methylene-8or-pyrrolizidine 71 , 7or-angelyl- l -
methylene-8or-pyrrolizidine 69, and 7or-angelyl-l-methylene-8or-pyrrolizidine-4-oxide 70 
(Table 2.7) have thirteen peaks which rule out the possibility of a diester, as eight signals 
are required for the necine base, leaving five, which are enough for a single angelate ester. 
There is one carbonyl peak as expected for a single angelate ester , but four vinylic 
carbons. Since only two are required for the angel ate moiety, the base was, thus, 
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presumed to be unsaturated . If a necine base is unsaturated the double bond is usually 
between carbons 1 and 2 but the shift for H-2 and the COSY coupling patterns preclude 
,his location. The proton shifts of the other ring protons (Table 2.6) show that there is no 
double bond within either of the base rings. This and the missing H-l resonance lead to 
the conclusion that there is an exocyclic double bond between carbons 1 and 9 in the 7-
angelyl- l -methylenepyrrol izidines. 
Table 2.7: Carbon-I3 NMR data (ppm) for 7cx-angelyl-l-methylene-8cx-pyrrolizidine 69, 
7cx-angelyl-l-methylene-8cx-pyrrolizidine-4-oxide 70, and 7B-angelyl-l-
methylene-8cx-pyrrolizidine 71. * 
Atom 69 
1 t 
2 33.45 
3 53 .70 
5 52.60 
6 34.21 
7 73 .91 
8 71.68 
9 109.89 
11 166.28 
12 127.16 
13 139.21 
14 15.69 
15 20.46 
For solutions In CDCl,. 
t Too weak to be detected. 
70 71 
139.74 147.09 
32.63 33.92 
68.47 54 .46 
67.36 52.81 
32.07 34.35 
72.41 74.95 
89.63 71.94 
112.49 107.68 
165.83 166.87 
126.63 127.86 
140.18 137.84 
15 .73 15.61 
20.32 20.55 
HMQC experiments [Figure 2.12 (7B-angelyl-l-methylene-8cx-pyrrolizidine 71) and 
Appendix] confirmed the existence of the exocyclic double bond, as both H-9 nuclei couple 
to the same vinylic carbon. After assigning all the other carbons , carbon-12 (ca. 127 ppm) 
was assigned by comparison with other angel ate esters , it was clear that the remaining 
quaternary carbon signal was due to carbon-I . 
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Figure 2.12: HMQC spectrum for 7Il-angelyl-l-methylene-8a-pyrrolizidine 71. 
The basic skeleton was thus determ ined to be 7-angelyl- l-methylenepyrrolizidine but the 
stereochemistry at carbons 7 and 8 had not been established. To determine the relative 
stereochemistry NOE-difference spectroscopy was used. If H-8 is assumed to be in the 
a position, which is most common, then the two possible diastereoisomers are 7Il-angelyl-
I-methylene-8a-pyrrolizidine 71 and 7a-angelyl- l-methylene-8a-pyrrolizidine 69. 
Irradiation of 7Il-angelyl-l-methylene-8a-pyrrolizidine 71 at the H-8 resonance frequency 
(see Figure 2. 13) produced an enhancement of the H-7 signal, while similar irradiation of 
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7et-angelyl-1-methylene-8et-pyrrolizidine 69 (see Figure 2.14) produced no enhancement 
of the H-7 signal. The N-oxide of 7et-angelyl-1-methylene-8et-pyrrolizidine, easily 
recognisable by H-8 and C-8 chemical shifts of 4.66 and 89.63 ppm, respectively, was 
also identified. 7B-Angelyl-1-methylene-8et-pyrrolizidine 71 was extracted in far higher 
concentrations than 7et-angelyl-1-methylene-8et-pyrrolizidine 69 and its N-oxide 70, which 
were each only identified by NMR spectroscopy in one fraction . 
(a) 
71 
(b) 7 
Figure 2.13: NOE difference spectrum (a), irradiated at H-8, for 7B-angelyl-l-
methylene-8et-pyrrolizidine 71 compared to the 'H NMR spectrum (b). 
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Figure 2.14: NOE-difference spectrum (a), irradiated at H-8, for 7a-angelyl- l-
methylene-8a-pyrrolizidine 69 compared to the 'H NMR spectrum (b). 
A stereoselective synthesis of 7fl-angelyl-l-methylene-8a-pyrrolizidine 71 was then 
undertaken to establish the absolute stereochemistry at positions 7 and 8 of the necine base 
portion of the alkaloid (see Section 4, p. 114). (Only a minute amount of 7a-angelyl-l-
methylene-8a-pyrrolizidine 69 was present in the plant extracts effectively preventing 
comparisons from being made with any synthetic material.) The synthesis confirmed the 
stereochemistry of the natural alkaloid as 7fl-angelyl-l-methylene-8a-pyrrolizidine 71. 
Since 7fl-angelyl-l -methylene-8a-pyrrolizidine 71 has the same stereochemistry at carbons 
7 and 8 as platynecine 25, it is possible that the 7a-angelyl analogue 69 has the same 
stereochemistry as hastanecine 26, the other necine base present in the alkaloids identified 
in this study, and could thus be 7fl-angelyl-l-methylene-8fl-pyrrolizidine. 
The EI mass spectra of 7fl-angelyl-l-methylene-8a-pyrrolizidine 71 and 7a-angelyl-l-
methylene-8a-pyrrolizidine 69 did not show the molecular ion; the highest mass peak was 
76, 
SENECIO CHRYSOCOMA AND SENECIO PANICULATUS SECTION 2.5.3 
at mlz 138, which represents the loss of the angelic acid moiety from the alkaloid. The 
base peak at mlz 95 is contra-indicative of esterification at position 9. The CI spectra 
confirmed the mass of these novel compounds (69, 70, and 71) to be 221. The formula 
of 7B-angelyl-1-methylene-8a-pyrrolizidine 71 and 7a-angelyl-1-methylene-8a-pyrrolizidine 
69, C13HX9N02, was also confirmed by high resolution mass spectrometry. 
2.5.3 THE MACROCYCLIC DIESTER PYRROLIZIDINE ALKALOIDS 
Retrorsine 9 was the only macrocyclic pyrrolizidine alkaloid identified and was also the 
only pyrrolizidine identified containing a "traditional" unsaturated necine base. Being a 
well-documented alkaloid, retrorsine was easily identified using the database (see Section 
3.2.3, p. 110). The major features of the proton and carbon-13 NMR spectra (Table 2.8) 
that distinguish retrorsine 9 from the other pyrrolizidine alkaloids in these plants are:-
i) the downfield positions of the H-2 (6.20 ppm) and corresponding C-2 signals (136.61 
ppm), indicating an unsaturated necine base; 
ii) the large difference between the chemical shifts for the non-equivalent 9-methylene 
protons (t.H-9 = 1.41 ppm) indicative of a 12-membered macrocycle (see Section 
3.2.1,p.102);and 
iii) characteristic resonances of the necic acid portion of the alkaloid, most notably the 
signal at 5.74 ppm for the H-20 vinylic proton and the signals at 3.62 and 3.74 ppm 
for the I8-methylene protons. The necic acid portion of retrorsine, isatinecic acid 
consists of ten carbons not five as in angelic, sarracinic and isosarracinic acids. 
77. 
SENECIO CHRYSOCOMA AND SENECIO PANICULATUS SECTION 2.5.3 
Table 2.8: Proton and carbon-13 NMR data (ppm) for retrorsine 9. * 
Atomt IH 13C 
1 132.38 
2 6.20 136.61 
3u 3.40 62.59 
3d 3.97 
Su 2.55 52.94 
Sd 3.29 
6u 2.08 34.73 
6d 2.40 
7 5.02 74.98 
8 4.31 77.47 
9u 4.10 61.06 
9d 5.51 
11 175.65 
12 81.29 
13 1.68 35.69 
14u 1.72 37.89 
14d 2.12 
15 131.18 
16 167.31 
18u 3.62 66.86 
18d 3.74 
19 0.85 11.68 
20 5.74 134.85 
21 1.83 15.05 
* For solutions III CDCl,. 
t Upfield (u) and downfield (d) shifts of non-equivalent methylene protons 
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2.6 A CHEMICAL COMPARISON OF THE TWO SPECIES, SENECIO 
CHRYSOCOMA AND S. PANICULATUS 
Although the pyrrolizidine alkaloids associated with each species were not identified by 
NMR spectroscopy in all the populations of that species, comparison of GLC 
chromatograms of the crude extracts revealed that the three populations of each group, 
viz., S. chrysocoma, borderline S. chrysocoma, and S. paniculatus, contained similar 
pyrrolizidine alkaloids and only slight differences between the groups were noted. 
A representative GLC chromatogram for each group is shown in Figure 2.15 (the other 
populations' chromatograms are in the Appendix). It is necessary to note that the GLC 
column used, the HP-ultra 2, was cleaned during the course of the study and a section of 
the column was removed, so the retention times for the alkaloids do not match precisely 
from one group to the next; the pattern of the peaks, however, is the same, and the 
chromatograms can be divided into several sections:-
i) impurities with a retention time of less than 9.5 minutes; 
ii) 7-angelyl-l-methylenepyrrolizidines with retention times between 9.5 and 11.5 
minutes; 
iii) monoesters with retention times between 11.5 and 16 minutes; 
iv) acyclic diesters eluting between 19 and 21 minutes; and 
v) macrocyclic diesters eluting at ca. 21 minutes (observed in one set of chromatograms 
only). 
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Figure 2.15a: The GLC chromatogram of the crude extract from the Humansdorp S. 
chrysocoma population. 
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Figure 2.15b: The GLC chromatogram of the crude extract from the 
Dieprivierhoogte S. chrysocoma population. 
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Figure 2.15c: The GLC chromatogram of the crude extract from the Assegaaibos 
S. paniculatus population. 
Most of the pyrrolizidine alkaloids responsible for peaks on the GLC chromatograms 
(Figure 2.15) have been identified by NMR spectroscopy and these peaks are labelled with 
the structure number of the alkaloid. From these chromatograms it can be seen that 7/l· 
angelyl-l-methylene-8a-pyrrolizidine 71 , 9-angelylplatynecine-4-oxide 68 , 7-
angelylhastanecine 66, 7-angelylplatynecine 38, 9-angelylhastanecine 67, 9-
angelylp latynecine 39, sarracine 36 and neosarracine 72 are present in the extracts from 
all three groups. 
The borderline S. chrysocoma populations (Dieprivierhoogte, Prince Alfred's Pass, and 
Wittedrif) have the same pyrrolizidine alkaloid content as the S. chrysocoma populations 
(Grahamstown, Humansdorp, and Van Stadens River dams), except that no 7a-angelyl- l-
methylene-8a-pyrrolizidine 69 was identified in extracts from the borderline populations . 
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7et-Angelyl-1-methylene-8et-pyrrolizidine 69 has a slightly shorter retention time than the 
diastereomeric 71l-angelyl-1-methylene-8et-pyrrolizidine 71, but it and its N-oxide 70 are 
not visible on the GLC chromatograms of the crude extracts as they are present in such 
low concentrations. In fact, 7et-angelyl-1-methylene-8et-pyrrolizidine 69 was only 
identified, by NMR spectroscopy, in extracts from the Van Stadens River dams population, 
while the N-oxide was only identified in extracts from the Grahamstown population. 
However, a peak for the unoxidised form was present in the chromatogram of the fractions 
obtained from crude extracts of the Grahamstown, Humansdorp, and Van Stadens River 
dams. 
The pyrrolizidine alkaloid content of the S. paniculatus populations (Assegaaibos, 
Robinson Pass, and Tradouw Pass) differs from that of the S. chrysocoma populations 
(Grahamstown, Humansdorp, and Van Stadens River dams) by the absence of7et-angelyl-
1-methylene-8et-pyrrolizidine 69 and the presence of a peak at ca. 21 minutes, which was 
later identified as retrorsine 9. This was the only macrocycle present and also the only 
"typical" unsaturated pyrrolizidine alkaloid. Retrorsine 9 was identified by NMR 
spectroscopy in the Tradouw Pass S. paniculatus population's extract, but a peak for the 
alkaloid appears on the GLC chromatograms of all three S. paniculatus populations. 
The hastanecine-based pyrrolizidines, 7-angelylhastanecine 66 and 9-angelylhastanecine 
67, were identified by NMR techniques in the S. chrysocoma populations but not in the 
borderline S. chrysocoma or S. paniculatus populations; however, there are corresponding 
signals for these alkaloids in the chromatograms for the S. chrysocoma borderline and S. 
paniculatus populations. 
Although the populations contain similar alkaloids they are present in different 
concentrations (Table 2.9a,b,c). In all the groups, 9-angelylplatynecine 39 has the highest 
concentration, while there is no clear pattern for the remaining pyrrolizidine alkaloids. 
Different locations and collection during different seasons are thought to be responsible for 
differences in pyrrolizidine alkaloid concentrations within a single species.3II ·m The 
reproductive organs and young leaves of plants have been shown to contain more 
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pyrrolizidine alkaloids than the mature vegetative parts; 184,313·317 therefore, for maximum 
alkaloid yields pre-flower and budding plants should be extracted. The plants extracted 
in this study, however, were not all collected during the same phase of their development; 
in particular, the S, chrysocoma borderline (Dieprivierhoogte, Prince Alfred 's Pass, and 
Wittedrif) and S. paniculatus (Assegaaibos, Robinson Pass and Tradouw Pass) populations 
were collected at the very end of, or just after, their flowering season, while the S. 
chrysocoma populations (Grahamstown, Humansdorp, and Van Stadens River dams) were 
collected at the beginning of, or during , their flowering season. Even though the S. 
chrysocoma borderline populations were collected at the end of their flowering season they 
generally contained more pyrrolizidines than the other S. chrysocoma populations, which 
is contrary to what was expected. The S. paniculatus populations, on the other hand , 
contained fewer pyrrolizidines than all the S. chrysocoma populations. 
Table 2.9a: Concentrations of identified pyrrolizidine alkaloids in plant extracts from the 
S. chrysocoma populations (A-Grahamstown, B-Humansdorp , and C-Van 
Stadens River dams) as a percentage of dry plant weight. 
Pyrrolizidine alkaloid A B C 
%/10.2 %/10.2 %110.2 
70<-angelyl- l-methylene-80<-pyrrolizidine 69 0.27 0.16 0.14 
7B-angelyl-l-methylene-80<-pyrrolizidine 71 6.6 2.1 2.9 
9-angelylplatynecine-4-oxide 68 0.95 0 .97 0.89 
7-angelylhastanecine 66 0.52 0.39 0.42 
7-angelylplatynecine 38 0 .20 0.44 0.42 
9-angelylhastanecine 67 5 .1 7.1 4.5 
9-angelylplatynecine 39 28 .8 22.1 11.0 
sarracine 36 3.9 1.2 1.9 
neosarracine 72 14.0 4.2 3.0 
Total concentration 60.3 38.7 25.2 
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Table 2.9b: Concentrations of identified pyrrolizidine alkaloids in plant extracts from the 
S. chrysocoma border-line populations (D-Dieprivierhoogte, E-Prince 
Alfred's Pass, and F-Wittedrif) as a percentage of dry plant weight. 
Pyrrolizidine alkaloid D E F 
%110.2 %/10.2 %/10-2 
7B-angelyl-l-methylene-8a-pyrrolizidine 71 0.90 3.2 3.4 
9-angelylplatynecine-4-oxide 68 0.30 0.44 0.41 
7-angelylhastanecine 66 0.13 0.44 1.2 
7-angelylplatynecine 38 0.052 0.63 0.48 
9-angelylhastanecine 67 1.2 12.0 12.6 
9-angelylplatynecine 39 11.8 49.0 35.1 
sarracine 36 0.41 0.27 0.80 
neosarracine 72 1.4 0.88 2.7 
Total concentration 16.2 66.9 56.7 
Table 2.9c: Concentrations of identified pyrrolizidine alkaloids in plant extracts from the 
S. paniculatus populations (G-Assegaaibos, H-Robinson Pass, and 1-
Tradouw Pass) as a percentage of dry plant weight. 
Pyrrolizidine alkaloid G H I 
%/10-2 %/10-2 %/10-2 
7B-angelyl-l-methylene-8a-pyrrolizidine 71 2.5 0.92 0.84 
9-angelylplatynecine-4-oxide 68 0.30 0.23 0.36 
7-angelylhastanecine 66 0.25 0. 12 0.25 
7-angelylplatynecine 38 0.71 0.48 0.34 
9-angelylhastanecine 67 4.7 3.8 2.7 
9-angelylplatynecine 39 11.3 12.5 7.5 
sarracine 36 0.32 0.47 1.1 
neosarracine 72 1.1 1.5 2.4 
retrorsine 9 0.11 0.32 0.21 
Total concentration 21.3 20.3 15.7 
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In the representative GLC chromatograms of the crude extracts (see Figure 2.15) there are 
five unidentified peaks on each chromatogram (labelled *) with retention times slightly 
longer than 76-angelyl - I-methylene- 8~-pyrrolizidine 71, 9-angelylplatynecine-4-oxide 68, 
9-angelylplatynecine 39, sarracine 36 and neosarracine 72, respectively. It is possible that 
these represent the corresponding tiglyl isomers, namely, 71l-tiglyl-I-methylene-8~­
pyrrolizidine 75, 9-tiglylplatynecine-4-oxide 76, 9-tiglylplatynecine 77, sarranicine 78 and 
neosarranicine 79. The mass spectra of these compounds correlate well with their 
corresponding angelyl isomers (Table 2.10); as the necic acid components are geometric 
isomers and necine bases are identical, similar mass fragmentation patterns are expected. 
75 
~OH o '-'::: o 
'----- N--' 
78 
O~ 
o 
HO 
'---N----' 
77 
'----- N--' 
79 
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Table 2.10: Mass spectral data of the proposed tiglyl derivatives and their angelyl 
isomers. 
I Pyrrolizidine alkaloid I Mass fragmentt I 
7B-angelyl- l -methylene- 138(42), 121(42), 95(100), 80(7), 67(7), 55(13). 
8a-pyrrolizidine 71 
7B-tiglyl-l-methylene-8a- 138(38), 121(45), 95(100), 67(7), 55(11) . 
pyrrolizidine 75 
9-angelylplatynecine 39 221(5), 195(1), 156(2), 140(6), 139(4), 138(5) , 122(9) , 
96(36), 95(100) , 82(94) , 55(19). 
9-tiglylplatynecine 77 221(7), 195(2) , 156(1), 138(4), 122(5), 96(13) , 95(100), 
82(72), 55(17) . 
sarracine 36 237(8), 222(10), 140(37), 139(32), 138(100), 123(26), 
122(57), 121(13), 96(46), 95(47), 83(35), 82(74), 55(35). 
sarranicine 78 237(11), 222(12) , 140(38), 139(29), 138(100), 122(78), 
96(38) , 95(49), 83(36), 82(76), 55(32). 
neosarracine 72 237(9), 222(9), 140(29), 139(27), 138(100), 123(22), 
122(38), 121(15) , 96(30), 95(51), 83(24) , 82(64), 55(27). 
neosarranicine 79 237(11) , 222(12) , 140(51) , 139(37), 138(100), 122(53), 
96(47), 95(79), 83(42), 82(90), 55(42) . 
Mlz values followed by % relative abundance in parentheses. 
Proton NMR spectra of fractions which, by GC-MS , contained a supposed tiglyl 
compound, revealed a quartet at ca. 6.7 ppm, which is characteristic of the vinylic proton 
of the tiglic acid moiety. The tiglyl compounds were never present in large amounts and 
no single tiglyl compound was completely identified by NMR techniques. The 
temperatures involved in GLC analyses could easily have caused an increase in the 
percentage of tiglyl isomers. Stelljes et al. 68 have noted that trans isomers always elute 
after their cis isomers. They were looking , in particular, at sarracine 36 (7-angelyl-9-
sarracinylplatynecine) and neosarracine 72 (7-angelyl-9-isosarracinylplatynecine) , and the 
corresponding tiglyl isomers, sarranicine 78 (7-tiglyl-9-sarracinylplatynecine) and 
neosarranicine 79 (7-tiglyl-9-isosarracinylplatynecine) . Isosarracinic acid is the trans 
isomer of sarracinic acid , while tiglic acid is the trans isomer of angelic acid . When the 
sarracine/neosarracine region of the GLC chromatograms in Figure 2.15 is expanded 
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(e.g. Figure 2.16), four peaks can be distinguished . The first two components have been 
identified by NMR spectroscopy as sarracine 36 and neosarracine 72; in view of the 
observation by Stelljes et ai., 68 the other two could be the corresponding tiglic isomers (78 
and 79). These deductions are consistent with the expectation that sarracine 36 (in which 
both necic acids, angelic and sarracinic, are the cis isomers) should have the shortest 
retention time of the four isomers, while neosarranicine 79 (in which both necic acids are 
the trans isomers) would have the longest retention time. 
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Figure 2.16: The expanded sarracine/neosarracine region of the GLC chromatogram. 
As indicated previously (p. 45), S. panicuiatus has been recorded as containing senecionine 
10 and platyphylline 17,"·33 but as neither of these was found to be present the original 
publ ication3l 8 was consulted and it was discovered that S. grarulifoiius and not S. 
paniculatus had actually been extracted. Nowhere has S. grarulifolius been found as a 
synonym for S. panicuiatus. On the other hand, S. graminifolius, which is given as a 
synonym for S. chrysocoma, has been found to contain the macrocyclic pyrrolizidine 
retrorsine 9. S. graminifolius could, therefore, be the genuine S. panicuiatus. 
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2.7 BIOLOGICAL ACTIVITY 
The cytotoxicity of pyrrolizidine alkaloids is caused by pyrrolic metabolites which are 
formed in the liver. 319 This, in turn, depends on the alkaloid having a structure that has 
the potential to be converted to toxic metabolites and the ability of an animal's enzymes 
to effect this conversion.319 The minimum structural requirements for hepatotoxicity of 
naturally occurring pyrrolizidine alkaloids include (see Figure 2.17):-
i) an unsaturated necine base portion; 
ii) a hydroxyl group on carbon 9 and, preferably, on carbon 7 too; 
iii) esterification of at least one of the hydroxyl groups; and 
iv) a branched necic acid moiety. 319 
Figure 2.17: The minimum structural requirements 
for hepatotoxicity of naturally 
occurring pyrrolizidine alkaloids. 319 
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The alkaloids identified in this study, with the exception ofretrorsine 9, do not fit the first 
requirement, which is essential for pyrrole formation. Retrorsine 9 is present in Senecio 
paniculatus, but in very low concentrations, and is absent in S. chrysocoma, so neither 
species should be exceedingly toxic to stock. The 7-angelyl-l-methylenepyrrolizidines (69, 
70, 71) have an exocyclic double bond on the necine base moiety but, as far as has been 
determined, this will not migrate to an endocyclic position to allow for pyrrole 
formation .320 It is interesting to note that Erhlich's spray reagent detects unsaturated 
. pyrrolizidine alkaloids as their pyrrole derivatives. 136.321 For TLC identification a 1 % 
solution o-chloranil in toluene is used as a spray to convert the alkaloids to their pyrrole 
derivatives,I34' I36 which then stain purple with Erhlich's reagent. Retrorsine 9 readily 
undergoes this conversion and is seen as a purple spot on TLC plates, while the 
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platynecine-based alkaloids did not give a positive response. The 7-angelyl- l-
methylenepyrrolizidines did not stain purple under the same conditions and were therefore 
assumed not to hrm the pyrrole derivatives essential for cytotoxicity. However, this does 
not rule out the possibility that enzymes can catalyse the conversion. 
The National Cancer Institute (NCI), in the United States of America, tested neosarracine 
72 and the 7l3-angelyl-l-methylene-8a-pyrrolizidine 71 for antitumour activity. A sample 
of neosarracine was requested by the NCI and as 7l3-angelyl-l-methylene-8a-pyrrolizidine 
was a novel pyrrolizidine and, therefore, an untested structural arrangement it was sent for 
testing. The NCI tests provide an initial evaluation of a potential antitumour agent on as 
little as 25 mg.322 In these tests, the cell panel consists of 60 human cell lines from nine 
cancer types (lung, colon, melanoma, renal, ovarian, central nervous system, leukaemia, 
prostrate and breast) against which the agents are tested at a minimum of five different 
concentrations. Cell viability or growth is estimated by a sulphorhodamine B (SRB) 
protein assay.322 Neosarracine 72 showed mild activity against a few cell lines and was 
thus tested twice, but 7l3-angelyl-l-methylene-8a-pyrrolizidine 71 exhibited no antitumour 
activity. 
71 
'----N---' 
72 
Dose response curves (in which percentage growth is plotted against the loglo of the 
concentration of test compound) for 7l3-angelyl-l-methylene-8a-pyrrolizidine 71 are shown 
in Figure 2.18. Horizontal lines representing a percentage growth of +50, 0, and -50 are 
gIVen. The concentrations corresponding to where the curves cross these lines, if they do, 
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are the 50% growth inhibition (GI50) , total growth inhibition (TGI), and 50% cytotoxicity 
(LC50) concentrations, respectively. From these curves it can be seen that for 7B-angelyl-
1-methylene-8c¥-pyrrolizidine 50% growth inhibition concentration is only achieved once, 
for a colon cancer, over the tested range. 
For neosarracine 72 the mean graphs (Figure 2.19) are shown instead of the dose response 
curves. These graphs summarise the data obtained from the dose response curves in a 
manner which readily shows any above average activity against any particular cell line. 
Bars extending to the right show sensitivity of that cell line to the test compound compared 
to the average of all the tested cell lines. The bar scale is logarithmic, hence, a bar two 
units to the right implies that the compound achieved the response parameter at a 
concentration one hundredth of the mean concentration required over all cell lines and 
thus, that cell line is particularly sensitive to the test compound. Bars to the left indicate 
sensitivity less than the mean. If a response parameter could not be determined by 
interpolation, on the dose response curves, the bar length shown is the highest or lowest 
concentration tested and the response parameter is preceded by > or < , respectively. 
Neosarracine 72 showed activity against leukaemia, colon cancer and melanoma cell lines 
and less activity against renal and breast cancer cell lines, but at no time was the activity 
exceptional and worthy of further investigation. It is interesting to note the activity shown 
against all the forms of leukaemia tested as it was against leukaemia that indicine-4-oxide 
3, the only pyrrolizidine alkaloid to undergo clinical trials, was marginally successful ;30 
the toxicity of the alkaloid being a major side effect. 234 
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Figure 2.18: Dose response curves for 7B-angelyl-l-methylene-8cx-pyrrolizidine's 71 
antitumour tests. 
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Figure 2.19 : Mean graphs of results of neosarracine's 72 antitumour tests. 
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Neosarracine 72 was also tested by the NCI as a potential anti-human immunodeficiency 
virus (HIV) agent. The test used by the NCI323 is designed to detect agents acting at any 
stage of the viral reproductive cycle and involves the killing of T4 lymphocytes by the 
HIV . The results of the test are shown in Figure 2.20. The solid line is the percentage 
surviving HIV-infected cells treated with neosarracine relative to un infected , untreated 
controls and the line, therefore, expresses the in vitro anti-HIV activity of neosarracine. 
The dashed line is the percentage surviving uninfected cells treated with neosarracine 
relative to the same uninfected, untreated controls and represents the in vitro growth 
inhibitory properties of the alkaloid. The viral cytopathic effect is represented by the 
dotted line and shows the extent of cell destruction by the virus in absence of treatment. 
This property is used as a quality control parameter. As can be deduced from the graph, 
neosarracine 72 was inactive against HIV. 
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Figure 2.20: The results of the anti-HIV tests preformed with neosarracine 72. 
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2.8 CONCLUSION 
In total, eight known pyrrolizidine alkaloids, 7-angelylhastanecine 66, 7-angelylplatynecine 
38, 9-angelylhastanecine 67, 9-angelylplatynecine 39 and its N-oxide 68, sarracine 36 , 
neosarracine 72 and retrorsine 9, were extracted from the plant material and identified by 
NMR spectroscopy. The NMR data for the known 7-angelylhastanecine 66 and 9-
angelylhastanecine 67 has been reported for the first time. The novel sttuctured 7a-
angelyl-l-methylene-8a-pyrrolizidine 69 and its N-oxide 70, 7B-angelyl-l-methy1ene-8a-
pyrrolizidine 71, were also identified in the plant extracts by NMR techniques. With the 
exception of 7a-angelyl- l-methylene-8a-pyrrolizidine 69 and its N-oxide 70, present in S. 
chrysocoma, and retrorsine 9, present in S. panicuiatus, all the remaining alkaloids were 
found in both S. chrysocoma and S. panicuiatus. The presence, in both species, of a further 
five alkaloids, 7B-tiglyl-l-methylene-8a-pyrrolizidine 75, 9-tiglylplatynecine 77 and its N-
oxide 76, sarranicine 36 and neosarranicine 72, has been proposed on the strength of the 
GC-MS data, but these compounds could be artefacts of the isolation and identification 
processes. 
A morphological difference between the two species, S. chrysocoma and S. panicuiatus, 
was definitely apparent in the plants collected for this investigation; those plants collected 
west of Uniondale had pinnatipartite leaves, while those east of Uniondale had linear-
lanceolate leaves. Despite the morphological difference between the two species, it was 
clear that there is very little difference in their pyrrolizidine alkaloid content. However, 
the presence of retrorsine 9 in S. panicuiatus is one distinguishing feature, particularly as 
it has a different basic structure from the other pyrrolizidines extracted from these plants. 
None of the alkaloids which have been identified, with the exception of retrorsine 9, have 
the requisite structure for hepatotoxicity. Moreover, retrorsine was present in such low 
concentrations (0.0011-0.0032% of dry plant weight) that the toxicity of S. panicuiatus to 
stock is probably negligible. Neosarracine 72 and 7B-angelyl-l-methylene-8a-pyrrolizidine 
71 were tested for anti tumour activity, and neosarracine 72 for anti-HIV activity. 
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Neosarracine exhibited limited anti tumour activity but no anti-HIV activity, while 73-
angelyl-I-methylene-8et-pyrrolizidine 71 showed no antitumour activity. 
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3. THE PYRROLIZIDINE ALKALOID DATABASE 
The physical data for many pyrrolizidine alkaloids are now known and are published in 
a wide selection of journals . When 'investigating a new plant this information can be used 
to identify the pyrrolizidines present, but the variety of ways in which the information is 
reported makes access difficult. Consequently, a database of the physical data of 
pyrrolizidine alkaloids was compiled during the course of this study. Combining all the 
known data into a single database has made the data more readily available and easier to 
use. Moreover, not only are the data in the same format, making comparisons decidedly 
simpler, but trends can also be determined. 
This database originally consisted of the physical data for about 100 pyrrolizidine alkaloids 
and was created using dBase® III. It has now been upgraded to hold the data for 490 
pyrrolizidines and has been transferred to a more user friendly relational database 
programme system, Paradox® 3.5. Since the original compilation of the database, Borland 
has released Paradox® 5.0 for Windows. The added advantage of the improved system 
is that figures can now be included alongside the text and, as it is a Windows-based 
programme, structures of the pyrrolizidine alkaloids can easily be imported from 
ChemWindow®, a powerful chemical structure drawing programme. It is pertinent to note 
that files in Paradox® 5.0 and dBase® are now interconvertible. 
3.1 THE DATA INCLUDED IN THE DATABASE 
As much published information as possible has been included (from 1940 to 1995), 
however, since Russian , Chinese and Japanese papers are not readily accessible or easily 
translated, most of the information has been gleaned from papers written in English, 
German, and French. The data held in the database can either be viewed on the screen 
as a table or as a printed report, the form of which can be designed by the user - a useful 
feature of Paradox®. Usually , the most suitable report would be one that presented all the 
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data for a single pyrrolizidine alkaloid on a single page; such a report has been designed 
and is illustrated in Figure 3.1. 
. In such reports, the pyrrolizidine is referred to by its common name (A), although any 
known synonyms, which may include other common names or a systematic/IUPAC name 
(B) are also recorded. In addition, the alkaloid is identified by its formula (C), written in 
the same format for all the pyrrolizidines, and its molecular mass (D). The Chemical 
Abstracts Service (CAS) registry number (E) is present for those alkaloids for which it is 
readily known. If the pyrrolizidine is a crystalline solid the melting point (F) is given in 
°C. If it is not a solid, "gum" or "oil" is recorded in the melting point column, depending 
on what is reported. The specific rotation (0), where it is known, is given together with 
the solvent in which it was measured. Although the data are only taken from a few papers, 
as many reports of the alkaloid as possible are noted (H), as they may give additional, 
helpful information, including reports of the occurrence of the alkaloid in different 
botanical , or in some cases zoological, species; the references from which each set of 
physical data were taken, are also quoted (I). All the pyrrolizidine alkaloids have been 
assigned a type depending on their basic structure; this is the system followed by Roeder2A 
in his carbon-13 NMR spectroscopy review. For ease of correlation each type has been 
given a number (J) as shown in Table 3.1. 
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Common name: Retrorsine A 
Synonyms, B-Longilobine B 
Formula , C18.H25 . N.06 C CAS registry no, 480-54-6 E 
G 
Molecular mass, 351 D Melting pt, 216-7 F 
References: 6,125,150,325-328 II 
Specific rotation: -23.2 EtOH 
Alkaloid type, 7J 
H-NMR data. K Solvent, CDC13 L Reference: 329 I 
------- -- ---------------------------------------------------------------- - --
1 7a 5.00 14a 1. 73 19a 0.85 26 
2a 6.20 7b 14b 2.19 19b 27 
2b 8 4.27 15 20a 5.71 28 
3a 3.39 9a 4.09 16a 20b 29 
3b 3.94 9b 5.49 16b 21 1.83 30 
Sa 2 . 53 12a 17a 22 
5b 3.26 12b 17b 23 OH 
6a 2.15 13a 1. 64 18a 3 . 62 24 
6b 2.38 Db 18b 3 .74 25 
C-13 NMR data.K Solvent' CDC13L Reference, 330 I 
1 132.5 9 61.1 17 24 
2 136.7 11 175.6 18 66 . 9 25 
3 62.8 12 81.4 19 11. 7 26 
5 53.0 13 35.7 20 134.6 27 
6 34.7 14 37.9 21 15.0 28 
7 75.0 15 131 .3 22 29 
8 77.5 16 167.3 23 30 
EI-MS reference, 142 I 
EI-MS 351 307 246 220 136 120B 117 95 93 80M 
NICI-MS reference: 331 I 
NICI-MS , 352 351B 333 319 231 114M 
PICI-MS reference, 332 I 
PICI - MS , 352 320 292 246 220 138 136 120B 95M 
IR reference: 146 I 
Infra-red data, 3580 3430 1738 1710N 
X-ray data reference, 980 
Figure 3.1: The report sheet for retrorsine, an example of a typical report sheet generated 
by Paradox@. 
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Table 3.1: The number assigned to each of the pyrrolizidine alkaloid types. 
No. Alkaloid Type Example 
1 necine bases retronecine 31 
2 7-monoesters 7-angelylplatynecine 38 
3 9-monoesters 9·angelylheliotridine 80 
4 7,9-acyclic diesters sarracine 36 
5 11-membered crotalananes monocrotaline 7 
6 ll-membered with otonecine base croaegyptine 81 
7 12-membered senecionanes senecionine 10 
8 12-membered otonecanes senkirkine 51 
9 12-membered pterophoranes pterophorine 82 
10 13-membered dorononanes doronenine 29 
11 13-membered madurensanes madurensine 83 
12 14-membered parsonanes parsonsianidine 84 
13 miscellaneous types 
5 13 
";t'2.--/' /' " 14 
II OH 
odS 
38 80 
36 7 
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The NMR data (K) were chosen from the indicated publication (I); the recorded shifts are 
not an average of many reports, but are the most complete and/or most up-to-date set. 
Preference was also given to data which were obtained in deuterated chloroform to 
facilitate standardisation. Some pyrrolizidine alkaloids, such as necine bases and N-oxides, 
however, are not soluble in chloroform so the solvent used is also recorded (L). For the 
mass spectrometry data (M) the ten strongest signals were chosen (if more than ten were 
published) and the base peak is indicated by a capital B after the mass value. This method 
does not necessarily show up the trends, some of which rely on the presence of triads (see 
Section 1.3.4, p . 18) , but the reference (I) permits the original report to be consulted . 
Only the first six absorption frequencies are quoted for the infra-red spectroscopy data (N), 
while only a reference (0) is given if the X-ray crystal structure has been determined. It 
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should be noted that for some pyrrolizidine alkaloids very little information has been 
reported and, therefore, there are a number of blank spaces. 
A complementary database of references accompames the database of pyrrolizidine 
alkaloids and the Paradox® system allows for on-screen linking between the two. The 
usual facts are listed in the reference database including author(s), journal, title and 
contents key words. The reference number is the link between the reference database and 
the pyrrolizidine alkaloid database. 
3.2 UTILISING THE DATABASE 
Although the database contains a variety of data, the NMR data have proved to be the 
most useful in identifying pyrrolizidine alkaloids. The only previously published major 
collection of pyrrolizidine data comprised carbon-13 NMR shifts for 136 pyrrolizidine 
alkaloids,324 which was updated in 1991 to include the data for 26 more pyrrolizidines. 333 
However, using the database developed in this project a paper containing the proton NMR 
shifts for 372 pyrrolizidine alkaloids has been published,'34 and a paper reporting the 
carbon-13 NMR data of ca. 300 pyrrolizidine alkaloids is to be submitted for 
publication. 335 As the data are now all in the same format, various trends in the proton 
and carbon-13 NMR shifts have become apparent. Comparison of the data for 
pyrrolizidine alkaloids with similar structures will be discussed below, and will be 
followed by an application of the database to a particular example. 
3.2.1 TRENDS IN THE PROTON NMR DATA FOR PYRROLIZIDINE 
ALKALOIDS 
As already noted pyrrolizidine alkaloids consist of two parts, the necine base and the necic 
acid(s). The protons of the necine base have very distinctive shifts, the degree of 
saturation and the oxygenation pattern being easily recognisable. The important signals 
are for the protons on carbons 2, 6, 7, 8 and 9. 
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The type of alkaloid, be it an acyclic mono- or diester or a macrocyclic diester, can often 
be determined from the chemical shifts of the 7- and 9-proton signals. When the necine 
base is hydroxylated at C-7 and C-9, the protons on carbons 7 and 9 resonate at ca. 04.5 
and 03.5, respectively. In both cases, if the hydroxyl group is esterified, the proton signal 
shifts ca. I ppm downfield. Should there be no oxygen on C-7, then the 7-methylene 
protons are usually chemically non-equivalent, being diastereotopic, and their shifts are in 
the region 01.5-2.2. The 9-methylene protons are also normally chemically non-equivalent 
and the difference in the two chemical shifts, .1.H-9, was shown by Culvenor and Woods 
to reflect the size of a macrocycle.216 These authors give a .1.H-9 range of 1.0-1.5 ppm 
for 12-membered macrocycles (e.g. senecionine 10) and .1.H-9 less than 0.9 ppm for 11-
membered macrocycles (e.g. monocrotaline 7). With all the NMR data now available for 
pyrrolizidine alkaloids , it has become clear that the .1.H-9 value (Table 3.2) is only 
unambiguously diagnostic for 12-membered macrocyclic rings between narrow limits (viz. 
1.25-1.54 ppm). It is also clear that there is no characteristic .1.H-9 value for 11-
membered macrocycles. Very few 13- and 14-membered macrocycles are known. For 
the 13-membered 7, 9-diester macrocycles (e.g. doronenine 29) there is no trend for .1.H-9, 
but for the 6,9-diesters (e.g. madurensine 83) the .1.H-9 value (1.58-1.65 ppm) is 
diagnostic. The 14-membered macrocycles (e.g. parsonsianidine 84) have a very small 
.1.H-9 value (0.75-0.95) and their N-oxides have an even smaller value (0.06-0.20), but 
they are not distinctive as they fall within the wider ranges for the 11- and 12-membered 
macrocycles. 
Table 3.2: .1.H-9 values for macrocyclic pyrrolizidine alkaloids. 
macrocyc1e size MI-9/ppm 
II-membered 0.15-1.24 (majority < 1.0) 
12-membered 0.08-1.54 
13-membered (6 ,9-diester) 1.58-1.65 
13-membered (7,9-diester) no trend 
14-membered 0.75-0.95 
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The H-8 signal shifts downfield for N-oxides, but, obviously, is absent for the otonecine-
based pyrrolizidine alkaloids. The signals of all the remaining protons of the necine base 
portion of pyrrolizidine alkaloids are also shifted down field for the N-oxide relative to the 
unoxidised form. Saturation of the base is indicated by the position of the H-2 signal. 
Thus, for saturated bases the signals are at approximately 02.0-2.5, and the two methylene 
protons can be non-equivalent, while for typical unsaturated bases, the signal is at 
approximately 05.8, and for 2-hydroxy bases at approximately 04.0. The 6-methylene 
protons may be observed to be non-equivalent but their signals tend to be close together 
and appear at approximately 2.3 ppm. If C-6 is hydroxylated the H-6 signal is observed 
at approximately 04.0; when the hydroxyl group at either C-2 or C-6 is esterified the 
methine proton resonates downfield at 05.0-5.5. 
The chemical shift values for protons on C-I vary between 2 and 4 ppm, with the larger 
values representing N-oxides. The signal is, of course, absent in the spectra of the 
common, t,2-unsaturated pyrrolizidines, as well as the rare I-hydroxy or I-methylene bases; 
it is also absent for the pyrrole types. Pyrroles will be distinguished by signals in the 
aromatic region, for example, the H-2 signal at 06.4-6.6. 
The chemical shifts of the necic acid protons are not as distinctive as those for the bases, 
since many of the acids have very similar structures. The acids themselves can be divided 
into four groups:-
i) the angelic/tiglic acid types; 
ii) the trachelanthic/viridifloric types; 
iii) the dicarboxylic acids which form macrocycles; and 
iv) a miscellaneous group containing aromatic rings, other ring systems and sulphur 
groups. 
(E)- and (Z)-double bonds in unsaturated necic acids can often be distinguished by the 
shifts of the vinylic protons. For the more common (Z)-configuration the vinylic proton 
resonates close to 06.0 - a pattern illustrated by the angelic acid moiety in 7-
angelylretronecine 85 (06.11),336 sarracinic acid in sarracine 36 (06.38),155 isatinecic acid 
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in retrorsine 9 (05.71),329 senecic acid in senecionine 10 (05 .71)329 and seneciphyllic acid 
in seneciphylline 11 (05.83).329 For the (E)-configuration the corresponding signal is 
typically further downfield; for example, the tiglic acid moiety in symphytine 12 (06.70),337 
isosarracinic acid in neosarracine 72 (06.97),147 integerrinecic acid in integerrimine 16 
(06.52),109 the isomer of seneciphyllic acid in spartioidine 86 (06.70)338 and retronecic acid 
in usaramine 8 (06.50).338 The peak mUltiplicity, viz. a quartet, distinguishes the vinyl 
signal in these acids from the H-2 signal in unsaturated pyrrolizidines which resonates as 
a broad singlet. 
HO j/ X YxH O~¥ 
. ~ 
N 
12 
'Y" O~R' 
.A~±sO R' o 0 
C~ 
85 
OH 
R" ! OH RV~~O 
~2tS 
. ~
N 
9 R' = Me, R" = H 
8 R' = H, R" = Me 
36 R' = Me, R" = H 
72 R' = H, R" = Me 
R" ~ OH R~yXyo R 
0& 
10 R'=Me,R" = H 
16 R'=H, R"=Me 
R" OH 
~ -;:::-0 
I 0 O/dS 
11 R' = Me, R" = H 
86 R' = H, R" = Me 
Certain trends may also be observed in the 1 H NMR data of the saturated viridifloric and 
trachelanthic type necic acids. These compounds are stereoisomers of 2,3-dihydroxy-2-
isopropylbutyric acid and all four isomers have been synthesised and characterised.289 
( + )-Viridifloric acid is the (2R,3R) isomer (87a, R=H) and, hence, the (2S,3S) isomer 
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(87b, R=H) is (-)-viridifloric acid, while the (2S,3R) and (2R,3S) (88a and 88b, R=H) 
isomers are the (+)- and (-)-trachelanthic acids, respectively. It is possible to distinguish 
between the viridiflorate and trachelanthate systems using the proton signals, but the 
differences are small and some of the signals are obscured by the signals for the necine 
base part of the pyrrolizidine. The viridifloryl moiety 87 in pyrrolizidine alkaloids is 
characterised by the following signals: H-5' greater than 02.10, H-4' usually greater than 
01.24 and H-3' less than 04.0. When an ester function is present at C-3', H-3 ' is shifted 
downfield to ca. 5 ppm and is no longer diagnostic. The equivalent shifts for the 
trachelanthic moiety 88 are: H-5' less than 02.10, H-4' usually less than 01.20 and H-3' 
greater than 04.0. In addition, the chemical shift difference between the H-6' and H-T 
signals is normally greater than 0.4 ppm for the viridifloric group and less than 0.4 ppm 
for the trachelanthic group. 
, 
6 , 
7 
HO V HO V 
oY)( 
RO H OH 
o 3' 4' oY)(: 
Ii OH RO H OH RO H OH RO 
R = necine base 
87a 87b 88a 88b 
Replacement of the hydrogen on carbon-5' of viridifloric and trachelanthic acids with a 
hydroxyl group provides lasiocarpic and echimidinic acids, respectively. There are far 
fewer reports on these acids, but they do appear to follow the same trends as viridifloric 
and trachelanthic acids and can be distinguished similarly. 
(-)-Heleuric acid (2-hydroxy-2-isopropyl-3-methoxybutyric acid) 89 is stereochemically 
analogous to (+ )-trachelanthic acid and H-4' and H-5' follow the trends observed for 
trachelanthic acid. However, H-3' resonates below 03.60 , which is upfield of the 
equivalent proton in trachelanthic acid. Similarly, curassavic acid (2,3-dihydroxy-2-
isobutylbutyric acid) 90 is analogous to viridifloric acid, and the H-3' and H-4' shifts of 
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curassavate systems follow the viridifloric acid pattern, but H-5' resonates further upfield 
and is found below 01.90. 
HO V 00;( 
HO H OCRj 
89 
o , 4 
HO Ii OH 
90 
3.2.2 TRENDS IN THE CARBON-13 NMR DATA FOR PYRROLIZIDINE 
ALKALOIDS 
The i3C NMR spectra of the necme bases reveal, as do the proton spectra, several 
important trends. The C-8 chemical shifts distinguish otonecine-based alkaloids and N-
oxides from the rest of the pyrrolizidine alkaloids . A C-8 shift of 065-80 ppm is typical 
for most pyrrolizidines . This signal shifts downfield to 086-98 ppm for their N-oxides and 
to 185-200 ppm for otonecine-based pyrrolizidines as C-8 is a carbonyl carbon in these 
bases. The otonecine base is also characterised by a signal at approximately 40 ppm 
corresponding to the N-methyl group. 
As indicated previously, if a necine base is unsaturated the double bond is usually between 
carbons 1 and 2. Therefore, if the base is unsaturated the signals for carbons 1 and 2 will 
generally be in the region of 0120-140. Other regions of unsaturation are found in the 
pyrrole-types and the I-methylenepyrrolizidines. In the pyrrole-types, carbons 1, 2, 3 and 
8 are sp2-hybridised and resonate in the double bond region of the spectrum. The double 
bond in I-methylenepyrrolizidines is exocyclic rather than endocyclic and the shifts for 
carbons 1 and 9 are approximately 142 and 110 ppm , respectively . 
In saturated necine bases the C- l signal is usually found between 35 and 54 ppm, however 
in the hadinecine-based pyrrolizidines , where C- l is hydroxylated, the signal appears 
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between 79 and 85 ppm. Carbon-2 , for saturated necine bases, and carbon-6, for all 
necine bases, resonate at 24-40 ppm but, when they are hydroxylated, the signals are found 
downfield between 68 and 79 ppm. 
The l3C signals for carbons 3 and 5 are typically found between 50 and 80 ppm. Carbon-3 
usually resonates further downfield than C-5, while both signals move further downfield, 
by approximately 15 ppm, if the nitrogen is oxidised . Carbon-7, when not hydroxylated, 
has a value of 025-31 ppm, and when hydroxylated the shift is 68-80 ppm. The shift 
values for C-9 usually range from 56 to 68 ppm. 
There are, however, fewer common trends for the carbons of the necic acid portion of the 
pyrrolizidine than there are for the necic acid protons. For example, the chemical shift 
differences for the carbons of (E)- and (Z)-double bonds are not as noticeable as those for 
the attached protons. In the case of the geometric isomers angelic acid 91 and tiglic acid 
92, however, there is a notable difference in the carbon shifts. For angel ate systems the 
shift for C-4' of the angelic acid moiety is between 15.4 and 16.2 ppm, while for tiglate 
systems it is approximately 11.9 ppm. The l3C NMR data for far fewer tiglic acid-
containing pyrrolizidines have been reported . The carbon-5' nucleus in angelate systems 
resonates between 1?8 and 21 ppm, compared to 14.5 ppm for tiglate systems. It is 
interesting to note that some authors have reversed the values for carbons 4' and 5', even 
varying the assignment within one report. '55 Increasing use is being made of two-
dimensional NMR techniques, and these have shown that carbon-5' resonates downfield 
of carbon-4'. Double bonds that only have substituents at one end, like the t," -bond in 
pterophorine 82 and the t,l3-bond in seneciphylline 11, have characteristic shifts, i.e. the 
substituted vinyl carbons resonate downfield (at 143-149 ppm) of the vinyl methylene 
carbons (at 114-123 ppm). The vinylic carbons (C-2' and C-3') in senecioate 93 systems 
are typically close to 115 and 159 ppm, respectively. An exception is fuchsisenecionine 
37 with the chemical shifts for the two carbons being 135.9 and 131.9 ppm, 
respectively.324 The carbons of the terminal methyl groups of the senecioic moiety 
resonate at two different values between 20 and 28 ppm. 
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Many pyrrolizidine alkaloids are acetylated at various sites; the acetyl carbonyl carbon 
resonates at approximately 170 ppm and the methyl carbon at approximately 21 ppm. 
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3.2.3 AN ll..LUSTRATIVE APPLICATION OF THE DATABASE 
The information held on the database helped to identify the pyrrol izidine alkaloid 
component of a fraction obtained from the extraction of the Tradouw Pass population of 
S. panicuiatus. The proton spectrum (Figure 3.2) showed a mixture of compounds that 
did not correspond to any compounds previously isolated from the extracts. As it was 
unclear which peaks belonged to the major component a COSY spectrum (Figure 3.3) was 
also acquired for this fraction. 
21 
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Figure 3.2: 'H NMR spectrum of a fraction obtained from the extraction of the Tradouw 
Pass S. panicuiatus population. 
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Figure 3.3: The COSY spectrum of the same fraction as depicted in Figure 3.2 to enable 
the signals of the major compound to be identified. 
With the help of known trends and the COSY coupling patterns, the alkaloid was identified 
as possibly having an unsaturated necine base with an H-2 signal at 6.2 ppm. A search 
of the data held for H-2 between 6. 1 and 6.3 ppm narrowed the choice from 490 to 71 
possibilities - s[ill too many for individual comparison with the acquired spectrum, 
Searching for H-7 chemical shifts greater than 4 .9 ppm but less than 5.1 ppm and H-8 
shifts between 4.15 and 4 .35 ppm reduced the options to a more manageable 15. The 
designated alkaloid type (see Table 3.1) , for the majority of the 15 pyrrolizidines, was 7, 
which represents 12-membered senecionanes. This observation suggested that the signal 
at 5.74 ppm could belong to H-20 on the necic acid portion of the alkaloid . Entering this 
option into the database narrowed the choice to one of three pyrrolizidine alkaloids, viz., 
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gynuramine-19-acetate 94, retrorsine 9 or senecionine 10. Comparison of the proton data 
available (e.g . Figure 3.1)329 for these three alkaloids with the acquired proton spectrum 
confirmed identification of the alkaloid as retrorsine 9. The carbon-13 assignments, made 
with the aid of an HMQC spectrum (Figure 3.4), also matched the published "c NMR 
data for retrorsine. 330 
94 10 
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Figure 3.4: The HMQC spectrum of the same fraction as depicted in Figure 3.2 to enable 
the carbon-13 shifts to be assigned . 
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4. THE SYNTHESIS OF 78-ANGELYL-l-METHYLENE-8a-
PYRROLIZIDINE 
71l-Angelyl- l -methylene-SO'-pyrrolizidine 71 was extracted from both Senecio chrysocoma 
and S. paniculatus. The pyrrolizidine structure is novel in that the unsaturation is 
exocyclic and there is no oxygen attached to carbon 9 (cf. Section 1.3.1, p. 14) . The basic 
structure and the relative stereochemistry were determined by NMR techniques (Section 
2.5.2, p. 70), but a synthesis was undertaken to determine the absolute stereochemistry at 
positions 7 and S. There are two general strategies for the synthesis of pyrrolizidine 
alkaloids: -
i) an ab initio approach starting with an acyclic or monocyclic precursor; and 
ii) the modification of an existing pyrrolizidine alkaloid system. 
71 
4.1 THE AB INITIO APPROACH 
In 1961 , Kochetkov et al. 339 published a synthesis of I-methylenepyrrolizidine 95 (Scheme 
4.1), starting with ethyl prolinate and methyl acrylate. This synthetic procedure indicated 
a possible approach to 71l-angelyl-1-methylene-SO'-pyrrolizidine 71 but , as a hydroxy group 
was required at position 7 of the 1-methylenepyrrolizidine 95, the starting material needed 
to be a 3-hydroxyprolinate. 
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Scheme 4.1: Reagents: i, reflux, 24 h; ii, EtONa, xylene, 150-160 DC, 1.5 h; iii, 10% Hel, 
reflux, 3 h; iv, triphenylphosphinomethylene, Et,O, reflux, 6 h, then room temperature, 48 h. 
Routes to non-racemic 3-hydroxyproline are rare, but Cooper et at. 263 (Scheme 4.2) have 
synthesised (+ )-cis-(2R,3S)-3-hydroxyproline 98 by bakers' yeast reduction of a 3-oxo 
proline derivative 96 , which in turn was synthesised from acyclic precursors (Scheme 
4.3).340 In the present study, an attempt was made to repeat this synthesis, but difficulties 
were encountered at the critical yeast reduction step. NMR analysis of the isolated product 
showed no signs of the desired product. This approach was abandoned when the 
modification of an existing system successfully gave the desired product with defined 
stereochemistry. In any event, the stereochemistry of the product from the ab initio 
approach may well have been questionable. Using (+ )-cis-(2R,3S)-3-hydroxyproline 96 
as the starting material would most likely have resulted in 7a-hydroxy-l-methylene-8a-
pyrrolizidine instead of the desired 73-hydroxy-l-methylene-8a-pyrrolizidine. Kochetkov 
et al.'s synthesis339 (Scheme 4.1) afforded racemic I-methylenepyrrolizidine 95 (resolved 
by crystallisation as the tartrate derivatives) but it is unclear if optically pure prolinate was 
used as the starting material. 
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Scheme 4.2: Reagents: i, bakers ' yeast, sucrose, H,O, 30°C, 24 h; ii, CH,Cl" trifluoroacetic 
acid, room temperature, 2 h; iii, KOH, CH,OH, H20, room temperature, 16 h; iv , H+ . 
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Scheme 4.3: Reagents: i, CH,COCl, CH,OH, 20°C, 18 h; ii, NaOH, H20; iii , di-ten-butyl 
dicarbonate (BOC20), CH,CI" Et,N; iv, KO'Bu , toluene; v, CH,COOH. 
* 2-methyl analogue of compound 96. 116. 
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4.2 MODIFICATION OF AN EXISTING PYRROLIZIDINE SYSTEM 
This approach to 7B-angelyl-l-methylene-8a-pyrrolizidine 71 was prompted by a recent 
synthesis published by Hanselmann and Benn,283 in which hadinecine 59 was synthesised 
from retronecine 31 with 7B-hydroxy-l-methylene-8a-pyrrolizidine 58 as an intermediate 
(Scheme 4.4). 
OH OH 
HO 
10 HO B B ... ",OH "'" i, ii iii .. ... N N 
31 58 59 
Scheme 4.4: Reagents: i, SOC]2; ii, Zn, 1M H2SO,; iii, OsO,(cat), 4-methyl morpholine N-oxide, 
acetone, H20 . 
The disadvantage of using this route to 7B-angelyl- l-methylene-8a-pyrrolizidine 71 is that 
the yield is limited by the amount of natural product that can be extracted and purified 
(or synthesised) for use as the starting material. The advantage, however, is that as the 
stereochemistry of retronecine is known, the stereochemistry of the product is pre-
determined . 
4.2.1 ISOLATION OF RETRONEClNE 
Retronecine 31 can be enantioselectively synthesised by a variety of procedures, but is 
readily available by saponification of retronecine-based macrocycies, e.g. monocrotaline 
7 or retrorsine 9 .202.208.236.282.284 Senecio orthonnaeflorus, a widely spread, local Senecio 
species, has been shown to contain large quantities of retrorsine 9 (1.2 % of dry plant 
weight) and no other pyrrolizidines .341 Consequently, dry, S. orthonnaeflorus plant 
material was extracted by conventional methods as described in Section 5.4.2 (p. 156). 
Retrorsine 9 was obtained as cream coloured crystals with a melting point of 214-216°C 
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(literature value 216°C'42.328). The 'H NMR spectrum (Figure 4.1) confirmed the absence 
of impurities so no recrystallisation was attempted and the retrorsine was hydrolysed by 
refluxing with bariUi'1 hydroxide in aqueous medium. 
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Figure 4.1: 'H NMR spectrum of retrorsine 9 extracted from S. orthonnaejlorus. 
The hydrolysis took longer than expected; refluxing for one to five hours202•284,,",2,,",3 failed 
to hydrolyse all the retrorsine 9, and a reflux period of approximately 10 hours was 
required . After the barium had been removed from solution as barium carbonate, the pH 
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was increased to 9 or 10 and the retronecine isolated by continuous extraction. The yield 
of retronecine was lower than expected (26%). (Heliotridine had been extracted in 85% 
yields by this method. 343) The solubility of retronecine in aqueous medium could have 
been the problem and the yield of retronecine 31 was improved when the hydrolysis 
product was evaporated to dryness and the gummy residue refluxed with chloroform to 
extract the retronecine. When this procedure was repeated a precipitate formed during the 
removal of the solvent, the amount of which increased when chloroform was added. The 
precipitate was removed by filtration and identified as isatinecic acid 104, while the filtrate 
subsequently afforded cream coloured crystals of retronecine 31 in a 37.7 % yield. 
Although the yield was still not as high as had been reported for other hydrolyses the 
product was clean and crystalline. Acetone has been the solvent of choice for crystallising 
retronecine, BO.202.278.284 .344 but no success was obtained with this solvent. Other mixtures of 
solvents were tried with equally little success and, eventually, the only method to give 
crystals involved dissolving the gummy retronecine in chloroform, then removing the 
chloroform in vacuo and leaving the sample under vacuum for many hours. Consequently, 
it was very pleasing to obtain clean crystalline retronecine 31 directly from work-up of the 
hydrolysis mixture. 
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4.2.2 MODIFICATION OF RETRONEClNE TO AFFORD 76-HYDROXY-l-
METHYLENE-8e>-PYRROLIZIDlNE 
7B-hydroxy-I-methylene-8e>-pyrrolizidine 58 was synthesised in two steps from retronecine 
31 following the route outlined in Scheme 4.5 . l-Chloromethyl-l,2-didehydro-7B-hydroxy-
8e>-pyrrolizidine hydrochloride 105 was prepared according to Adams and van Duuren's 
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procedure,345 which involved slowly adding crystalline retronecine to thionyl chloride. To 
facilitate the addition of gummy retronecine 31 to thionyl chloride, the necine base was 
pre-dissolved in dichloromethane, however the yield obtained was significantly lower 
(13%) than that obtained from the solvent-free method (64%) . 
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Scheme 4.5: Reagents: i, SOCl2, DoC; ii, Zn, 1M-H2S04 , 
The hydrochloride 105, once formed, was reduced with zinc dust and acid, as described 
by Culvenor and Smith,346 to yield a mixture of the desired product, 7fi-hydroxy-l-
methylene-8c;-pyrrolizidine 58, together with l,2-didehydro-7fi-hydroxy-l-methyl-8c;-
pyrrolizidine 106. Both compounds are distinctly indicated by the vinyl signals in the 'H 
NMR spectrum of the product [Figure 4.2 (COSY and HMQC spectra in the Appendix)] 
and the impurities are clearly minimal. From the integration of the signals for the vinylic 
protons the ratio of 7fi-hydroxy-l-methylene-Sc;-pyrrolizidine 58 to 1,2-didehydro-7fi-
hydroxy-l-methyl-Sc;-pyrrolizidine 106 was determined to be 5 to 2. The two compounds 
were not separated at this stage as they were only formed in small amounts and, due to the 
known irreversible binding of pyrrolizidines to silica, considerable loss of product could 
have occurred. An attempt to obtain separation on TLC was unsuccessful as with all 
systems tried the two compounds had the same Rr val ue . It was hoped that once the two 
compounds , 7fi-hydroxy-l-methylene-Sc;-pyrrolizidine58and l ,2-didehydro-7fi-hydroxy-l-
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methyl-Sa-pyrrolizidine 106, had been esterified with angelic acid 91 separation would be 
possible. 
9-CH,58 
,-I'-.. 
I~n"/\-! '" "I I"'· c 0 "I 0, _ 0:> 
; 
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Figure 4.2: IH NMR spectrum of the mixture of 7B-hydroxy-1-methylene-Sa-
pyrrolizidine 58 and 1 ,2-didehydro-7B-hydroxy-1-methyl-Sa-pyrrol izidine 
106. 
4_2_3 SYNTHESIS OF ANGELIC ACID 
Angelic acid 91 is not as stable as its trans isomer, tiglic acid 92; isomerisation has been 
observed to take place under acidic or basic conditions especially at high 
temperatures. 347,348 As a result, care must be taken during the synthesis and subsequent 
reactions of angelic acid 91. It is, however, possible to handle the angelic acid 91 under 
mild conditions without marked isomerisation,347 and crystalline angelic acid can be kept 
in the laboratory for years without any isomerisation taking place.347 There are many 
syntheses for tiglic acid,347,349 while for angelic acid the most effective synthesis , which 
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affords the required product uncontaminated by tiglic acid , is the one reported by Buckles 
and Mock (Scheme 4.6) .349 
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Q, ~ ~Br X "I iii • 
108 
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91 
Scheme 4.6: Reagents: i, Br,; ii, 25% KOH in CH,oH, K,CO" 55°C; iii, Na-Hg amalgam, 
H,O, room temperature. 
In the present investigation, commercially available tiglic acid 92 was used for the 
synthesis. The only change from Buckles and Mock's procedure' 49 was that 6-
bromoangelic acid 108 was stirred with the sodium-mercury amalgam for longer than 24 
hours, i.e. until the mercury had been restored. As expected, angelic acid 91 was obtained 
without contamination by tiglic acid 92 - the quartet at ca. 6.7 ppm for the vinylic proton 
of tiglic acid clearly being absent from the proton NMR spectrum of the product (Figure 
4.3) . 
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Figure 4.3: 'H NMR spectrum of angelic acid 91 with no quartet at ca. 6.7 ppm for 
tiglic acid 92 contamination. 
Having now synthesised both the necine base, 7B-hydroxy-l-methylene-8Cl'-pyrrolizidine 
58 , and the necic acid, angelic acid 91, all that remained was to couple the two together. 
4.2.4 SYNTHESIS OF 7B-ANGELYL-l-METHYLENE-8Cl'-PYRROLIZIDTh'E 
The coupling of angelic acid 91 with 7B-hydroxy-l-methylene-8Cl'-pyrrolizidine 58 and 1,2-
didehydro-7B-hydroxy-l-methyl-8Cl'-pyrrolizidine 106 was not as simple as had originally 
been anticipated . 
N,N'-Carbonyldiimidazole (CDI) has been used for the coupling of necic acids and necine 
bases202.236.299,350 and, in particular, for the selective synthesis of 9-monoesters of 
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retronecine 31. However, diesters of retronecine 31 and heliotridine 33 and 7-monoesters 
of heliotridine have also been synthesised using CDJ.202.299.351 Consequently, it was hoped 
that in the absence of the 9-hydroxyl group, as in 7B-hydroxy-l-methylene-8a-pyrrolizidine 
58 and 1,2-didehydro-7B-hydroxy-l-methyl-8a-pyrrolizidine 106, esterification would 
occur at the 7-hydroxyl group. Hoskins and Crout's procedure,202 involving stirring a 
mixture of CD! and angelic acid in chloroform until carbon dioxide production had stopped 
and then adding retronecine and stirring overnight, was followed but, after stirring for 24 
hours at room temperature, TLC analysis showed that no product had formed . There was 
obvious reluctance to heat the mixture in case the angelic acid isomerised and, therefore, 
the reaction mixture was stirred at room temperature for 72 hours, by which time some 
product had formed. Heating the reaction mixture initially to 35°C and then to reflux , 
appeared to increase the amount of product but, after work-up, none of the desired product 
could, in fact, be identified by 'H NMR spectroscopy . This technique provides a quick 
method of checking if esterification has taken place as the signal for the H-7 nucleus shifts 
downfield from ca. 4.5 ppm for the unesterified necine base to ca. 5.5 ppm for the 
esterified base. 
Coupling of retronecine 31 with various acids has also been achieved by using N,N'-
dicyclohexylcarbodiimide (DCC), with or without 4,4-dimethylaminopyridine (DMAP) . 
However, application of this method of coupling angelic acid to an alcohol has been 
observed to afford a large proportion of the tiglyl isomer, particularly when heat was 
involved.202.352 Despite this drawback, an attempt was made to synthesise 7B-angelyl- l-
methylene-8a-pyrrolizidine 71 using these reagents and the procedure given in Section 
5.4.2 (p. 156). The reaction was attempted in deuterated dichloromethane to facilitate 
rapid NMR analysis, but no esterification was observed; not even a tiglyl isomer was 
obtained , despite stirring the reaction mixture for 24 hours. The 'H NMR spectrum did 
show that a large portion of the angelic acid had been isomerised to tiglic acid (indicated 
by the appearance of a quartet at 6.7 ppm), so heating of the mixture was not attempted. 
The alkaloid, 7B-angelyl-l-methylene-8a-pyrrolizidine 71, was finally obtained by coupling 
angelic acid chloride 109 with the lithium alkoxide of the necine base, which was 
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generated using butyllithium. Angelyl chloride 109 has previously been synthesised by 
first treating angelic acid 91 with one equivalent butyllithium to produce the lithium 
carboxylate, before reacting with oxalyl chloride,353 or by the reliction of the sodium salt 
of angelic acid with phosphorus oxychloride. 347 In both cases the angelyl chloride 109 was 
used immediately without isolation or purification as angelyl chloride 109 rapidly 
decomposes to angelic acid on exposure to moisture. Beeby'54 reacted potassium angelate 
110 with oxalyl chloride and a drop of dimethyl formam ide at DoC to give the acid 
chloride 109 (Scheme 4.7) and this was the method used in the present study. 
0., ~ 11 
109 
Scheme 4.7: Reagents: i, (COCl)2, dimethylformamide (I drop), Er,O, ooe. 
The potassium angelate 110 was prepared by neutral ising a solution of angelic acid 91 in 
ethanol with an equimolar amount of 30 % ethanolic potassium hydroxide. The original 
procedure cites an 85 % solution"4 but this could not be achieved. After addition of 
acetone a salt precipitated which was dried under a high vacuum before being converted 
to the acid chloride. After stirring potassium angelate with oxalyl chloride for two hours 
under dry nitrogen, the excess oxalyl chloride was removed under a slight vacuum without 
heating, while carefully avoiding exposure to moisture. 
Angelyl chloride 109 has been coupled to secondary alcohols by simply stirring it in 
solution with the alcohol at room temperature. 354.355 However, after several unsuccessful 
attempts, it was decided to add the angelyl chloride 109 to the lithium alkoxide derivative 
of the necine base (a 5:2 mixture of7fl-hydroxy-l-methylene-8a-pyrrolizidine 58 and 1,2-
didehydro-7fl-hydroxy-l-methylpyrrolizidine 106) to ensure coupling - a method which has 
been reported to inhibit tiglate formation."2.35. The reaction mixture was easily purified, 
after work-up , by preparative layer chromatography on silica gel to give a 5:2 mixture of 
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the required 73-angelyl-I -methylene-8a-pyrrolizidine 71 together with 73-angelyl-I,2-
didehydro-I-methyl-8a-pyrrolizidine 111 (Figures 4.4 and 4.5); a small amount of the 
tiglate isomer was also formed as indicated by a quartet at 6.75 ppm on the proton 
spectrum. Separation of the two major components could not be achieved by various 
preparative chromatographic techniques. A wide range of solvents with differing polarities 
were used with normal and reverse phase silica, alumina and cellulose. Even if the 73-
angelyl- I-methylene-8a-pyrrolizidine 71 and 7fi-angelyl-l,2-didehydro-I-methyl-8a-
pyrrolizidine 111 could have been separated from each other, the residual tiglate isomer 
would still have interfered if optical rotations were used to distinguish between the 
synthetic and natural products. Chiral differentiating techniques were therefore used to 
determine if the extracted alkaloid was the enantiomer of the synthesised alkaloid or not. 
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Figure 4.4: COSY spectrum of the mixture of 71l-angelyl-1-methylene-8a-pyrrolizidine 
71 and 71l-angelyl-1 ,2-didehydro-1-methyl-Sa-pyrrolizidine 111 with a quartet 
at 06.75 indicating the presence of tiglyl isomers. 
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Figure 4.5: HMQC spectrum of the mixture of 7B-angelyl-1-methylene-8a-pyrrolizidine 
71 and 71l-angelyl-1 ,2-didehydro-1-methyl-8a-pyrrolizidine 111. 
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An NMR chiral shift reagent, tris[3-(heptafluoropropylhydroxymethylene)-( +)-
camphoratoJeuropium, was added separately to the synthesised product, the natural prod'lct 
and a mixture of the two. Chiral shift reagents tend to cause peak broadening which is 
more pronounced at high frequency (400 MHz)."7 The shifts that were easiest to 
recognise were those for the 9-methylene protons and the mixture of the synthesised and 
natural products exhibited only one set of these peaks in the' H NMR spectrum suggesting 
the same absolute stereochemistry. Figure 4.6 shows the 'H NMR spectrum of the 
mixture of the synthesised and natural products compared to the same sample after the 
addition of chiral shift reagent. The H-9 signals have shifted downfield but have not split. 
\(\I~I 
I..: ' c:i l 
. " 
"" 
Figure 4.6: 'H NMR spectra of a mixture of synthesised and natural 7B-angelyl-l-
methylene-8a-pyrrolizidine 71 before (b) and after (a) the addition of a chiral 
shift reagent. 
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Both analytical HPLC and analytical GLC , using chiral columns, were then used to 
examine the synthesised product, the natural product, and a mixture of the two. No 
splitting of the peaks occurred when the mixture was injected supporting the 
stereochemical identity of the products. Two different solvent systems were used with a 
reverse phase, chiral HPLC column and, in neither case, was any peak splitting observed 
(see Figure 4.7). 
Three different temperatures, 90, 100, and 1lOoC, were used for the GLC analyses . At 
110°C two peaks were visible on the chromatogram of the synthesised product, 
presumably corresponding to the two products, 7B-angelyl-1-methylene-8cx-pyrrolizidine 
71 and 7B-angelyl-l,2-didehydro-l-methyl-8cx-pyrrolizidine 111. Decreasing the 
temperature to lOO°C, caused the peak with the higher retention time to split, possibly due 
to the presence of both angelyl and tiglyl isomers. A further decrease to 90 °C did not 
change the peak pattern, but only increased the retention times. Consequently, all three 
samples were run at lOO°C. Figure 4.8 shows the chromatograms at 100°C for the 
synthesised product, the natural product and the mixture of the two and it is clear that the 
major constituents have identical retention times. 
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Figure 4.7: HPLC chromatograms, using a 6:4 
ratio of methanol (with 0.2% 1FA) 
and water as the solvent system on 
a chiral HPLC column, for (a) the 
synthesised product, (b) the 
mixture of synthesised and natural 
products, and (c) the natural 
product. 
(a) 
(b) 
(c) 
SECTION 4.2.4 
solvent 
time ..... 1----__ _ 
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Figure 4.8: OLC chromatograms obtained using a chiral OLC 
column at 100°C for (a) the synthesised product, (b) a 
mixture of synthesised and natural products, and (c) the 
natural product. 
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The 7R,8R-stereochemistry is , in fact, expected for the natural alkaloid as the platynecine-
based alkaloids, which predominate in these plants, have that stereochemistry and the 
GLC, HPLC and NMR evidence all point towards the synthesised and natural product 
having the same stereochemistry . It is therefore concluded that the alkaloid isolated from 
Senecio chrysocoma and S. paniculatus was 7R-angelyl-l-methylene-8R-pyrrolizidine 71. 
71 
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5. EXPERIMENTAL 
5.1 GENERAL METHODS 
The separation of pyrrolizidine alkaloids and the progress of reactions were monitored by 
analytical thin layer chromatography (TLC) on plastic backed, 0.2 mm thick silica gel 60 
F254 plates (Merck Art. no. 1.05735) Two different spray reagents were used for the 
visualisation of pyrrolizidine alkaloids, viz., Dragendorff's reagent (see below) and onho-
chloranillErhlich's reagent (see below) . For flash column chromatography358 silica gel 60 
(230-400 mesh ASTM ; Merck Art. no. 1.09385) was used. Preparative layer 
chromatography plates (10x20 cm and 20x20 cm) were prepared from silica gel 60 PF254 
(Merck Art. no. 7747) according to the supplier's instructions . For small samples « 15 
mg) pre-coated (with a layer thickness of 0.25 mm), glass backed 5x20 cm silica gel 60 
F254 plates were used (Merck Art. no. 5714). A Biichi B-670 chromatograph was used, 
in descending mode, for droplet counter current chromatography (DCCC) . 
Standard analytical gas liquid chromatography (GLC) was performed on an HP 5890A 
chromatograph fitted with an HP ultra-2 fused silica capillary column (0.2 mm x 25 m) 
packed with cross-linked 5 % phenyl methyl silicone (film thickness 0.33 /Lm). An initial 
temperature of 120°C was maintained for 1 minute; the temperature was then increased 
at 10°C per minute to a final temperature of 275°C, which was maintained for 15-25 
minutes. The injector and detector temperatures were 275 and 300°C, respectively, and 
the carrier gas was hydrogen. 
Chiral GLC was performed on an HP 5890 chromatograph fitted with an FS-Lipodex A 
fused silica chiral column (0.25 mm x 50 m) . The injector and detector were set at 250°C 
and the carrier gas was helium. Isothermal run conditions were used at 90, 100 or 110°C. 
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A Spherisorb S5-chiral 1 reverse phase column was used for HPLC analyses with two 
different solvent systems:-
i) methanol with 0.2% trifluoroacetic acid at 0.5 mL per minute or 
ii) a 6:4 ratio of methanol (with 0.2% trifluoroacetic acid) and water at 1 mL per minute. 
The detector was a Waters R401 differential refractometer. 
For gas chromatography-mass spectrometry determinations an HP 5890A gas 
chromatograph was coupled to an HP 5988A mass spectrometer. The same OLC column, 
an HP ultra-2, was used but the operating conditions were slightly different from those used 
for analytical OLC. An initial temperature of 110°C was maintained for 1 minute before 
the temperature was increased by 10°C per minute to a final temperature of 275°C which 
was maintained for 20 minutes. The injector and detector temperatures were 275 and 
300°C, respectively. The carrier gas was helium. Both electron impact (EI) and chemical 
ionisation (CI; using either methane or ammonia as the ionising gas) mass spectra were 
obtained. 
High resolution mass spectral data was obtained on a Kratos MS 80RF mass spectrometer 
at the Cape Technikon Mass Spectrometry Unit. 
All NMR spectra were acquired on a Brtiker AMX400 spectrometer at 400 MHz for 
protons and 100 MHz for carbon-13 and at a temperature of 303K unless otherwise stated. 
The solvent used, unless otherwise stated, was deuterated chloroform and chemical shifts 
are quoted relative to the solvent peaks [07.25 (for IH) and 077.0 (for 13C)]. Solvent peaks 
were also used to reference spectra run in deuterated dimethylsulphoxide [DMSO-d6 (OH 
2.50; oe 39.43)]. For proton spectra determined in deuterium oxide (DP) the signals are 
quoted relevant to the solvent peak (04.82) and for carbon-13 spectra a drop of deuterated 
methanol was added for calibration (049.05). J values are given in Hertz. 
Melting points are uncorrected and were determined on a Kofler micro heating stage. 
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Antitumour and anti-human immunodeficiency virus tests were performed by the National 
Cancer I nstitute in the United States of America. 
Dragendorff's reagent. I38-
The stock solution was prepared by mixing a solution of bismuth (III) nitrate (0.S5 g), 
glacial acetic acid (10 mL) , and water (40 mL) with a solution of potassium iodide (20 g) 
and water (50 mL). Stock solution (1 mL) , glacial acetic acid (2 mL), and water (10 mL) 
were mixed together to make the spray solution, which stained pyrrolizidine alkaloids 
bright orange. 
ortho-ChloranillErhlich's reagent. 136-
For the identification of unsaturated pyrrolizidine alkaloids, developed TLC plates were 
initially sprayed with a 1 % solution of ortho-chloranil in toluene and warmed in the oven 
(SO°C) for several minutes before being sprayed with Erhlich's reagent. 
Erhlich 's reagent was prepared in small volumes as it is highly moisture sensitive. para-
Dimethylaminobenzaldehyde (0.5 g) was dissolved in dried absolute ethanol (25 mL) 
containing boron trifluoride etherate (0.5 mL). After spraying with Erhlich's reagent the 
plate was again warmed for several minutes at SO°C. Unsaturated pyrrolizidine alkaloids 
stained purple. 
5.2 DRY SOLVENTS 
Ethanol was dried by reaction with magnesium ethoxide. 359 Clean dry magnesium turnings 
(5 .0 g) , iodine (0.5 g) , and absolute ethanol (75 mL) were heated in a 2 L round bottom 
flask , under dry nitrogen, until a vigorous reaction occurred. After the reaction had 
subsided, heating was continued until all the magnesium had been converted to the white 
ethoxide. Absolute ethanol (1 L) was added and the mixture boiled under reflux for 1 
hour before the dry solvent was distilled off. Methanol was dried by the same procedure. 
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Dichloromethane and toluene were stored over anhydrous calcium chloride before being 
boiled under reflux and then distilled from calcium hydride. Carbon tetrachloride was 
dried by boiling under reflux with calcium chloride. 
Ethanol-free, dry chloroform was prepared by washing the chloroform five times with an 
equal volume of water, drying over calcium chloride in the dark for 24 hours , boiling 
under reflux and then distilling.202 
Diethyl ether and tetrahydrofuran were dried by boiling under reflux, in an atmosphere of 
dry nitrogen, with sodium wire and benzophenone as an indicator. 
5.3 EXTRACTION, PURIFICATION, AND IDENTIFICATION OF 
THE PYRROLIZIDINE ALKALOIDS 
Plants from 6 populations of Senecio chrysocomLl and 3 populations of S. paniculatus were 
collected . The S. chrysocomLl populations were collected from Mountain Drive, 
Grahamstown; Trifolia, Humansdorp; Van Stadens River dams; Wittedrif road; Prince 
Alfred 's Pass; and close to the Dieprivierhoogte picnic spot. The former three were 
collected in November 1991, January 1992, and February 1992, respectively, while the 
latter three were all collected in February 1994. The S. paniculatus populations were 
collected in February 1994 on the farm Assegaaibos near Riversdale, beside the Robinson 
Pass 40 km from Oudtshoorn, and at the summit of the Tradouw Pass . Voucher 
specimens for all popUlations are held by the Selmar Schonland Herbarium, Albany 
Museum, Grahamstown. 
5 .3.1 EXTRACTION PROCEDURE (see Table S. la,b for data for each population) 
Air-dried , milled plant material (roots , stems, leaves and flowerheads) (column A, Table 
S.la,b) was initially covered with cold hexane and soaked for 2 days to remove fats . The 
hexane was decanted and replaced with cold methanol for 4 days to extract the 
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pyrrolizidines. The methanol extract was concentrated in vacuo and the resulting gummy 
residue dissolved in equal volumes of 2M-sulphuric acid and chloroform (column B, Table 
5.1a,b) . The aqueous and organic phases were separated, and the organic phase was 
further extracted with 2M-sulphuric acid (three times using the volume quoted in column 
C; Table 5.1a,b). The combined aqueous phases were washed with chloroform (three 
times using the volume quoted in column C; Table 5.1a,b) and then zinc dust was added 
and the mixture stirred overnight to reduce the N-oxides. The solution was filtered to 
remove excess zinc, basified to approximately pH 10 with concentrated ammonium 
hydroxide, and immediately extracted with chloroform. The chloroform was evaporated 
to leave the crude alkaloidal mixture. Before attempting any chromatographic separations, 
this mixture was cleaned further by redissolving in a smaller volume of chloroform and 
extracting with 2M-sulphuric acid. The acid extracts were basified to pH 10 with 
ammonium hydroxide, as before, and extracted with chloroform. The chloroform was 
removed in vacuo to leave the mixture ofpyrrolizidine alkaloids (column D, Table 5.1a,b). 
Table S.la: Data for the extraction of Senecio chrysocoma populations. 
s. chrysocoma A: B: c: D: 
populations dry mass volume of volume of Yield of crude 
(g) 2M-H2SO4 solvent alkaloids (mL)* (mL) (g),(%)t 
Grahamstown 1204 500 200 8.803,(0.73) 
Humansdorp 864 500 200 5.530,(0.64) 
Van Stadens 
River Dams 728 250 200 3.067,(0.42) 
Dieprivierhoogte 139 50 60 0.326,(0.23) 
Prince Alfred's 
Pass 357 100 100 3.015,(0.84) 
Wittedrif 280 100 100 1.820,(0.64) 
Together With an equal volume of CHCl,. 
t The crude pyrrolizidine alkaloids as a percentage of dry plant weight. 
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Table 5.lb: Data for the extraction of Senecio paniculatus populations. 
S. palliculatus ,\. : B: C: D: 
populations dry mass volume of volume of Yield of crude 
(g) 2M-H2SO4 solvent alkaloids (mL)* (mL) (g),(%)t 
Assegaaibos 859 150 100 2.203, (0.26) 
Robinson Pass 819 100 100 2.184,(0.27) 
Tradouw Pass 497 150 100 0.992,(0.20) 
Together With an equal volume of CHCI,. 
t The crude pyrrolizidine alkaloids as a percentage of dry plant weight. 
5.3.2 SEPARATION AND PURIFICATION OF THE PLANT EXTRACTS 
The separation of the extracts of the nine populations is shown on flow charts (Figures 
5.1-5.9); several techniques (designated: A; Bl-3; and C) were used for separating and 
purifying the crude extracts. 
A: Flash column chromatography performed on columns with a diameter of 50 mm and 
a silica bed height of 350 mm. A gradient elution was employed using varying ratios 
of chloroform and methanol (Table 5.2) and 50 mL fractions were collected. 
B: Preparative thin layer chromatography using 20x20 cm plates for ca. 50 mg samples, 
lOx20 cm plates for 20-25 mg samples and 5x20 cm plates for samples smaller than 
15 mg. Samples larger than 50 mg were separated on more than one 20x20 cm plate. 
Three different solvent systems were used:-
1: chloroform-methanol-25 % ammonium hydroxide (85: 14: 1) 
2: chloroform-cyclohexane-diethylamine (5:4: 1) 
3: chloroform-methanol-25 % ammonium hydroxide (80: 19: I) 
C: Droplet counter current chromatography with chloroform-benzene-methanol-water 
(5:5:7:2) as the solvent system and a drop rate of 15 mL per hour. 
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Table 5.2: Chloroform: methanol volume ratios used for gradient elution flash column 
chromatography, with the volume of each mixture used in parentheses. 
Population ChloToform:Methanol(volume/L) 
Humansdorp 85: 15(1); 3:2(1); 0: 1(0.5) 
Van Stadens River Dams 4:1(1); 3:1(1); 3:2(0.5); 0:1(0.25) 
Wittedrif 4:1(1); 7:3(1); 3:2(1); 0:1(0.3) 
Prince Alfred's Pass 4: 1(1); 7:3(1); 3:2(1); 0: 1(0.25) 
Robinson Pass 4: 1(1); 7:3(1); 13:7(1); 0: 1(0.25) 
Tradouw Pass 4:1(2); 7:3(1); 1:1(1) 
1: (43 .3) 
ii: (199.5) 
iii: (300.7) Further separation 
(8407) Bl iv: (613.8) shown below (in 
v: (297.7) Figures 5.1b and 5.1e) 
vi: (604.5) 
vii: (998.3) 
~::aee~ : impurity (4.8) 
(118) Bl I (8600) -: neosarraeine and sarraeine (45.0) 9-angelylplatynecine (119.2) 
impurity (2.3) 
(47.0) Bl traces of pyrrolizidine alkaloid (11. 7) 9-angelylplatyneeine, its N-oJcide 
and neosarraeine (8.1) 
9-angelylhastaneeine (2.5) 
Figure 5.la: Flow diagram for the separation of the crude extract from the Grahamstown 
S. chrysocoma population, the mass of each fraction (in mg) being indicated 
by the figure i.n parentheses. 
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impurity (10.6) 
[i] Bl 
B2 
: 
;nmurity (3.2) 
(4.7) ~,_....... 
- neosarracine (1.0) 
impurity and traces ofpyrrolizidine alkaloids (6.9) 
impurity (1.S) " 
~impurity(13.S) [ii] Bl isosarracinic and sarracinic acid methyl ester (46.6) impurity(3.0) " 
• 
[iii] Bl 
isosarracinic acid methyl ester (IS.4) 
7B-angelyl-I-methylene-S a-pyrrolizidine and impurity (36.2) 
~ impurity «I) 7B-angelyl-I-methylene-S a-pyrrolizidine (2.4) (62.S) Bl impurity (1.7) 7 a-angelyl-l-methylene-S a-pyITolizidine 
-4-oxide (O.S) 
impurity (13.9) 
(30.S)~,_: impurity(1.0) 
- 7B-angelyl-l-methylene-Sa-pyrrolizidID.e (4.7) 
[iv] Bl neosarracine (551) 
neosarracine, sarracine and 
" 7B-angelyl-l-methylene-Sa-pyrrolizidine (411) 
B2 9-angelylplatynecine (2.9) 
-~ traces ofa number"ofpyrrolizidine alkaloids«I) 
(13.4) 9-angelylhastanecine and 9-angelylplatynecine (2.1) 
impurity( 1 0.4) 
Figure 5.lb: Flow diagram (contd.) for the separation of the crude extract from the 
Grahamstown S. chrysocoma population, the mass of each fraction (in mg) 
being indicated by the figure in parentheses. 
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[v] B2 
,-----<~ impurity ( I. 2) 
(18.6) _B=-l~ __ ~ ~g} 
I-----<~ « 1) unknown 
'------<~ ( < 1) 
SECTION 5.3.2 
: 
pyrrolizidine alkaloid traces and impurities (2.8) 
(53.3) -=:B..::.3-+ ___ neosarracine and sarra cine (32.3) 
'------<~ impurity (2.3) 
(57.7) B3 
r--_ impurity (2.2) 
1--. neosarracine, sarracine and 
7-angelylhastanecine (8.2) 
f---. 7-angelylhastanecine (13.3) 
'--_. 9-angelylplatynecine (10.7) 
neosarracine and sarracine (129) 
~ impurity (10.0) [vi] B2 . 9-angelylplatynecine (151.9) 9-angelylplatynecine-4-oxide (125.2) 
mwurity (10.6) 
~ impurity (2.5) Bl (2.3) (31.4) (2.6)} unknown (2.3) 
[vii] B2 ~ impurity (1.0) (78 2) B2 9-angelylplatynecine (24.6) . 9-angelylplatynecine and other mono esters (10.4) impurity (11. 9) 
9-angelylplatynecine (29.8) 
impurity (132.1) 
Figure S.le: Flow diagram (contd.) for the separation of the crude extract from the 
Grahamstown S. chrysocoma population, the mass of each fraction (in mg) 
being indicated by the figure in parentheses . 
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crude A 
extract 
(5200) 
~ 7fl-angelyl-I-lllethylene-8a 1;(11.2) Bl -pyrrolizidine(10.2) (17.4) Bl impurity «1) 9-angelylplatynecine-4-oxide (2.3) impurity (2.7) 
r--; .... ~ (10.7) Bl and impurity (1. 1) ~ 7a-angelyl-I-methylene-8a-pyrrolizidine 
(41.4)..J!! 
1--. 
impurity (4.2) 
7fl-angelyl-I-methylene-8a-pyrrolizidine and impurity «I) 
7fl-angclyl- l-mcthylcnc-8a-pyrrolizidine (10.8) 
impurity and traces ofpyrrolizidil1e alkaloids(3.5) 
1---- neosarracine and sarra cine (3.3) 
'-. impurity (2.2) 
impurity and traces of7a-angelyl-I-methylene-
8a-pyrrolizidine (8.8) 
(1702,r B~I,+-_ impurity(12.0) 
7fl-angelyl-I-methylene-8a-pyrrolizidine (41.8) 
neosarracine and sarra cine (884) 
mixture ofpyrrolizidine alkaoids (19.0) 
( 1275)Bl ~ impurity and traces ofpyrrolizidine alkaloids (14.6) ~ neosarracine and sarracine (792) 
~ impurity (40.5) (408) Bl neosarracine and sarracine (197) 9-angelylplatynecine and traces of other monoestcrs (169) 
r-. impurity (8.7) 
~ impurity (2.2) 1-__ (5.5) 81 9-angelylhastanecil1c (1.5) neosarracine and sarra cine (1.4) 
-"E impurity (2.3) (385) .J!!I-__ ( ) Bl neosarracine «1) 8.1 impurity ( 1. 6) . 9-angelylplatynecine and traces 
of others (1. 9) 
~ impurity (3.0) L-__ (104) Bl 7-angelylhastanecine (5.8) 9-angelylplatynecine (55.0) 
Figure 5.2: Flow diagram for the separation of the crude extract from the Humansdorp 
S. chrysocoma population, the mass of each fraction (in mg) being indicated 
by the fignre in parentheses. 
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,----. (19.5) ~ 7a-angelyl-l-methylene-8a-pyrrolizdine (10.1) 
impurity (8.2) 
;--.impurity (10.5) 
;--.(44.5) Bl . impurity(4.0) 1; 7a-angelyl-l-methylene-8a-pyrrolizidine and mixture of pyrrolizidine alkaloids (3.4) 
7B-angelyl-l-methylene-8a-pyrrolizidine (36.3) 
~ impurity(9.1) crude ::--,A~_. (44.5) Bl 7a-angelyl-l-methylene-8a-pyrrolizidine (3.1) extract (2300) mixture ofpyrrolizidine alkaloids (15 .0) 
f-.... neosarracine and sarracine (765) 
1--.... (77.2) Bl neosarracine and sarracine (46.8) ~ impurity(6.6) neosarracine, sarra cine and traces of others (11 .2) 
,--_ impurity (6.7) 
impurity and traces of pyrrolizidine alkaloids (3 .3) 
neosarracine and sarra cine (12.1) 
L-.... (66 . 6)--,B~1~_ ... neosarracine, sarra cine and 
7-angelylmonoester alkaloid (7.2) 
1--.... mixture of monoester alkaloids (6.5) 
9-angelylliastanecine (3 .3) 
Figure 5.3: Flow diagram for the separation of the crude extract from the Van Stadens 
River dams S. chrysocoma population, the mass of each fraction (in mg) 
being indicated by the figure in parentheses . 
r----''' 7B-angelyl-l-methylene-8a-pyrrolizidine (6.3) 
f---... neosarracine and sarracine (14.2) 
crude Bl mixture ofpyrrolizidine alkaloids (3.9) 
extract (200) 9-angelylplatynecine (27.3) 
L......_ ... 9-angelylliastanecine (3.6) 
Figure 5.4: Flow diagram for the separation of the crude extract from the 
Dieprivierhoogte S. chrysocoma border-line population, the mass of each 
fraction (in mg) being indicated by the figure in parentheses. 
144. 
EXPERIMENTAL SECTION 5.3.2 
impurity and traces of pyrro1izidine alkaloids (21.5) 
52.6) Bl I : ~B-an~e1yl-l-methylene-8a-pyrrolizidine (37.2) 
unpunty (4.9) 
7B-angelyl-l-methylene-8a-pyrrolizidine (16.6) 
neosarracine (85.6) 
neosarracine and sarracine (5.5) 
: 
7B-angelyl-l-methylene-8a-pyi-rolizidine (1.1) 
(23 .7) -"B!..!.I-j-__ - neosarracine and sarra cine (4.4) 
L----c~ 9-angelylplat}necine-4-oxide (1.3) 
r--_impurity (7.7) 
crude A .B" 
::-'-"+-(96.2', .~ 
I--.-neosarracine and sarra cine (14.0) 
9-angelylplat}necine-4-oxide (5.0) 
I--_.-mixture ofpyrrolizidine alkaloids (5.9) 
L.....--l~9-angelylplat}necine (8.0) 
extract 
(1500) 
(42.3) Bl 
r--- impurity (2.6) 
1--- 7-angelylplat}necine and impurity (15.5) 
1-_'- 7-angelylplat}necine (12.0) 
7-angelylplat}necine and 9-angelylplat}necine 
-4-oxide (3.9) 
I-----c~ monoester alkaloids and impurities (1.2) 
~_ impurity (1.2) 
: 
impurity (14.8) 
(183) ----"'B"'I'-+_~~ 9-angelylplat}necine and 7-angelylplat}necine (11.1) 
L-~_~ 9-angelylplat}necine (7.6) 
Figure 5.5: Flow diagram for the separation of the crude extract from the Prince Alfred's 
Pass S. chrysocoma border-line population, the mass of each fraction (in mg) 
being indicated by the figure in parentheses . 
145. 
EXPERIMENTAL 
crude A 
extract 
(1010) 
SECTION 5.3.2 
Bl impurity (9.4) ~ 9-angelylplatynedne-4-oxide (5.4) (23.S) impurity and traces ofpyrrolizidine alhloid (5.2) impurity (3.1) 
-t: 
impurity (S.I) 
Bl impurity and 71l-angelyl-l-methylene-
(43.3) Sa-pyrrolizidine (9.0) 
impurity (5.5) 
-t: 71l-angelyl-1-methylene-Sa-pyrrolizidine (21.7) (7S.9) Bl 71l-angelyl-1-m~thylene-Sa-pyrrolizidine and neosarracme (11.1 impurity (7.S) 
~. 71l-angelyl-1-methylene-Sa-pyrrolizidine (2.7) (1020 Bl neosarracine and sarracine (59.9) . sarra cine and neosarracine (12.7) traces ofpyrrolizidine alkaloids (3.5) 
r--- impurity (1.3) 
1--__ neosarracine and sarra cine (l1S.S) 
(199.2) Bl 9-angelylplatynecine-4-oxide and 
other monoester alkaloids (9.1) 
L-__ mixture ofpyrrolizidine alkaloids (S.O) 
_ (105.2) Bl 9-angelylplatynecine and its N-oxide (S.O) t neosarracine and sarra cine (43.7) traces ofpyrrolizidine alkaloids (2.0) 
~. impurity (5 .2) neosarracine and sarracine (6.4) (l11.S) Bl 7-angelylplatynecine (9.6) 7-angelylplatynecine and 9-angelylplatynecine (20.3) 9-angelylplatynecine (4.2) 
Figure 5.6: Flow chart for the separation of the crude extract from the Wittedrif S. 
chrysocoma border-line population, the mass of each fraction (in mg) being 
indicated by the figure in parentheses. 
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__ impurity (15.6) 
__ 711-angelyl-1-methyiene-8a-pyyroJizidine (19.0) 
-- neosarracine and 7Jl-angelyl-I-methylene-8a-pyrrolizidine(13.0) 
__ sarracine and traces ofneosarracine (16.4) 
r----c" impurity «I) 
crude l!! f---+- 9-angelylplatynecine-4-oxide (3.6) 
extract __ (69 3) --,B~l,---+-__ 9-angelylplatynecine and its N-oxide (7.3) 
(300)' 9-angelylplatynecine (9.0) 
'-----c.. impurity (3.1) 
,--" impurity ( 1. 9) 
L...-.(134) 
1---" 7Jl-angelyl-I-methylene-8a-pyrrolizidine (9.6) 
~B:::..:..l~. -+_--;l~ neosarracine and sarracine (l0.5) · . 
f---+- sarra cine, neosarracine and monoester (20.7) 
'----_ .. 9-angelylplatynecine (2.9) 
Figure 5.7: Flow chart for the separation of the crude extract from the Assegaaibos S. 
paniculatus population, the mass of each fraction (in mg) being indicated by 
the figure in parentheses. 
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: 
impurity (1. 9) r-- (39.7) --,,:B:.!l'-lf-_ mixture of alkaloids (IDA) 
'---_- impurity (19.2) 
1---(462)~ 713-angelyl-l-methylene-8a-pyrrolizidine and impurities (11.8) impurities and traces of alkaloids (20.0) 
impurity (14.7) 
crude A _-=B:.:l'-t ___ 
extract-=-=-+---( 68.2) 
7B-angelyl-l-methylene-8 a-pyrrolizidine and 
impurities (5.9) 
713-angelyl-l-methylene-8 a-pyrrolizidine and 
monoester alkaloids( 6.8) (975) impurity (6.6) 
~ neosarracine and sarracine (23.6) r--(489) Bl mixture ofpyrrolizidine alkaloids (4.0) . mixture ofpyrrolizidine alkaloids (2.6) impurity (4.8) 
1--- neosarracine, sarra cine and 9-angelylplatynecine-4-oxide (76.5) 
'---_ neosarracine, sarracine and impurities (49.9) 
Figure 5.8: Flow chart for the separation of the crude extract from the Robinson Pass S. 
paniculatus population, the mass of each fract ion (in mg) being indicated by 
the figure in parentheses. 
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,.-. impurity (51. 6) 
1--. (27.2) _.1B!J.l-iI==:: impurity (16.8) 
. traces ofpyyrolizidine alkaloids (5.7) 
1--. impurity (69.2) 
1--. 7fi-ange1y1-1-methy1ene-8a-pyrrolizidine (28.2) 
1--. retrorsine, impurities and traces of other pyrrolizidine alkaloids (6.7) 
crude A 
extract-'-"- impurity «1) 
(800) Bl neosarracine and sarra cine (8.6) 
t--. (37.1) 9-ange1y1platynecine(0.7) 
'--_. impurity (18.4) 
1--. (107.9) _""B",I_ ___ neosarracine and sarracine (32.4) 
"---. (78.7) 
: 
neosarracine and sarracine (51.4) 
_",B ..... l-+-__ • 9-ange1y1p1atynecine and its N-oxide (4.8) 
'------;_. impurity ( 1. 6) 
Figure 5.9: Flow chart for the separation of the crude extract from the Tradouw Pass S. 
paniculatus population, the mass of each fraction (in mg) being indicated by 
the figure in parentheses . 
5.3.3 ANALYTICAL DATA FOR THE ISOLATED ALKALOIDS 
Retrorsine 9; 0,. see Section 5.4.2 (p. 156); Oc see Section 5.4.2 (p. 156); EI mlz 
246(12 %) , 220(22), 139(11) , 138(45) , 137(24), 136(95), 122(21) , 121(45), 120(100), 
119(77), 118(18), 109(16), 108(19) , 95(40) , 94(63), 93(76) , 80(29),53(22) and 44(38); 
CI(CH.) mlz 350[(M-W, 100%],349(6) , 348(7),336(2) , 151(2), 136(3), 119(3), 118(19), 
117(14) and 116(4) . 
Sarracine 36; gum; OH 1.88(3H, 20-CH3), 1.95(2H, 2-CH,), 1.97(3H, 19-CH3), 2.03(3H, 
14-CH3), 2.05 and 2. 14(2H , 6-CH,), 2.79 and 3.52(2H, 5-CH,), 2.83(1H, 1-CH), 2.90 
and 3.33(2H, 3-CH,) , 3.84(IH, 8-CH), 4.22(2H, 15-CH,), 4.24 and 4.40(2H, 9-CH2), 
5.41(IH, 7-CH), 6. 120H, 18-CH) and 6.36(1H, 13-CH); Oc 15.67(C-14), 15 .78(C-19), 
20.21(C-20), 28.64(C-2), 34.76(C-6), 40.01(C-i), 53.44(C-5) , 54 .62(C-3), 63 .23(C-9), 
149. 
EXPERIMENTAL SECTION 5.3.3 
68.87(C-8), 68 .89(C-15), 74.69(C-7), 126.62 (C-17), 131.74(C-12), 140.55(C-18), 
140.98(C-13), 166.36(C-16) and 166.68(C-ll); EI mlz 237(8%), 222(10), 140(37), 
139(32), 138(100), 123(26), 122(57), 121(13),96(46),95(47),83(35),82(74) and 55(35); 
CI (CH.) mlz 336[(M-W, 100%], 335(6), 318(7), 237(4), 236(21), 235(8), 220(17), 
138(3), 120(6), 118(3) and 117(3). 
7-Angelylplatynecine 38; gum; ~ 1.90(3H, 15-CH3), 1.91 and 2. 14(2H, 2-CH2)' 2.02 (3H, 
14-CH3)' 2.17 and 2.26(2H, 6-CH2), 2.31(lH, l-CH), 2.68 and 3.38(2H, 3-CH2), 2.77 
and 3.42(2H, 5-CH2), 3.57 and 3.72(2H, 9-CH,), 3.89(1H, 8-CH), 5.37(1H, 7-CH) and 
6.15(1H, 13-CH); Dc 15.88(C-14), 20.58(C-15), 30.98(C-2), 34.85(C-6), 40. 13(C-l), 
52.33(C-5) , 55. 13(C-3), 64.75(C-9), 71. 82(C-8), 73 . 93(C-7) , 126.96(C-12) , 140.23(C-13) 
and 166.83(C- l1); EI mlz 239(M+ ,I %), 208(1), 156(40), 140(21), 139(85), 138(29), 
109(10), 108(41), 83(30), 82(100) and 55(16); CI(NH3) mlz 240[(M + W , 100%], 238(2), 
156(1), 149(2), 139(2), 138(3), 122(1) and 99(1) . 
9-Angelylplatynecine 39; gum; DH 1.78 and 1.90(2H, 2-CH2), 1.81 and 1.91(2H, 6-CH,) , 
1.87(3H, 15-CH3)' 1.97 (3H, 14-CH3)' 2.64(IH, l-CH), 2.75 and 3. 13(2H, 3-CH2), 2.81 
and 3.27(2H, 5-CH2), 3.36(1H, 8-CH), 4.23(lH, 7-CH), 4.47 and 4.57(2H, 9-CH2) and 
6.06(IH, 13-CH); Dc 15.65(C-14), 20.68(C-15), 28.91(C-2), 37.41(C-6), 40.70(C-l), 
53 .69(C-5) , 55 .23(C-3) , 64.33(C-9), 70.30(C-8), 72 .72(C-7), 127.77(C-12), 137.83(C-13) 
and 168.10(C- ll); EI mlz 239(M+,2%), 221(5),195(1),156(2),140(6),139(4),138(5), 
122(9), 121(2), 120(2), 96(36) , 95(100), 94(5), 83(28), 82(94) and 55(19); CI(NH3) mlz 
240[(M + W ,100%], 140(2), 138(1) 99(1) and 95(1) . 
7-Angelylhastanecine 66; gum; DH 1.88(3H, 15-CH3), 2.01(3H , 14-CH3)' 2.05 and 
2.08(2H, 2-CH2), 2.22 and 2.36(2H, 6-CH2), 2.42(1H, l-CH), 2.84 and 3.65(2H, 3-CH2), 
2.88 and 3.68(2H, 5-CH2), 3.60 and 3.77(2H , 9-CH2), 4.22(1H, 8-CH) , 5.46(lH, 7-CH) 
and6.18(1H, 13-CH) ; Dc 15.87(C-14), 20.51(C-15) , 30.26(C-2) , 34.48(C-6), 40.22(C-l), 
52.36(C-5) , 54 .88(C-3) , 63.46(C-9), 71.69(C-8), 73 .29(C-7) , 126.59(C-12), 140.83(C-13) 
and 166.29(C-ll); EI mlz 239(M +,O.3%), 219(0.2),156(47),140(6),139(64),138(13) , 
150. 
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114(12), 113(13), 83(13) , 82(100) and 55(9); CI(NH3) mlz 240[(M + 1)+, 100%], 239(2), 
238(11), 139(4), 138(8), 136(2), 134(1), 122(2), 120(3), 118(2), 114(1), 99(1) and 96(1). 
9-Angelylhastanecine 67; gum; 0" 1.87(3H, 15-CH3), 1.98 (3H, 14-CH3)' 2.12 and 
2.26(2H, 2-CH2), 2. 17(2H, 6-CH2), 2.83(1H, 1-CH), 3.19 and 3.64(2H, 3-CH2), 3.21 and 
3.93(2H, 5-CH2), 4.18(1H, 8-CH) , 4.49 and 4.62(2H, 9-CH2), 4.60(1H, 7-CH) and 
6.IO(lH, 13-CH); Dc 15.47(C-14), 20.54(C-15), 28.69(C-2), 36.73(C-6), 39.98(C-l), 
53 .85(C-5), 54.32(C-3), 62 .28(C-9), 71.48(C-8), 71.55(C-7), 127.20(C-12), 139.20(C-13) 
and 167.65(C-ll); EI mlz 239(M+ ,6%), 221(32) , 195(6), 155(5), 140(29), 139(11) , 
138(16), 122(49), 121(7), 120(7), 96(91), 95(100), 94(19), 83(28), 82(96) and 55(71); 
CI(NH3) mlz 240[(M+ W, 100%], 238(3), 156(2), 140(3), 139(3), 138(3), 122(2) and 
113(1). 
9-Angelylplatynecine-4-oxide 68; gum; 0" 1.86(3H, 15-CH3), 1. 98 (3H, 14-CH3), 2.14 and 
2.32(2H, 2-CH2), 2.20 and 2.60(2H, 6-CH2), 3.19(IH, l-CH) , 3.70-4.01(5H, 3-CH2' 5-
CH2, 8-CH), 4.47 and 4.63(2H, 9-CH2), 4.69(IH, 7-CH) and 6.IO(1H, 13-CH); Dc 
15.86(C-14), 20.56(C-15), 28.94(C-2), 34.81(C-6) , 37.98(C-l), 62.58(C-9), 68.24(C-5) , 
70.41(C-3), 71.51(C-7), 88.18(C-8), 127.35(C-12), 138.98(C-13) and 167.78(C-ll); EI 
mlz 219(1), 120(14), 119(100), 118(7), 107(5), 106(59), 79(6), 77(4) and 55(5). 
7cx-Angelyl-I -methylene-8cx-pyrrolizidine 69; gum (Found: M+, 221.1415 . CnHI9N02 
requires M, 221.1416); 0" 1. 83(3H, 15-CH3), 1.97(3H, 14-CH3)' 2.17 and 2.32(2H, 6-
CH2), 2.66(2H, 2-CH2), 2.90 and 3.41(2H, 3-CH2), 2.92 and 3.60(2H, 5-CH2), 4.46(lH , 
8-CH), 4.96 and 5 .04(2H, 9-CH2), 5.62(lH, 7-CH) and 6.07(lH , 13-CH); Dc 15.69(C-14), 
20.46(C-15), 33.45(C-2), 34.21(C-6), 52 .60(C-5), 53.70(C-3), 71.68(C-8), 73.91(C-7), 
109.89(C-9) , 127.16(C-12), 139.21(C-13) and 166.28(C-ll); EI mlz 138(41 %),121(38), 
95(100) , 80(6) , 67(7) and 55(14) ; CI(NH3) mlz 222[(M+W, 100%], 158(1), 138(2), 
121(2) and 95(3). 
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7a-Angelyl-I-methylene-8a-pyrrolizidine-4-oxide 70; gum; OH 1. 84(3H, 15-CH3), 1. 98(3H, 
14-CH3)' 2.22 and 3.01(2H, 6-CHz), 2.69 and 3.12(2H, 2-CH,), 3.79(2H, 3-CHz), 3.84 
and 3.91(2H, 5-CHz), 4.66(IH, 8-CH), 5.04 and 5.24(2H, 9-CH,) , 5.84(1H, 7-CH) and 
6.1O(1H, 13-CH); oe 15.73(C-14), 20.32(C-15), 32.07(C-6), 32.63(C-2), 67.36(C-5), 
68.47(C-3), 89.63(C-8), 72.4I(C-7), 112.49(C-9), 126.63(C-12), 139.74(C-I), 140.18(C-
13) and 165.83(C-ll). 
7j3-Angelyl-I-methylene-8a-pyrrolizidine 71; gum (Found: M+, 221.1419. C13H'9NOZ 
requires M , 221.1416); OH 1. 84(3H, 15-CH3), 1.99(3H, 14-CH3)' 2.08 and 2.17(2H, 6-
CHz), 2.55(2H, 2-CHz), 2.76 and 3.16(2H, 3-CHz), 2.83 and 3.27(2H, 5-CHz), 4. 14(1H, 
8-CH), 4.88 and 5.07(2H, 9-CHz), 5.52(1H, 7-CH) and 6.03(1H, 13-CH); oe 15.61(C-14), 
20.55(C-15), 33.92(C-2) , 34.35(C-6) , 52.81(C-5) , 54.46(C-3) , 71.94(C-8), 74.95(C-7) , 
107.68(C-9), 127.86(C-12), 137. 84(C-13), 147.09(C-l) and 166.87(C-l1); EI mlz 
138(42 %), 121(42),95(100), 80(7),67(7) and 55(13); CI(NH3) mlz 222[(M + W, 100%), 
158(1), 138(2) , 121(3) and 95(4). 
Neosarracine 72; gum; OH 1.75 and 1.81(2H, 2-CHz), 1.83(6H, 14-CH3' 20-CH3), 
1.91(3H, 19-CH3), 1.94 and 2.02(2H, 6-CHz), 2.68(1H, l-CH), 2.74 and 3.13(2H, 3-
CH2) , 3.28 and 3.64(2H, 5-CHz), 3.58(IH, 8-CH) , 4. 14 and 4.29(2H, 9-CH2), 4.24(2H, 
15-CH2), 5.25(1H, 7-CH), 6.02(1H, 18-CH) and 6.88(1H, 13-CH); oe 14.04(C-14), 
15 .51(C-19), 20.51(C-20) , 28.49(C-2), 34.69(C-6) , 39.94(C-l), 53 .27(C-5), 54.68(C-3) , 
56.10(C-15), 63.90(C-9), 68.43(C-8), 74.91(C-7), 126.79 (C-17), 131.93(C-12), 
139.55(C-18), 140.93(C-13), 166.46(C-16) and 166.89(C-ll); EI mlz 237(9%) , 222(9), 
140(29),139(27),138(100),123(22),122(38),121(15), 96(30), 95(51), 83(24) , 82(64) and 
55(27) ; CI(NH3) mlz 338[(M + W, 100%), 322(1),236(3),220(2), 140(1), 139(1), 137(3), 
134(5), 133(1) , 123(1) , 122(7), 118(2), 95(2) and 94(1) . 
152. 
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5.4 THE SYNTHESIS OF 78-ANGELYL-I-METHYLENE-8a-
PYRROLIZIDINE 71 
5.4.1 AB INITIO APPROACH 
Methyl 3-bromopropanoate 99. 34°_ 
Acetyl chloride (2.0 mL, 28 mmol) was added dropwise to a stirred solution of 3-
bromopropanoic acid (100 g, 654 mmol) in dry methanol (400 mL). Stirring was 
continued at room temperature for 21 hours and the solvent was then removed in vacuo 
keeping the temperature below 30°C. The residue was dissolved in dichloromethane (250 
mL) , and washed sequentially with saturated aqueous sodium hydrogen carbonate (50 mL), 
water (2x50 mL) and saturated brine (50 mL) , before being dried with anhydrous 
magnesium sulphate. The solvent was evaporated to give methyl 3-bromopropanoate 99 
as a yellow oil (104 g, 95 .2 %) sufficiently pure to be used directly in the next step; DH 
2.87(2H, t, 12.3 6.8, 2-CH2), 3.52(2H, t, 12,3 6.8, 3-CH2) and 3.67(3H, s, CH30); DC 
25.74(C-3), 37.46(C-2), 51.89(CHP) and 170.83(C-I). 
Methyl glycinate hydrochloride 100.-
Thionyl chloride (73 mL, 1.0 mol) was added dropwise to a stirred solution of glycine (75 
g, 1.0 mol) in dry methanol (750 mL) . Stirring was continued at room temperature 
overnight. The solvent was removed in vacuo to afford crystalline methyl glycinate 
hydrochloride 100 as white needles (124 g, 98,8%); m.p. 174-176°C (iit. ,360 175°C) (from 
methanol and chloroform) ; DH(D20) 3,95(3H, s , CH30) and 4.04(2H, s, 2-CH2); Dc(D,D) 
42.73(C-2) , 56 .03(CHP) and 171.30(C-I). 
Dimethyl 3-azahexane-l , 6-dicarboxylate 101.340-
10M-Sodium hydroxide (11. 9 mL) was added in one portion to a cooled, stirred solution 
of methyl glycinate hydrochloride 100 (15 .0 g, 119 mmol) in water (35 mL) . When the 
temperature had returned to O°C, methyl 3-bromopropanoate 99 (19.9 g, 119 mmol) in 
methanol (70 mL) was added dropwise over 35 minutes, followed by a solution of 
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potassium carbonate (7.9 g, 57 mmol) in water (88 mL). The resulting cloudy mixture 
was stirred at room temperature overnight. The solvents were removed in vacuo at 40°C 
until a precipitate began to form. Just enough water was added to dissolve the precipitate 
and the resulting mixture was extracted with dichloromethane (5x45 mL) . The combined 
extracts were dried with anhydrous magnesium sulphate and the solvent evaporated to give 
dimethyl 3-azahexane-l,6-dicarboxylate 101 (12 .04 g, 57.6%); OH l.77(1H, s, NH) , 
2.47(2H, t, 1'.5 6.6, 5-CH2), 2.86(2H, t, 1'.5 6.6, 4-CH2), 3.38(2H, s, 2-CH2), and 3.65 
and 3.68(6H, sand s, 2xCH,O); Oc 34.58(C-5), 44.69(C-4), 50.60(C-2), 51.55 and 
5 1. 69(2xCH,O) , and 172.60 and 172.76(C-l, C-6). 
3-tert-Butyl 1, 6-dimethyl 3-azahexane-I ,3, 6-tricarboxylate 102.340-
Di-tert-butyl dicarbonate (20.6 g, 94.2 mmol) in dry dichloromethane (60 mL) was added 
dropwise over 30 minutes to an ice-cold, stirred solution of dimethyl 3-azahexane-l,6-
dicarboxylate 101 (15.0 g, 85.6 mmol) and triethylamine (12 .3 mL, 8.8 mmol) in dry 
dichloromethane (60 mL). The resulting solution was stirred at room temperature 
overnight before being diluted with dichloromethane (80 mL) and washed sequentially with 
2M-hydrochloric acid (190 mL), water (2x190 mL), and saturated brine (95 mL) . The 
organic layer was then dried with anhydrous magnesium sulphate and the solvent was 
evaporated. The resulting oil was vacuum distilled (ca. 0.6 mmHg) to give two fractions : 
one boiling at 88-92°C which was tert-butyl alcohol and the other at 124-129°C which was 
the desired 3-tert-butyl 1,6-dimethyl 3-azahexane-l ,3,6-tricarboxylate 102 (21.7 g, 
92.1 %); MDMSO-d6 , 353K) l.39[9H, s, (CH,),C], 2.S7(2H, t, 1'.5 6.9, 5-CH2), 
3.48(2H, t, 1'.56.9, 4-CH2), 3.61 and 3.66(6H, sand s, 2xCH,O) and 3.96(2H, s, 2-CH2)' 
odDMSO-d6 , 353K) 27.39[(CH,),C], 32.51(C-5), 43 . 76(C-4) , 48. 93(C-2) , 50.59 and 
SO.91(2xCH,O), 78.79[(CH,),C], 154.02(NC02), and 169.72 and 171.15(C-l, C-6). 
I-ten -Butyl 2-methyl 3-oxopyrrolidine-I , 2-dicarboxylate 103. 26'_ 
A solution of 3-tert-butyl 1,6-dimethyl 3-azahexane-l ,3,6-tricarboxylate 102 (6.30 g, 22.9 
mmol) in dry toluene (11.5 mL) was added dropwise to an ice-cold, stirred solution of 
potassium tert-butoxide (3 .60 g, 32.1 mmol) in dry toluene (65 mL) under dry nitrogen. 
Stirring was continued at O°C for 15 minutes. Glacial acetic acid (2.5 mL) was added in 
154. 
EXPERIMENTAL SECTION 5.4.1 
one portion followed immediately by an ice-cold solution of sodium dihydrogen phosphate 
(92 mL of a 10% aqueous solution of NaH2PO .. 2H20) . The mixture was shaken, left to 
separate, and the organic layer removed. The aqueous phase was extracted with 
dichloromethane (4x50 mL). The combined organic extracts were washed with pH 7 
phosphate buffer (3x75 mL), dried with anhydrous magnesium sulphate and the solvent 
evaporated . The crude residue was dissolved in toluene (150 mL) , washed with pH 9.5 
carbonate buffer (lOx50 mL) and water (20 mL) , and then dried with anhydrous 
magnesium sulphate. The solvent was evaporated to give the desired regioisomer I-ten-
butyl2-methyl 3-oxopyrrolidine- l,2-dicarboxylate 103 (3.48 g, 62.4 %); ~ 1.39-1.50[9H, 
m, (CH3)3CJ , 2.63(2H, t, J 2.6, 4-CH2), 3.65-4.01(2H, m, 5-CH2), 3.78(3H, s, CH30) 
and 4.52(1H, m, 2-CH); oe 28 .20[(CH3)3CJ, 36.32(C-4), 4 l.52(C-5) , 65 .59[(CH3)3CJ, 
81.05(C-2), 153.95(N-C02) and 170.71 (C02CH3) . 
pH 7 Phosphate Buffer.-
Sodium chloride (8.0 g) , potassium chloride (0.2 g) , potassium dihydrogen phosphate (0.2 
g) and sodium phosphate'2H20 (0.15 g) were dissolved in de ionised water (1000 mL) and 
carefully brought to pH 7 with a few drops of concentrated sodium hydroxide. 
pH 9.5 Carbonate Buffer.-
Sodium hydrogen carbonate (11.76 g) and sodium carbonate (6.36 g) were dissolved in 
de ionised water (1000 mL) . 
Attempted preparation of I-tert-butyl 2-methyl 3-hydroxypyrrolidine-I,2-dicarboxylate 
112*.263_ 
A mixture of I-ten-butyl 2-methyl 3-oxopyrrolidine-l,2-dicarboxylate 103 (1.0 g, 3.9 
mmol), tap water (80 mL), sucrose (15 g) and dried baker 's yeast (10 g) was shaken at 
30°C for 24 hours . Celite was added to the mixture, which was filtered and the solids 
were washed with water (20 mL). The combined filtrates were saturated with sodium 
chloride and extracted with diethyl ether (5x50 mL) . The combined extracts were washed 
with water (2x25 mL), dried with anhydrous magnesium sulphate and the solvent was 
* 2-metbyl analogue of compound 97 (Scheme 4.2 . p. 116). 155. 
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evaporated in vacuo, but the desired product, I-ten-butyl 2-methyl 3-hydoxypyrrolidine-
1,2-dicarboxylate 112 could not be identified in the residue. 
5.4.2 MODIFICATION OF THE NATURAL PYRROLIZIDINE SYSTEM, 
RETRONECINE 31, TO AFFORD 76-ANGELYL-l-METHYLENE-8a-
PYRROLIZIDINE 71 
Retrorsine 9.-
Dried Senecio onhonnaejlorus plant material (1.226 kg) was extracted by the same general 
procedure as described for S. chrysocoma and S. paniculatus. The methanol extract was 
concentrated and dissolved in a mixture of 2M-sulphuric acid (500 mL) and chloroform 
(500mL) . The organic and aqueous phases were separated and the organic layer was 
extracted with 2M-sulphuric acid (3x200 mL) . The combined aqueous layers were washed 
with chloroform (3x200 mL) and then stirred overnight with zinc dust. The solution was 
filtered to remove excess zinc, basified to pH 10 with concentrated ammonium hydroxide 
and extracted with chloroform (5x200 mL) . The chloroform extracts were dried with 
anhydrous magnesium sulphate and the solvent evaporated to give retrorsine 9 as a 
crystalline solid (20.55 g, 1.7% of dry plant weight); m.p. 214-216°C (lit.,'42,328 216°C); 
DH 0.86(3H, d, J 6.4, 19-CH3), 1.68(1H, m, 13-CH), 1.74 and 2. 12(2H, m and m, 14-
CH2), 1.83(3H, dd, J 1.4 and 7.0, 21-CH3L 2.21 and 2.39(2H , d and dd, J 12.8 and J 
5,9, 14,0, 6-CH2), 2.53 and 3.25(2H, m and t, J 8.4, 5-CH2) , 3.39 and 3.93(2H, dd and 
d, J 7.1, 15.4 and J 14.3, 3-CH2), 3.63 and 3.74(2H, d and d, J 11.2 and J 11.2, 18-
CH2), 4.10 and 5.50(2H, d and d, J 11.5 and J 11 .8, 9-CH2), 4.26(1H, d, J 2.0, 8-CH) , 
5.00(IH, t, 13 .2, 7-CH), 5.72(1H, q, 17.2, 20-CH) and 6.21(1H, s, 2-CH); Dc 11.65(C-
19), 14.99(C-21) , 34.73(C-6), 35.64(C-13) , 37.91(C-14), 52.96(C-5) , 61.12(C-3), 
62.85(C-9), 66.89(C-18), 75 . 11(C-8) , 77. 49(C-7) , 81.36(C-12), 131.29(C-15), 132.519(C-
I), 134,54(C-2), 136.86(C-20), 167.41(C-16) and 175.63(C-11). 
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Retronecine 31.-
Method 1: A mixture ofretrorsine (20.0 g, 56.9 mmol) and barium hydroxide octahydrate 
(16.0g, 50.7 mmol) in water (250 ml) was boiled under reflux for four hours. After cooling 
the mixture, it was saturated with carbon dioxide using dry ice and filtered to remove the 
precipitated barium carbonate. The filtrate was concentrated in vacuo to approximately 100 
mL, brought to pH 9 with sodium carbonate, then saturated with sodium chloride and 
continuously extracted with chlorofonn for 17 hours. The chlorofonn extract was 
concentrated in vacuo to yield a gummy residue which was shown, by NMR analysis, to 
contain some retronecine. Hydrolysis was deemed to be incomplete and the chlorofonn 
insoluble material (7.02 g) was boiled under reflux with barium hydroxide octahydrate 
(15.0g, 47.5 mmol) in water (200 mL) for 20 hours. The same workup procedure as above 
was followed, except that the continuous extraction took 72 hours, yielding retronecine 31 
as a gum (2.35 g, 26.5%). 
Method 2: A mixture of retrorsine (7.5 g, 21 mmol), barium hydroxide octahydrate (17.4 
g, 55.2 mmol) and water (150 ml) was boiled under reflux for 9.5 hours. After cooling the 
solution was saturated with carbon dioxide using dry ice and filtered to remove precipitated 
barium carbonate. The filtrate was evaporated in vacuo and the residue dissolved in 
methanol. The methanolic solution was filtered and evaporated to leave a brown gum 
which was boiled under reflux with chlorofonn for 5.5 days. The chlorofonn was changed 
twice during this time. The chlorofonn extracts were combined, dried with magnesium 
sulphate and the solvent evaporated in vacuo to give crude retronecine (2.13g, 65.4%). 
Attempted recrystallisation from acetone was unsuccessful. 
Method 3: A mixture of retrorsine (21.0 g, 60.0 mmol), barium hydroxide octahydrate 
(48.9 g, 155 mmol) and water (450 ml) was boiled under reflux for 16 hours. The cooled 
solution was saturated with carbon dioxide using dry ice and then filtered to remove 
precipitated barium carbonate. The filtrate was evaporated in vacuo until a precipitate 
began to fonn. Chlorofonn was added and the resulting mixture was stirred vigorously 
overnight at room temperature before filtering to remove the precipitate, which was 
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identified as isatinecic acid 104, 0,,(020) 0.94(3H, d, 13.8 6.0, 8-CH3) ' 1.74(3H, d, 1'.10 
6.8, 10-CH3), 2.05(2H, m, 4-CH2)' 2.31(1H, m, 3-CH) . 3.75 and 3.86(2H, d and d, 17 •7 
11.6 and 17•7 11.6, 7-CH2), and 5.43(lH, q, 1'.10 6.8 , 9-CH); OC(020) 13.00(C-8) , 
15.42(C-I0), 37.38(C-3), 38.00(C-4) , 67. 17(C-7), 83.38(C-2), 124.49(C-9), 139.97(C-5), 
180.54(C-6) and 181.16(C-1). 
The organic and aqueous layers of the filtrate were separated. The organic layer was dried 
with anhydrous magnesium sulphate and the solvent evaporated to yield a brown gum, 
which contained a small amount retronecine 31 . The aqueous layer was evaporated to 
dryness in vacuo and was stirred with additional chloroform, at room temperature for six 
days, after which the chloroform was removed, dried with magnesium sulphate and the 
solvent evaporated in vacuo to yield retronecine 31 as cream crystals (3.52 g, 37.7 %); 
m.p. 119-121 °C (lit.,202 120-121°C); OH 1.99(2H, m, 6-CH2)' 2.78 and 3.32(2H, m and 
t, J 7.2 , 5-CH2), 3.46 and 3.93(2H, dd and dd, 15.4, 15.5 and J 2.0, 15.6, 3-CH2), 4.17 
and 4.38(2H, d and d, 1,., 11.6 and 1,., 12.0, 9-CH2), 4.27(1H, s, 8-CH), 4.34(lH, t, J 
3.0, 7-CH) and 5.74(lH, s, 2-CH); Oc 35.43(C-6), 54.09(C-5), 59.1O(C-3), 61.93(C-9), 
71.19(C-7) , 79.47(C-8) , 127.46(C-2) and 137.32(C-1). 
I-Chloromethyl-l, 2-didehydro-7ji-hydroxy-8cx-pyrrolizidine hydrochloride 10S.345_ 
Retronecine 31 (0.186 g, 1.20 mmol) was added slowly, under dry nitrogen, to ice-cold , 
stirred thionyl chloride (0.28 mL, 3.9 mmol) . The mixture was stirred at O°C for 30 
minutes before the excess thionyl chloride was removed under vacuum without heating. 
The black, gummy residue was dissolved in absolute ethanol , decolourised with activated 
carbon and filtered. Oiethyl ether was added to give 1-chloromethyl-1,2-didehydro-7B-
hydroxy-8cx-pyrrolizidine hydrochloride lOS as crystals (0.161 g, 63.9%); m.p. 150-153 °C 
(from absolute ethanol and diethyl ether) (lit. , 345 152-153°C) ; OH(020) 2.32(2H, m, 6-
CH2), 3.43 and 4.06(2H, m and m, 5-CH2), 4.06 and 4.59(2H, m and d, J 16.0, 3-CH2), 
4.38 and 4.50(2H, d and d, 1'.9 13 .1 and 19.9 13.0, 9-CH2), 4.84(1H, s, 7-CH), 5.16 (IH, 
s, 8-CH) and 6.08(lH, s, 2-CH) ; OC(020) 36. 19(C-6), 40.21(C-9) , 55 . 19(C-5), 62.40(C-
3), 70. 19(C-7) , 79.25(C-8) , 125 .74(C-2) and 134.37(C-l). 
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7j3-hydroxy-I-methylene-8cx-pyrrolizidine 58 and 1, 2-didehydro-7j3-hydroxy-I-methyl-8cx-
pyrrolizidine 106 .346-
A mixture of l-chloromethyl-l ,2-didehydro-7B-hydroxy-8cx-pyrrolizidine hydrochloride 
105 (230 mg, 1.09 mmol), 1M-sulphuric acid (7 mL) and zinc dust was stirred for 2 
hours. The solution was filtered to remove excess zinc, basified to pH 10 with dilute 
sodium hydroxide and extracted with chloroform (5x20 mL). The extracts were dried with 
anhydrous magnesium sulphate and evaporated to give a 5:2 mixture of 7B-hydroxy-l-
methylene-8cx-pyrrolizidine 58 [~ 1.93 and 2.04(2H, m and dd, 16.4 and 13.2, 6-CH2), 
2.53(2H, t,16.7, 2-CH2), 2.65 and 3. 11 (2H, mand m, 3-CH2), 2.79 and 3.11(2H, mand 
m, 5-CH2) , 3.92(1H, s, 8-CH) , 4.15(1H, t, 13.8, 7-CH), and 4.88 and 5.18(2H, sand 
s, 9-CH2); Dc 34.n(C-2) , 35 .58(C-6), 52 .85(C-5), 54.98(C-3), n .26(C-7), 73.79(C-S), 
107 . 15(C-9) and 149.08(C-l)] and 1,2-didehydro-7B-hydroxy-l-methyl-8cx-pyrrolizidine 
106 [~ l.75(3H, S, 9-CH3)' l.S5-1.93(2H , m, 6-CH2), 2.65 and 3.20(2H, m and m, 5-
CH2), 3.26 and 3.S2(2H, m and d, 1 S.O, 3-CH2), 4.02(lH, s, S-CH) , 4. 1S (1H, t, 13 .1, 
7-CH) and 5.46(IH, s, 2-CH); Dc 14. 16(C-9), 36.53(C-6) , 53 .95(C-5) , 63.15(C-3), 
70.6S(C-7) , SO.25(C-S), 124.71(C-2) and 134.14(C-I)] . 
cx,j3-Dibromo-cx-methylbutyric acid (2,3-dibromo-2-methylbutanoic acid) 107.349_ 
Bromine (12.9 mL, 0.250 mol) was added dropwise to an ice-cold , stirred solution oftiglic 
acid 92 (25.0 g, 0.250 mol) in dry carbon tetrachloride (50 mL) . After completion of the 
addition the reaction mixture was allowed to warm to room temperature, left to stand 
overnight and then boiled under reflux until the solution was light orange in colour. The 
solvent was removed in vacuo to give crystals of cx,B-dibromo-cx-methylbutyric acid 107 
(55 .24 g, S5 .0%); m.p. SI-S3 °C (from hexane) (lit. , 349 S2-SS 0C) ; ~ 1.91(3H, d, 13.4 6.S , 
4-CH3), 1.99(3H, s , 5-CH3), 4.S4(lH , q, 13.4 6.S, 3-CH) and 9.S6(lH , br s, OH) ; Dc 
20.93(C-4), 21.12(C-5) , 51.06(C-3) , 61.45(C-2) and 174.S9(C-l) . 
j3-Bromoangelic acid [(E)-3-bromo-2-methyl-2-butenoic acid] 108 .349_ 
To a stirred solution of cx ,B-dibromo-cx-methylbutyric acid 107 (40.0 g, 0.154 mol) in 
methanol (25 mL) was added , dropwise, a 25 % methanolic potassium hydroxide solution 
(226 mL). Potassium carbonate (4 .0 g) was added to prevent decarboxylation and the 
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reaction mixture was heated for 2 hours at ca. 55°C. Excess potassium hydroxide was 
removed by saturating the hot mixture with carbon dioxide, using dry ice and filtering 
while warm. The filter cake was washed with warm methanol and the combined methanol 
fractions were evaporated to dryness. Water (30 mL) was added to the residue which was 
then acidified to pH 3 with 3M-hydrochloric acid to precipitate f3-bromoangelic acid 108 
(8.35g, 30.4%); m.p. 90-93°C (from hexane) (lit.,349 92-94SC); ~ 2.11(3H, d, 14•5 1.5, 5-
CH3), 2.75(3H, d, 14•5 1.5, 4-CH3) and 8.53(lH, br s, OH); Oe 20.94(C-5), 28.53(C-4), 
127.39(C-2), 140.41(C-3) and 171.42(C-1). 
Angelic acid [(Z)-2-methyl-2-butenoic acid] 91.349_ 
f3-Bromoangelic acid 108 (1.00 g, 5.59 mmol) was stirred in water (9 mL) at 5°C and small 
pieces of a 9% sodium-mercury amalgam were added. The resulting reaction mixture was 
stirred slowly at room temperature for 64 hours. The solution was separated from the 
mercury, which was rinsed with water (10 mL). The combined aqueous fractions were 
acidified to pH 3 with concentrated hydrochloric acid. Angelic acid 91 precipitated on 
cooling (0.337 g, 60.3%); m.p. 42-44°C (from hexane) (lit. ,349 44-46°C); OR 1.91(3H, t, 1 
1.5, 5-CH,), 2.03(3H, dd,1 1.5 and 6.6, 4-CH,) and 6.22(lH, dq, 1 1.4 and 7.3, 3-CH); oe 
16.00(C-4), 20.31(C-5), 127.23(C-2), 141.03(C-3) and 173.72(C-1). 
9% Sodium-mercury amalgam.361-
Sodium (6.0 g, 0.26 mol), cut into small pieces, was placed in a 250 mL round bottom 
flask fitted with a dry nitrogen inlet, a nitrogen outlet and a dropping funnel. The dropping 
funnel was charged with mercury (60 g, 0.30 mol). About one third of the mercury was 
added to the sodium and the flask was warmed cautiously with a bunsen flame until the 
reaction started. The remainder of the mercury was added slowly with shaking and heating. 
The molten amalgam was poured into a mortar where it solidified immediately. The 
amalgam was crushed, in the mortar, under a stream of dry nitrogen. 
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lfi-angelyl-I-methylene-801-pyrrolizidine 71 and lfi-angelyl-l, 2-didehydro-l-methyl-801-
pyrrolizidine 111.-
A solution of 7B-hydroxy-I-methylene-801-pyrrolizidine S8 and 1,2-didehydro-7B-hydroxy-
l-methyl-801-pyrrolizidine 106 (0.345 g, 5:2 mixture, 2.48 mmol) in dry tetrahydrofuran 
(10 mL) was added, via cannula, to a flame-dried, 4-necked flask flushed with nitrogen. 
The mixture was cooled to O°C and 1.6 M-butyllithium in hexane (1.6 mL, 2.48 mmol 
BuLi) was added dropwise. The mixture was stirred at O°C for 30 minutes before angelyl 
chloride 109 (0.586 g , 4.94 mmol) was added. The reaction mixture was then allowed 
to warm to room temperature and was stirred overnight. The pH was adjusted to 9 with 
aqueous sodium bicarbonate and the mixture was extracted with chloroform (5x15 mL). 
The combined extracts were dried with anhydrous magnesium sulphate and the solvent 
evaporated in vacuo to give a brown oil. Preparative layer chromatography on silica gel 
with chloroform-methanol-25 % ammonia (85: 14: I) as eluent yielded a 5:2 mixture (145 
mg, 26.4%) of 7B-angelyl-I-methylene-801-pyrrolizidine 71 [~ 1.81(3H, s, 15-CH3), 
1.95(3H, d, J 6.8, 14-CH3), 2.09 and 2.15(2H, m and m, 6-CH2), 2.53(2H, br s, 2-CH2), 
2.78 and 3. 13(2H, m and m, 3-CH2), 2.81 and 3.26(2H, m and t, J 8.0, 5-CH2), 
4.08(IH, s, 8-CH), 4.85 and 5.02(2H, sand s, 9-CH2), 5.50(1H, t, J 4.2, 7-CH) and 
6.04(IH, m, 13-CH) ; Dc 15.64(C-14), 20.53(C-15), 33.89(C-2), 34.33(C-6), 52.81(C-5), 
54.43(C-3), 71. 96(C-8), 74.88(C-7), 107.83(C-9), 127.80(C-12), 137.98(C-13), 146.87(C-
I) and 166.83(C-II); EI mlz 221(M+, 1 %),139(8),138(84),122(15),121(89), 120(23), 
96(59), 95(100), 94(22), 83(8), 82(8), 80(14), 67(13) and 55(16)) and 7B-angelyl-l ,2-
didehydro-l-methyl-801-pyrrolizidine 111 [DH 1.67(3H, S, 9-CH3)' 1.81(3H, s, 15-CH3), 
1.95(3H, d, J 6.8, 14-CH3), 2.09(2H, m, 6-CH2), 2.66 and 3.35(2H, m and m, 5-CH2), 
3.32 and 3.89(2H, m and d, J 14.0, 3-CH2), 4.20(1H, s, 8-CH) , 5.36(1H, s, 2-CH), 
S.43(1H, t, 13.6, 7-CH) and 6.06(IH, m, 13-CH); Dc 13.96(C-9), 15.60(C-14), 20.45(C-
15), 34.60(C-6), 54. 19(C-5), 62.83(C-3), 73.32(C-7), 78.64(C-8), 123.02(C-2), 134.36 
and 136.97(C-I and C-12), 138.45(C-13) and 166.97(C-ll); EI mlz 139(4%), 138(49), 
122(8) , 121(57), 120(15),96(35),95(100),94(17),83(5),82(6),80(7), 67(9) and 55(15)) 
together with traces of corresponding tiglyl isomers. 
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SECTION 5.4.2 
Angelic acid 91 (72 mg, 0.72 mmol) and N,N' -carbonyldiimidazole (124 mg, 0.763 mmol) 
were stirred together in dry, ethanol-free chloroform (2 mL) under a dry nitrogen 
atmosphere for 1 hour. A 5:2 mixture of711-hydroxy-l-methylene-8a-pyrrolizidine 58 and 
1 ,2-didehydro-711-hydroxy-1-methyl-8a-pyrrolizidine 106 (100 mg, 0.718 mmol) was added 
in dry, ethanol-free chloroform (2 mL) and the reaction was left to stir at room 
temperature for 24 hours . Analytical TLC showed that no reaction had taken place so 
reaction was stirred at room temperature for another 3 days after which time TLC showed 
that a product had begun to form . The mixture was heated at 35 °C for 1.5 hours and then 
under reflux for 2 hours. The reaction mixture was diluted with chloroform (5 mL) and 
extracted with 2M-sulphuric acid (5x5 mL). The combined acid extractions were washed 
with chloroform (3x5 mL), basified to pH 10 with 25 % ammonium hydroxide and 
extracted with chloroform (5xlO mL). The combined chloroform layers were dried with 
anhydrous magnesium sulphate and the solvent was evaporated. None of the desired 
product was found to be present in the residue (as determined by NMR analysis). 
Method 2: DCC-DMAP coupling.-
Two solutions were prepared in flame dried, 3 mL, stoppered test tubes:-
a) 711-hydroxy-l -methylene-8a-pyrrolizidine 58 and 1,2-didehydro-711-hydroxy-1-methyl-
8a-pyrrolizidine 106 (5 mg, 5:2 mixture, 35 Jimol) and 4-dimethylaminopyridine 
(DMAP) (15mg) in deuterated dichloromethane (0.7 mL); and 
b) angelic acid 91 (14 mg , 140 Jimol) and dicyclohexylcarbodiimide (DCC) (70 mg) 
dissolved in deuterated dichloromethane (0.3 mL) by shaking and warming. 
When the bubbling in (b) had stopped, the DMAP/alcohol solution (a) was added to the 
angelic acid/DCC solution (b) and the mixture shaken well. The mixture was left to stand 
with occasional shaking for 0.5 hour. NMR analysis of the mixture showed that no 
coupling had taken place; the reaction mixture was then left to stir overnight, but still no 
coupling resulted . 
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Angelyl chloride 109. 354_ 
A suspension of potassium angelate 110 (0.872 g, 6.31 mmol) was stirred in dry diethyl 
ether (20 mL) at O°C under" dry nitrogen atmosphere. Oxalyl chloride (3.5 mL) and a 
drop of dry dimethyl formam ide were added and the stirring was continued at O°C for 2 
hours. The excess oxalyl chloride was removed under a slight vacuum at room 
temperature. Dry carbon tetrachloride was added to aid the removal of oxalyl chloride. 
Angelyl chloride 109 (0.586 g, 78 .3 %) was obtained as a pale yellow oil , which was used 
immediately without further purification. 
Potassium angelate 110.'54-
Angelic acid 91 in ethanol was neutralised by the dropwise addition of an eqimolar 
quantity potassium hydroxide in ethanol. The solvent was removed in vacuo without 
heating to afford potassium angelate 110 as a white crystalline product. 
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7. APPENDIX 
7.1 TWO DIMENSIONAL NMR SPECTRA NOT INCLUDED IN THE 
TEXT 
Figure 7.1 COSY spectrum of 7-angelylhastanecine 66. 
Figure 7.2 COSY spectrum of 9-angelylhastanecine 67. 
Figure 7.3 COSY spectrum of 7-angelylplatynecine 38. 
Figure 7.4 COSY spectrum of 9-angelylplatynecine-4-oxide 68. 
Figure 7.5 COSY spectrum of sarracine 36. 
Figure 7.6 COSY spectrum of neosarracine 72. 
Figure 7.7 HMQC spectrum of7-angelylhastanecine 66. 
Figure 7.8 HMQC spectrum of 9-angelylhastanecine 67. 
Figure 7.9 HMQC spectrum of 7-angelylplatynecine 38. 
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7.2 GLC CHROMATOGRAMS OF CRUDE EXTRACTS NOT 
INCLUDED IN THE TEXT 
Figure 7.19 GLC chromatogram of the crude extract from the Grahamstown S. 
chrySOCOfTUl population. 
Figure 7.20 GLC chromatogram of the crude extract from the Van Stadens River dams 
S. chrySOCOfTUl population. 
Figure 7.21 GLC chromatogram of the crude extract from the Prince Alfred's Pass S. 
chrySOCOfTUl border-line population. 
Figure 7.22 GLC chromatogram of the crude extract from the Wittedrif S. chrySOCOfTUl 
border-line population. 
Figure 7.23 GLC chromatogram of the crude extract from the Robinson Pass S. 
paniculatus population. 
Figure 7.24 GLC chromatogram of the crude extract from the Tradouw Pass S. 
paniculatus population. 
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Figure 7.19: GLC chromatogram of the crude extract from the Grahamstown S. 
chrysocoma population. 
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Figure 7.20: GLC chromatogram of the crude extract from the Van Stadens River dams 
S. chrysocoma population. 
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Figure 7.21: GLC chromatogram of the crude extract from the Prince Alfred's Pass S. 
chrysocoma border-line population. 
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Figure 7.22: GLC chromatogram of the crude extract from the Winedrif S. chrysocoma 
population. 
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Figure 7.23 : GLC chromatogram of the crude extract from the Robinson Pass S. 
paniculatus population . 
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